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ABSTRACT
The rise of terrorism has created an interest in better ways to detect when humans
are exposed to neurotoxins, especially nerve gases developed for military use, most of
which are acetylcholinesterase inhibitors. Many current methods of detection are based
on mass spectrometry, a method that is cumbersome and not particularly robust when
used as an early warning method. The detection of acetylcholinesterase inhibitors would
benefit from a combined model of the processes occurring in the neuromuscular junction
between the presynaptic action potential and the motor end-plate action potential that
includes the kinetics of acetylcholine and acetylcholinesterase in the synaptic cleft. The
ability to simulate the impact of different amounts of neurotoxin on the physiological
processes needed for the generation of an action potential and subsequent muscle
contraction would allow better estimates on the physiological toxicity of a nerve agent
and its impact on an organism.
The goal of this research was to assist the future development of a unified model
and simulation of the chemical kinetics and electrical dynamics occurring in the synaptic
cleft during acetylcholinesterase inhibition by neurotoxins. The first objective towards
the goal of this research was to develop an accurate and useful model of the kinetics of
acetylcholinesterase inhibition that can be simulated and coupled to the voltage and
current signals generated by a neuron. A one dimensional diffusion model was used
which took advantage of geometric symmetry to focus on the dominant transport effects.
iii
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It will be shown that the simulation herein can reproduce the work of earlier
research in depicting the time and spatial course of a normal action potential, and the time
and spatial

course

of action potentials

influenced

by different

degrees

of

acetylcholinesterase inhibition. This is the first simulation to achieve a model of
acetylcholinesterase inhibition during the diffusion of a neuro-toxic inhibitor into the
neuromuscular junction, and show the altered subsequent action potentials. Also
illustrated will be how this simulation could detect the time and space dynamics of
moving concentration gradients in the neuromuscular junction under suitable conditions.
In addition, an in vivo simulation of inhibited acetylcholinesterase being returned to the
active state through the kinetics of pralidoxime therapy will be shown. The mathematical
method used in these simulations easily generalizes to a complete three dimensional
transport model of the diffusion-reaction processes occurring in the neuromuscular
junction.
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CHAPTER 1

INTRODUCTION
The rise of terrorism has created an interest in better ways to detect when humans
are exposed to neurotoxins, especially nerve gases developed for military use, most of
which are acetylcholinesterase inhibitors [1], [2]. Military acetylcholinesterase inhibitors
are usually organophosphorus-type (OP) compounds. Many current methods of detection
are based on mass spectrometry, a method that is cumbersome and not particularly robust
when used as an early warning method. The ability to detect acetylcholinesterase
inhibitors would benefit from a combined model of the processes occurring in the
neuromuscular junction between the presynaptic action potential and the motor end-plate
action potential that includes the kinetics of acetylcholine and acetylcholinesterase in the
synaptic cleft. The ability to simulate the impact of different amounts of neurotoxin on
the physiological processes needed for the generation of an action potential, and
subsequent muscle contraction would better estimate the physiological toxicity of a nerve
agent and its impact on an organism.
Chemical warfare agents, particularly nerve gases, present a potential threat to
military personnel in theater and a definite threat to civilian populations at home. While
considerable concern for this threat exists, the early detection of nerve agents and
determination of their effects when present in the environment in differing quantities is
problematic at this time.
1

2
Determining the physiological effects of specific quantities of neural-toxin on the
generation of an action potential and the subsequent muscle contraction requires the
development of an integrated model that encompasses both the chemical kinetics within
the gap between the synaptic terminal and the motor end-plate; and the electrical
dynamics of the excitable motor nerve fiber and the excitable muscle fiber. This
combined modeling and simulation approach is what has been lacking so far. There has
been extensive research associated with developing models of the activity of excitable
neuron and muscle cells [3]-[9], and the kinetics associated with the inhibiting effects of
the neural toxins on acetylcholinesterase in the synaptic gap [10]-[17]. However, no work
has been published that presents a combination of those processes. The goal of this
research is to develop a unified model and simulation of the chemical kinetics and
electrical dynamics occurring in the synaptic cleft during acetylcholinesterase inhibition
by neurotoxins.
Several research teams have modeled the electro-chemical processes in the
neuromuscular junction during a normal action potential event [18]-[20], and they have
also examined how the activity of uniformly inhibited acetylcholinesterase affects the
length of the action potential and end-plate currents [21]-[25]. The simulation herein is
the first to model or address:
•

The effects of acetylcholinesterase inhibitors diffusing into the junction
during the action potential while the action potential occurs.

•

The effects of non-uniformly inhibited acetylcholinesterase in time and
space on the duration of the overall action potential.
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•

The space and time distribution of each state of the acetylcholine receptors
in the neuromuscular cleft.

•

The

potential

efficacy

of

the

regeneration

of

deactivated

acetylcholinesterase in the neuromuscular junction via oxime reaction
kinetics as a method of therapeutic recovery from OP exposure.
The point where activity is transmitted from one cell to another cell is called a synapse.
The general components of any biological synapse are called the presynaptic terminal,
the postsynaptic terminal, and the synaptic gap (or cleft), which separates them. Nerve
cells can be a part of two types of synapses, in one case a neuron connects to another
neuron, and in the other a motor-neuron connects to a muscle-cell. This work concerns
the case of a neuron connecting to a muscle-cell, called the neuromuscular junction, and
it is in this region that a neuron signals a muscle fiber to contract. The neuromuscular
junction consists of three main portions: the neuron (presynaptic terminal), the portion of
the muscle's outer membrane (sarcolemma) where the neuron is connected, called the
motor end-plate (postsynaptic terminal), and the cleft separating them where the
chemistry of muscle movement is initiated. An electron micrograph image of a crosssection of the neuromuscular junction is shown in Figure 1.1 which depicts the major
structures comprising this organ. The section taken is normal to the plane of the cleft and
shows the relative size of the junctional folds compared to the width of the cleft. A global
illustration of the neuromuscular junction is shown in Figure 1.2, where a neuron is
attached to a muscle fiber at the motor end-plate. Figure 1.3 follows with a more detailed
view of the junction. At the neuromuscular junction, the motor-nerve fiber (presynaptic
membrane) loses its fatty myelin sheath and branches into fine terminals. Each terminal

lies in a shallow gutter-like depression on the surface of the muscle cell (postsynaptic
membrane) [14], [15].
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Figure 1.1. Electron micrograph cross-section of the neuromuscular junction [26].

Figure 1.2. A global view of the neuromuscular junction. (1) Neuron, (2) Motor endplate, (3) Musclefiber,(4) Myofibril [27].
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At the nerve-muscle synapse, the membranes of the nerve terminal and the muscle
cell are separated by a fluid filled cleft approximately 50 nanometers (nm) wide. About
every micrometer along the nerve terminal there are specialized areas which are
associated with clusters of tiny vesicles, each containing on the order of 10,000 molecules
of the neurotransmitter acetylcholine (C7HK5NO2). In the muscle membrane, directly
opposite from the vesicle clusters, are deep invaginations called junctional folds. At the
crests of these folds and part of the way down into them are the acetylcholine receptors.
These receptors are specialized protein molecules embedded in the membrane of the
motor end-plate and can be found anywhere on the surface of a muscle cell [17], [18].
The receptors are tightly packed in these regions, and their density falls off by a factor of
at least 100 only a few micrometers from the crest of the fold [3], [22]. Qualitatively, this
means that the receptors are densely packed and concentrated along the ridges of the
motor end-plate surface, and are very sparse in the junctional fold troughs. That
placement makes sense because the acetylcholine receptors are localized in the regions of
high acetylcholine concentration.
An impulse arriving at the presynaptic nerve terminal causes an influx of calcium
(Ca+2) ions across its membrane. This induces several hundred of the synaptic vesicles to
fuse with the presynaptic membrane at specialized regions called active zones, liberating
the vesicles' content of acetylcholine molecules into the synaptic cleft [14]. The
transmitter diffuses rapidly across the cleft to the muscle cell membrane, where it
combines with the embedded receptor molecules. Each receptor can bind two
acetylcholine molecules, and the acetylcholine molecules stay attached for about 1
millisecond (ms) [17], [23].

6

Figure 1.3. Detailed view of the neuromuscular junction. (1) neuron, (2) Sarcolemma, (3)
Synaptic vesicles, (4) Acetylcholine receptor, (5) Mitochondrion, the mitochondria
supply the energy needed for all cellular processes [28].

Within 0.3 milliseconds after each acetylcholine packet or vesicle load is released,
it causes approximately 2,000 receptors in the muscle-cell membrane to change their
conformation into an open state. In this open state, the receptors are channels which can
pass both sodium (Na+) and potassium (K+) ions through the membrane. This flow of ions
(Na+ into the muscle, and K+ out) gives rise to a net electric current that short-circuits the
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normal potential of-90 millivolts (mV) across the resting cell membrane [15]. This brief
depolarization is known as the end-plate potential or the excitatory postsynaptic
potential. Under normal conditions, the end-plate potential exceeds the threshold value
for initiating an impulse that spreads through the entire muscle-cell membrane and causes
the muscle-cell to contract. Other protein structures in the membrane powered by
adenosine triphosphate (ATP), called protein pumps, actively transport Na+ and K+ ions
continuously through the membrane in their opposite directions, respectively. This
simultaneous process consumes energy and restores the depolarized membrane back to its
normal resting potential when the open receptors return to their closed state [29], [30].
Acetylcholine molecules would linger in the synaptic cleft, diffusing from one receptor to
another on the post-synaptic membrane and opening additional channels, if it were not for
the enzyme acetylcholinesterase, which catalytically breaks acetylcholine down into
acetate and choline molecules. The molecules of this enzyme are not embedded in the
muscle cell membrane like the acetylcholine receptors; instead, they are immobilized
within a loose matrix of collagen and mucopolysaccaride fibers that extend throughout
the synaptic cleft and deep into the junctional folds [5], [6], [23]. Acetylcholinesterase
destroys about a third of the acetylcholine molecules before they even reach the receptors
and then rapidly cleaves those remaining as they detach from the receptors. The speed
with which acetylcholine is bound to the receptors and inactivated makes it possible for
the entire process of neuromuscular transmission to be repeated up to several hundred
times per second [22].
The acetylcholine receptor belongs to a family of cell membrane embedded
proteins called ligand-gated ion channels, where ligand refers to an effector molecule
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when it binds to a specific site on a target protein [31]. The receptor, which binds the
effector(s), and the ion channel are part of the same nanomolecular protein complex. The
ion channel is embedded in the membrane, and the receptor protrudes above the
membrane. The best known members of this group respond to the extracellular
neurotransmitters acetylcholine, glycine, Y-aminibutyric acid (GABA), and glutamate,
and mediate rapid synaptic transmission in the central and peripheral nervous systems.
Many of these ligand-gated ion channels share a common structure whose subunits have
homologous protein sequences [30]. Most acetylcholine receptors used in experimental
research are obtained from the electricity generating organs of the marine ray Torpedo
marmarota and the famous Amazonian electric eel (Electrophorus electricitus). These
fish use their electric organs for electrogenesis and electroreception during the activities
of hunting, navigation, and defense, but the details of the electroreception mechanisms
are not yet well understood [30], [31]. The electric organs are built up from charge
generating cells called electrocytes, or electroplaxes (an older term). Electrocytes are flat
disk-shaped cells that are stacked in sequence in a similar manner to a battery. The
electric organ consists of vertical stacks of several thousand electrocytes that are
innervated by a cholinergic nerve on one surface. Stimulation of the nerve causes
depolarization of the innervated face of each electrocyte, producing a potential difference
between the two sides of the cell. The potentials across the cells in each column add to
produce a large electric discharge. The cells function by pumping Na+ and K+ ions out of
the cell with ATP powered transport proteins to build up a resting potential, and
acetylcholine is secreted to open the receptors and equilibrate the ionic concentration
with the environment outside the cell. Postsynaptically, electrocytes work much like

9
muscle cells, but an electric charge is emitted instead of a kinetic contraction. The
membranes of electrocytes are packed with acetylcholine receptors. These receptors can
be purified from electrocyte membranes for protein sequence and cloning experiments, or
the entire membrane with the embedded receptors intact can be used for receptor function
experiments [31], [32], [33].
The acetylcholine receptor is comprised of five subunits; three are designated as
/?, 8, and y, and two with identical structure designated as a. Each a-unit can bind one
acetylcholine molecule at a special acetylcholine binding site. These receptors are
normally closed in the absence of ligand binding, and can open within approximately 20
microseconds of an appropriate ligand binding event. The receptor subsequently closes
after dissociation of at least one ligand from the receptor. Figure 1.4 below shows the
general structure of the acetylcholine receptor. The protein structure and sequence of
ligand-gated ion channels is a broad and complex discipline with many good references
available [33], [35], [36].
The response of the acetylcholine receptor can be separated into two steps. Each
receptor, which is normally in the closed state, binds two acetylcholine molecules, one to
each subunit a, to form what is called a ligand-receptor complex. After binding, this
complex undergoes a conformation transition which opens a pore into the muscle
membrane that is permeable to Na+, K+, and Ca+2. The binding and unbinding steps are
relatively slow; transitions to and from the open state of the pore are, in contrast,
relatively rapid. Thus, channel openings occur in short bursts which can last several
milliseconds, and which represent the lifetime of the ligand-receptor complex. During the
burst, the channel flickers open and shut [29], [32], [33].
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Figure 1.4. The structure and function of the acetylcholine receptor, while embedded in
the cellular plasma membrane [34].

If the receptor is exposed to acetylcholine or other molecules which mimic the
function of acetylcholine (agonists) for a period of seconds or minutes, then the receptor
becomes desensitized or unresponsive [32], [33]. Conversion of the ligand-receptor
complex to the desensitized state occurs at a rate that is influenced by the extracellular
concentration of Ca+2 and other factors. Receptor desensitization is responsible for the
paralyzing effect of anti-cholinesterase drugs which, by inhibiting acetylcholinesterase,
prolong the lifetime of acetylcholine in the synaptic cleft [31], [33].
The rapid depolarization and re-polarization events which constitute the manytimes-per-second neuromuscular transmission process are possible, in part, because of the
activity of the cholinesterase protein. There are at least two kinds of cholinesterases
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found in humans: acetylcholinesterase, and butyrylcholinesterase. The difference
between them is that each has a preference to react with its root-named effector molecule
(the substrate), acetycholine and butyrylcholine, respectively [36]. Acetylcholine and
butyrylcholine are both transmitter-type molecules with similar chemistry, and each
cholinesterase can react with the other's substrate as well, though not preferentially.
Acetylcholinesterase is found primarily in the blood and neural synapses, while
butyrylcholinesterase is located primarily in the liver [36], [37].
While the consensus in the research literature agrees that acetylcholine is hydrolyzed
by cholinesterases, none of them have determined exactly how many cholinesterases exist
in the body and their quantity, or their precise distribution [37]. For most purposes,
distinguishing between acetylcholinesterase and butyrylcholinesterase is sufficient.
Current

evidence

suggests that

in lower

animal

forms

butyrylcholinesterase

predominates, gradually giving way to acetylcholinesterase with evolution. Although
their molecular forms are similar, the two enzymes are distinct entities, encoded by
specific genes. An interesting criterion for differentiating these enzymes is the substrate
concentration versus activity relationship which will be described in Chapter 3, where the
fundamentals of enzyme chemistry and kinetics will be discussed [37].
As stated earlier, the function of acetylcholinesterase is to deactivate
acetylcholine. This is accomplished via a hydrolysis (water using) reaction that cleaves
acetylcholine into the molecules choline (C5H14NO) and acetic acid (CH3COOH). The
molecular weight of acetylcholinesterase is approximately 7,500,000 grams per mole
[37]. Like most enzymes, acetylcholinesterase is a large polymer where the conformation,
and inter-molecular and intra-molecular forces of its structure play important roles in its
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function. Because of these conditions, the portion of this molecule where its chemical
activity is located may be significantly smaller than the body of the entire molecule (in
other cases, the entire molecular body may be used to build the active region). In
addition, the molecule could have multiple active regions. Consequently, descriptions of
the chemical kinetics of enzymes usually focus on their active sites: their characterization
and number rather than quantifying the properties of individual enzyme molecules [38],
[39].
The structure of acetylcholinesterase is shown in Figure 1.5. This illustration is
intended to give the reader a general idea of the relative size and complexity of protein
enzymes. The position of the active site is indicated by the cluster of spheres in the
center. In this dissertation, the function of acetylcholinesterase is the focus rather than
issues related to the protein's structure and conformation. The interested reader is invited
to examine the following references for more information on protein structure: [41], [42],
[43].
The activity of acetylcholinesterase is extremely high. Each active site of this
enzyme is able to hydrolyze approximately 14,000 acetylcholine molecules per second at
normal body temperature [39], which is also close to the theoretical number of molecular
collisions at that same temperature [41]. Typical chemical reactions depend on the
number of collisions between molecules and their orientation relative to each other. Some
orientations result in a reaction and some do not. Thus, most feasible reactions depend on
a high number of collisions to proceed at a rate that scientists would have a reason to find
interesting.
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Figure 1.5. The structure of acetylcholinesterase, showing the conformations of the
primary and secondary structure, and the location of the active site [40].

For acetylcholinesterase, this high activity means that essentially every collision
between acetylcholinesterase and acetylcholine molecules results in a reaction, and
enzymes with that property are termed diffusion limited. Qualitatively, this means the
reaction speed of acetylcholinesterase is controlled only by how quickly acetylcholine
molecules can reach the active sites. Some enzymes are thought to accelerate catalysis to
this limit by using dipolar electric fields to pre-orient their substrate to the optimal
position as it is drawn in to the enzyme's active site [39], [41]. The ability to catalyze a
reaction with every substrate collision also makes acetylcholine a very reliable enzyme,
and reliability is a useful and important attribute for an enzyme whose function is such an
integral part of movement and cognition.

CHAPTER 2

ENZYME KINETICS FUNDAMENTALS
A chemical reaction is a process where a substance (or substances) is changed
into one or more new substances. A chemical equation is the method used to represent a
chemical reaction in a standard way, and it uses symbols to show what happens during a
chemical reaction. In a chemical equation, the reactants are conventionally written on the
left and the products on the right of the reaction arrow. A more general definition is to
say that the arrow points away from the reactants and towards the products.
Any chemical reaction can be represented by the general equation
reactants —* products

(2.1)

This equation tells that during the course of a reaction, reactants are consumed while
products are formed. As a result, the progress of a reaction can be followed by
monitoring either the decrease in concentration of the reactants or the increase in
concentration of the products.
Chemical equations are almost always written in a way that conserves the total
number of atoms which are depicted on the reactant and product sides of the reaction
arrow, referred to as a balanced stoichiometric equation. A stoichiometric equation can
be very simple with two species in one reaction:
30 2 -* 20 3
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(2.2)
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Or several reactant species and product species in one reaction:
4/V//3 + 50 2 -» 4N0 + 6H20

(2.3)

In general, a balanced stoichiometric reaction equation can be represented in the
following form:
aA + bB <-> cC + dD

(2.4)

Where the upper case letters A, B, C, and D represent the molecular formula of each
chemical species participating in the reaction, and the lower case letters a, b, c, and d are
called the stoichiometric coefficients, and represent the number of molecules of each
participating species. Any subscript numbers which might appear in a molecular formula
represent the number of atoms of each different atomic species in that molecule which is
represented by the formula.
If a number of reactants and products are involved in several different reactions
which are combined in a stoichiometric reaction network, then there exists a coupled
system like the following:
S02 ->S+ 02

(2.5)

2 5 + 30 2 -» 2S03
S03 + H20 <-> tf2S04
Biological processes are well known (notorious even) for the complexity and size
of their chemical reaction networks. Chemical networks which describe metabolism may
easily contain several hundred species, many of which are enzymes.
Enzymes are proteins which function as catalysts in chemical reactions. A catalyst
is a substance which can increase the speed and yield of a chemical reaction without
being a reactant or product in the reaction. Because enzymes are proteins, they are
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typically involved in cellular reactions and are of primary importance in metabolic
pathways. Ordinarily, these metabolic reaction cascades would need large amounts of
energy (heat) to proceed. Enzymes allow these reactions to take place at rapid rates and
lower temperatures. Enzymes are also known to be highly specific for both substrate and
reaction type. The basic lock and key theory describes this process as illustrated in Figure
2.1. It assumes that the structure of the enzyme and substrate molecules explain the
specificity and inhibition features observed in enzymatic reactions. In particular, an
enzyme joins with its substrate and lowers the energy requirements for activation of the
reaction, then the reaction occurs, after which the enzyme is then released unchanged and
used again.
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Figure. 2.1. The lock and key theory of enzyme function. The synthesis reaction creates a
larger molecule from smaller molecules. The breakdown reaction breaks a large molecule
into smaller parts. Both reaction types are equally common in biology [44].
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While this model explains enzymes' specificity, it fails to explain the stabilization
of the transition state that enzymes achieve. Daniel Koshland [45] suggested a
modification to the lock and key model. Since enzymes are rather flexible structures, the
active site can be reshaped by interactions with the substrate as the substrate interacts
with the enzyme. As a result, the amino acids which make up the active site are molded
into the precise positions that enable the enzyme to perform its catalytic function. In
some cases, such as glycosidases, the substrate molecule also changes shape slightly as it
enters the active site.
Consider a single enzyme-plus-substrate-to-product reaction:

E+sKE.s5£+f

<2-6>

where it is assumed that an intermediate substrate-enzyme complex E-S is formed.
Further, the reaction E-S —>• E + P is assumed irreversible. While multiple active site
enzymes occur and have a developed kinetic theory, the typical enzyme reaction involves
1:1 stoichiometry: one active site per enzyme molecule and one molecule substrate
creates one molecule product. Some other important kinetic assumptions are:
(1) Only initial reaction rates are considered. These rates decrease with time due
to the decline in substrate concentration. However, this effect can be ignored with
the proper experimental technique.
(2) There is an excess of substrate concentration in the reaction with the enzyme.
The rate constant kE+2 is small compared to kE.j and thus the reaction E +S *-*•
E-S reaches equilibrium quickly and maintains this equilibrium throughout the
overall reaction.
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After a negligible time, the rate of formation and dissociation of the complex ES
becomes and remains very small compared to the rate of changes for S and P, which is
the "quasi-steady state" assumption. The Michaelis-Menten derivation [42] uses these
assumptions to apply mathematical techniques that simplify the kinetic equations for the
system. Because of the computing power presently available, it will not be required to
apply these simplifications to the model proposed herein.
While enzymes have evolved to react specifically with a particular (or small set
of) substrate(s), there also exist molecules which can bind with an enzyme and decrease
or increase its activity. Molecules which decrease an enzyme's activity are called
inhibitors, and those which increase its activity are called activators. Enzyme inhibitors
are more common than the activators.
The inhibitor binding process can obstruct the substrate reaching the enzyme's
active site and/or impede the enzyme catalysis reaction. Inhibitor binding is defined as
either reversible or irreversible, though the distinction between these terms is not absolute
and may be difficult to make if the inhibitor-enzyme complex is highly stable. If the
effect of an inhibitor can be changed by varying the concentration of the inhibitor, then
the inhibition is said to be reversible because of the invocation of LeChatier's principle
[42]. There are three main classes of reversible inhibition: competitive, non-competitive,
and mixed. The classification is correlated according to the type of effect on the enzyme
kinetics when the inhibitor's concentration is varied. This investigation will focus on
irreversible inhibition. Several researchers have described the fundamental kinetics of
reversible inhibition, and unless specifically stated otherwise, their work will form the
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framework for this area throughout the remainder of this dissertation, [39], [42], [46],
[47].
Irreversible inhibitors usually covalently modify an enzyme. Thus, the inhibition
cannot be reversed with concentration changes and equilibrium. Two typical
stoichiometric equations involving irreversible inhibitors are shown below (with
chemical symbol definitions offered in the text following):
E + / «-i

kEtl

E-S

+ I «-±

1E•I - ^

fcB-!

E

• /•

kdead

* E • S • / -=^ E • /* + S

V" '>

O Q\

^-^

Irreversible inhibitors are also different from irreversible inactivators. For example, in
extreme concentrations the hydroxide ion (OFT) functions as an irreversible inactivator
because it can permanently destroy (denature) the entire structure of many enzymes;
however, this effect is non-specific and is not connected to the special structure of any
particular enzyme. An irreversible inhibitor, however, is usually specific for one class of
enzyme and inhibits by altering only the active site of its target. Irreversible inhibitors
form a reversible non-covalent complex with the enzyme species (EI) or with the
enzyme-substrate species (ESI), which then reacts to produce the covalently bonded
"dead" or "poisoned" complex, E-I*. The rate at which the dead complex forms is called
the inactiviation rate, or kdead- Since formation of EI may compete with E-S, binding of
irreversible inhibitors can be prevented by competition either with substrate or with a
second, reversible inhibitor. This protection effect is good evidence of a specific reaction
of the irreversible inhibitor with the active site [42].
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In the past, highly toxic organophosphorous compounds have been developed for
use as pesticides and chemical warfare

agents. The toxic effects

of these

organophosphorous compounds are mainly due to the increased quantity of inhibited
acetylcholinesterase in the neuromuscular junction. Organophosphorous compounds
inhibit acetylcholinesterase by reacting with and altering the amino acid units that
comprise the protein sequences used to build up the enzyme's active site. In this case, the
amino acid serine is phosphylized by the phosphorus atom of the organophosphorous
compound. The inability of poisoned enzyme to hydrolyze acetylcholine results in the
accumulation of that transmitter and the subsequent over-stimulation of the cholinegeric
receptors, which is followed by the breakdown of transmission in all synapses that use
the acetylcholine/cholinegeric receptor system. Organophosphorous compounds are not
irreversible inactivators of acetylcholinesterase because they chemically modify only the
active site of the enzyme, and therefore, other chemical reactions are able to retro-modify
the active site and restore functionality to the enzyme. Restoration reactions with oxime
compounds are the most effective and best understood in biological systems [48], [49].
Oxime compounds can reactivate acetylcholinesterase by attaching to the phosphorus
atom and forming

an oxime-phosphonate which then splits away from

the

acetylcholinesterase protein molecule. Oximes have the general stoichiometric formula of
R4R2CNOH, where Rj and R2 are un-reactive organic side chains consisting only of
carbon and hydrogen atoms. Some of the most effective oxime nerve-agent antidotes are
obidoxime, pralidoxime, and methoxime. However, the effectiveness of the oxime
treatment depends on the particular nerve agent used to inhibit the acetylcholinesterase
[50], [51]. Chapters 4 and 5 will explore the chemistry and kinetics of oximes more fully.
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A stoichiometric equation makes a statement about the species population at the
beginning of a reaction and at the end, but may omit information about intermediate
kinetic steps in a complicated reaction. By itself the stoichiometric equation also says
nothing about how to follow the progress of the reaction with time, or the rates of species
population change. Chemical kinetics is the area of chemistry concerned with the speeds,
or rates, at which a chemical reaction occurs. The word "kinetic" suggests movement or
change; here, kinetics refers to the rate of a reaction, or the reaction rate, which is the
change in the concentration of a reactant or product with time.
There are many reasons for studying the rate of a reaction. To begin with, there is
intrinsic curiosity about why reactions have such vastly different rates. Some processes,
such as the initial steps in vision and photosynthesis and nuclear chain reactions, take
place on a time scale as short as 10"12 to 10"6 seconds. Others, like the curing of cement
and the conversion of graphite to diamond, take years, or millions of years to complete.
On a practical level, knowledge of reaction rates is useful in drug design, in pollution
control, and in food processing. Industrial chemists often place more emphasis on
speeding up the rate of a reaction rather than maximizing its yield. What follows is a
description of fundamental chemical kinetics and some rules which allow derivation of
kinetic rate equations from a known stoichiometric reaction or reaction network.
The equation below depicts a simple reaction in which a molecules of species A
are converted to b molecules of species B:
aA —• bB

(2.9)

In general, it is more convenient to express the reaction rate in terms of the change in
concentration with time. Thus, the simple reaction aA —* bB can be rate expressed as
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rate

=

_ I £ M or rate = ^
a At

(2-10)

b At

where A[A] and A[B] are the changes in concentration (mole/liter) over time period At.
Because the concentration of A decreases during A/, A[AJ is a negative quantity. The rate
of a reaction is a positive quantity, so a minus sign is needed in the rate expression to
make the rate positive. On the other hand, the rate of product formation does not require a
minus sign because A[B] is a positive quantity (the concentration of B increases with
time). These rates are average rates because they are averaged over a certain time period
At [52].
The rate law or rate equation for a chemical reaction is an equation which links
the reaction rate with concentrations or pressures of reactants and constant parameters
(normally rate coefficients and partial reaction orders), and is derived from the law of
mass action. In chemistry, the law of mass action has two aspects: 1) the equilibrium
aspect, concerning the composition of a reaction mixture at equilibrium, and 2) the
kinetic aspect concerning the rate equations for elementary reactions.
Taken as a statement about kinetics, the rate law states that the rate of an
elementary reaction (a reaction that proceeds through only one transition state, that is,
one mechanistic step) is proportional to the product of the concentrations of the
participating molecules. In modern chemistry, this is derived using statistical mechanics
[53].
The hypothesis that reaction rate is proportional to reactant concentrations is,

strictly speaking, only true for elementary reactions (reactions with a single mechanistic
step). In general, many reactions occur with the formation of reactive intermediates,
and/or through parallel reaction pathways. However, all reactions can be represented as a
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series of elementary reactions and, if the mechanism is known in detail, the rate equation
for each individual step is given by a particular rate expression so that the overall rate
equation can be derived from the individual steps. In biochemistry, there has been
significant interest in deducing the rate laws for chemical reactions occurring in the
intracellular medium. Although deviations of the law of mass action have been reported,
it has been shown that the law of mass action can be valid in intracellular environments
under certain conditions [54].
To determine the rate equation for a particular system, one combines the reaction
rate with a mass balance for the system. For a generic reaction A + B —• C, the simple
rate equation (as opposed to the much more common complicated rate equations) is of the
notationally simplified form:

f-^KW

(2U)

This rate equation is a differential equation, and as such it can be integrated to obtain the
integrated rate equation that links concentrations of reactants or products with time [55].
In this equation, [XJ expresses the concentration of a given species X, and k(T) is known
as the reaction rate coefficient or rate constant. Under the imposed experimental
conditions used to study chemical kinetics, this rate constant can be treated as constant. In
reality, the rate coefficient depends on many things that affect the reaction rate besides
the species concentrations. It is mainly a function of temperature, and also ionic strength,
surface area of the adsorbent and light irradiation.
The exponents m and n are called reaction orders and depend on the reaction
mechanism. The stoichiometric coefficients and reaction orders are equal only in simple,
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one step reactions. Usually, the reaction orders are determined via experimental
measurement, and can be any real number value.
In the more general case, given a known reaction or reaction network, the rate
equation for each species in the reaction(s) can be expressed as:
d[Xj]
dt

(2.12)
k

[Xh]fjh

=^\ ij^Yl
j=± \

h=i

This form is structurally very rich and general, because for the real number j ^ ^ , the
system can represent any multinomial, and thus a multidimensional Taylor series
approximation, to any continuous and differentiable rate law. In the general case, the
stoichiometric coefficients do not explicitly appear in the rate equation and are absorbed
into the rate constant. For these purposes, Equation (2.12) shows that the total rate
derivative of some particular species / is equal to the sum of the individual reaction rate
terms of that species in the reactions where it is a participant. By convention, each
reaction rate term is expressed as a function only of the reactant species participating in
that particular reaction. As a consequence, chemical species which are purely products
will not appear in their own differential rate expressions.
It should also be mentioned here that when species X( is mobile, and can diffuse
throughout the geometry of the system in a way that produces concentration gradients,
then (2.12) is modified to the form below:
dJ

^ =v•

(DAvlXtB+£

FT
h=l

}

(2J3)
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The additional term in (2.13) represents the description of the transport of species Xi in
the system. Equation (2.13) describes a reaction-diffusion system, and treatment of these
systems will be more developed in Chapter 3 [56].
The rules for deriving rate expressions from stoichiometric equations are best
illustrated by the following examples. For instructional purposes, the reaction kinetics of
these examples are assumed to be one step; thus, the stoichiometric coefficients of each
species will be explicitly included in the kinetic expressions.

Example 1:
2C0 + 02 ^ 2C02

(2ll4)

The stoichiometric equation depicts one kinetic reaction comprised of three
chemical species. Description of this system will require the development of three kinetic
rate equations: dfCOJ/dt, d[02]/dt, and d[C02]/dt.
Species CO participates in one reaction designated by rate constant kj, therefore
the kinetic rate equation for species CO will consist of one term. In reaction ki_ species
CO is a reactant, and so that term will be negative and expressed as a multiplicative
product of its stoichiometric coefficient, the rate constant kj, and all the reactant species
concentrations which participate in reaction kj, each raised to the power of their
respective stoichiometric coefficient. More explicitly, the term will be negative 2ki, times
[CO]2, times [Orf, thus: -2ki[CO]2[O2]• The complete kinetic rate equation for species
CO is shown below as:
d[CO] _
dt =

nj

r™l2r„ n

-2/qtCOm]

(2.15)
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Species O2 participates in one reaction designated by rate constant k]\ therefore,
the kinetic rate equation for species O2 will consist of one term. In reaction kj, species O2
is a reactant, and so that term will be negative and expressed as a multiplicative product
of its stoichiometric coefficient, the rate constant ki and all the reactant species
concentrations which participate in reaction ki, each raised to the power of their
respective stoichiometric coefficient. More explicitly, the term will be negative ki, times
[CO]2, times [O2], thus: -kj[CO]2[02]. The complete kinetic rate equation for species O2
is shown below as:
d

i°2]
=
dt

,. r _ l 2 r „ ,
-kx[CO]2[02]

(2.16)

Species CO2 participates in one reaction designated by rate constant kj\ therefore,
the kinetic rate equation for species CO2 will consist of one term. In reaction kj, species
CO2 is a product, and so that term will be positive and expressed as a multiplicative
product of its stoichiometric coefficient, the rate constant kj and all the reactant species
concentrations which participate in reaction k}, each raised to the power of their
respective stoichiometric coefficient. More explicitly, the term will be positive 2kj, times
[CO]2, times [O2], thus: 2ki[CO]2[O2]• The complete kinetic rate equation for species
CO2 is shown below as:
d[C02]
~ ~ =

,
2k1[CO]2[02]

(2.17)
K

}

Taken all together, the stoichiometric reaction equation, and the kinetic reaction rate
equations with their associated initial conditions are shown in (2.18):
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(2.18)

2C0 + 02 S 2C02
Kinetic reaction rate equations

Initial conditions

d[CO]
= -2/q[CO] 2 [0 2 ]
dt

[CO](0) = [CO]0
[O2](0) = [O 2 ] 0

d[Q2]
dt
d[CQ2]
=
dt

[CO2](0) = [CO2]0

2kx[CO]2[02]

Example 2:
4N0 2 + 0 2 ^ ^

2W205

( 2 - 19 )

The stoichiometric equation depicts two kinetic reactions (one forward, one
backward) comprised of three chemical species. Description of this system will require
the development of three kinetic rate equations: d[N02]/dt, d[02]/dt, and dffyOsJ/dt.
Species NO2 participates in two reactions, designated by the rate constants kj and
k.i\ therefore, the kinetic rate expression for species NO2 will be a sum of two terms. For
the reaction controlled by ki, species NO2 is a reactant, and the first term is expressed as a
negative multiplicative product of its stoichiometric coefficient, the rate constant &/, and
all the reactant species concentrations which participate in reaction kj, each raised to the
power of their respective stoichiometric coefficient, written as: -4ki[N02]4[02]For the reaction controlled by k.i, species NO2 is a product, and the second term is
expressed as a positive multiplicative product of its stoichiometric coefficient, the rate
constant k.i, and all the reactant species concentrations which participate in reaction k.i,
each raised to the power of their respective stoichiometric coefficient, written thus: 4k.
i[N20sf. The complete kinetic rate equation for species NO2 is shown below as:
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S.-^i^py +

tt.,^^

(220)

Species O2 participates in two reactions designated by the rate constants kj and k.
1; therefore, the kinetic rate expression for species O2 will be a sum of two terms. For the
reaction controlled by kj, species O2 is a reactant, and the first term is expressed as a
negative multiplicative product of its stoichiometric coefficient, the rate constant ki, and
all the reactant species concentrations which participate in reaction kj, each raised to the
power of their respective stoichiometric coefficient, written thus: -ki[N02p'[O2]'. For the
reaction controlled by k.i, species O2 is a product, and the second term is expressed as a
positive multiplicative product of its stoichiometric coefficient, the rate constant k.i, and
all the reactant species concentrations which participate in reaction k.i, each raised to the
power of their respective stoichiometric coefficient, written as: k-jffyOs]2. The complete
kinetic rate equation for species O2 is shown below as:

^

= -kdN02no2]

+ k.dNzOs?

(221)

Species N2O5 participates in two reactions, designated by the rate constants kj and
k.i\ therefore, the kinetic rate expression for species N2O5 will be a sum of two terms. For
the reaction controlled by ki, species N2O5 is a product, and the first term is expressed as
a positive multiplicative product of its stoichiometric coefficient, the rate constant ki, and
all the reactant species concentrations which participate in reaction ki, each raised to the
power of their respective stoichiometric coefficient; written as: 2kj[N02j4[02j. For the
reaction controlled by k.i, species N2O5 is a reactant, and the second term is expressed as
a negative multiplicative product of its stoichiometric coefficient, the rate constant k.i,
and all the reactant species concentrations which participate in reaction k.i, each raised to
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the power of their respective stoichiometric coefficient, written thus; -2k.i[NiOif'. The
complete kinetic rate equation for species N2O5 is shown below as:
d[N2Q5]
l4r_ .
— — — = 2fc1[ArO2]4[02] -

r

(2.22)

12

2k_x[N2OsY

Taken all together, the stoichiometric reaction equation, the kinetic reaction rate
equations, and their associated initial conditions are shown in (2.23):
( 2 - 23 )

4N02 + 02 *^—i 2N205
Kinetic rate equations

Initial conditions

d[N02]_
„,, r _ l 4 r n l ^
r w n l 2
= -4fc 1 [iV0 2 ] [0 2 ] + 4fc. 1 [iV 2 0 s ]'
dt

[NO2](0) = [NO2]0

d

\-°2\ _

dt

^M

u r„„

i4r« i . ,.

r„

12

= -fci[^02] 4 [0 2 ]+fc-i[^20n5 ]'

= 2kl[N02n02] - 2^[N205r

MP)

=

Mo

^ ° ^ = ^Jo

Example 3:
2NH3 4 yv2 + 3// 2

(2.24)

2/V02 + 7//2 ^ 2N//3 + 4H20
N2 + 202 ^ 4 2W02
The stoichiometric equation depicts four kinetic reactions (distributed among
three equations) comprised of six chemical species. Description of this system will
require the development of six kinetic rate equations: d[NHi]/dt, d[N2]/dt, d[H2]/dt,
d[N02]/dt, d[H20]/dt, and dfOJ/dt.
Species NH3 participates in two reactions, designated by the rate constants k] and
k2; therefore, the kinetic rate expression for species NH3 will be a sum of two terms. For
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the reaction controlled by ki, species NH3 is a reactant, and the first term is expressed as a
negative multiplicative product of its stoichiometric coefficient, the rate constant k], and
all the reactant species concentrations which participate in reaction ki, each raised to the
power of their respective stoichiometric coefficient, written as: -2ki[NHi]2. For the
reaction controlled by kz, species NH3 is a product, and the second term is expressed as a
positive multiplicative product of its stoichiometric coefficient, the rate constant &?, and
all the reactant species concentrations which participate in reaction fe, each raised to the
power of their respective stoichiometric coefficient, written thus: 2k2[NOrf*'fHj'''. The
complete kinetic rate equation for species NH3 is shown below as:

d

Jm=.2kl[NH3?+2k2[N02nH2r

p-*)

Species N2 participates in three reactions designated by the rate constants ki, k3
and k.3; therefore, the kinetic rate expression for species N2 will be a sum of three terms.
For the reaction controlled by kj, species N2 is a product, and the first term is expressed
as a positive multiplicative product of its stoichiometric coefficient, the rate constant kj,
and all the reactant species concentrations which participate in reaction kj, each raised to
the power of their respective stoichiometric coefficient, written as: ki[NH3]2. For the
reaction controlled by £3, species N2 is a reactant, and the second term is expressed as a
negative multiplicative product of its stoichiometric coefficient, the rate constant fcj and
all the reactant species concentrations which participate in reaction £3, each raised to the
power of their respective stoichiometric coefficient, written thus: -ksffy][O2]2. For the
reaction controlled by k.3 species N2 is a product, and the third term is expressed as a
positive multiplicative product of its stoichiometric coefficient, the rate constant k.3, and
all the reactant species concentrations which participate in reaction k.3, each raised to the
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power of their respective stoichiometric coefficient, written thus: k.3 [NOJ2. The
complete kinetic rate equation for species N2 is shown below as:
^

= kl[NH3r

- k3[N2][02?

+ k_3[N02}*

(2 26)

-

Species H2 participates in two reactions, designated by the rate constants kj and
kf, therefore, the kinetic rate expression for species H2 will be a sum of two terms. For
the reaction controlled by ki, species H2 is a product, and the first term is expressed as a
positive multiplicative product of their respective stoichiometric coefficient, the rate
constant kj, and all the reactant species concentrations which participate in reaction ki,
each raised to the power of its stoichiometric coefficient, written as: 3ki[NHs]2. For the
reaction controlled by k2, species H2 is a reactant, and the second term is expressed as a
negative multiplicative product of its stoichiometric coefficient, the rate constant k2, and
all the reactant species concentrations which participate in reaction fo, each raised to the
power of their respective stoichiometric coefficient, written as follows: -7k2[N02] [H2] .
The complete kinetic rate equation for species H2 is shown below as:

$M = 3kl[NH3r - 7k2[N02r[H2]7

(Z27)

Species NO2 participates in three reactions designated by the rate constants k2, k$
and L3; therefore, the kinetic rate expression for species NO2 will be a sum of three terms.
For the reaction controlled by k2, species NO2 is a reactant, and the first term is expressed
as a negative multiplicative product of its stoichiometric coefficient, the rate constant fe,
and all the reactant species concentrations which participate in reaction k2, each raised to
the power of their respective stoichiometric coefficient, written as: -2k2[N02]2[H2]7. For
the reaction controlled by ki, species NO2 is a product, and the second term is expressed
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as a positive multiplicative product of its stoichiometric coefficient, the rate constant fa,
and all the reactant species concentrations which participate in reaction fa, each raised to
the power of their respective stoichiometric coefficient, written thus: 2fa/7V^'[Orf1'. For
the reaction controlled by k.3 species NO2 is a reactant, and the third term is expressed as
a negative multiplicative product of its stoichiometric coefficient, the rate constant k.3,
and all the reactant species concentrations which participate in reaction k.3, each raised to
the power of their respective stoichiometric coefficient, written thus: -2k.3 [N02]2- The
complete kinetic rate equation for species NO2 is shown below as:

^

1

= -2k2[N02f[H2V

+ 2k3[N2][02]2 - 2fc_3[JV02]2

(2 28)

'

Species H2O participates in one reaction designated by the rate constant fa. For
the reaction controlled by fa, species H2O is a product, and the first term is expressed as a
positive multiplicative product of its stoichiometric coefficient, the rate constant fa, and
all the reactant species concentrations which participate in reaction fa, each raised to the
power of their respective stoichiometric coefficient, written thus: 7k2[NOJ [HJ . The
complete kinetic rate equation for species H2O is shown below as:

«

= 7*,fl«UW

(229)

Species O2 participates in two reactions, designated by the rate constants fa and k.
3; therefore, the kinetic rate expression for species O2 will be a sum of two terms. For the
reaction controlled by fa, species O2 is a reactant, and the first term is expressed as a
negative multiplicative product of its stoichiometric coefficient, the rate constant fa, and
all the reactant species concentrations which participate in reaction fa, each raised to the
power of their respective stoichiometric coefficient, written as: -2fa/7V2/[O2J2'. For the
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reaction controlled by k.3, species O2 is a product, and the second term is expressed as a
positive multiplicative product of its stoichiometric coefficient, the rate constant k.3, and
all the reactant species concentrations which participate in reaction k.3, each raised to the
power of their respective stoichiometric coefficient, written thus: lk.3 [NO2]2. The
complete kinetic rate equation for species O2 is shown below as:
^

= -2k3[N2][02r

+

(230)

2k_3[N02]*

Taken all together, the stoichiometric reaction equation, and the kinetic reaction rate
equations with their associated initial conditions are shown in (2.31):
( 2 - 31 )

2NH3 ^ N2 + 3// 2
2N02 + 1H2 ^ 2NH3 + 4H20
N2 + 202 ^ 1 2iV02
Kinetic Rate Equations

*M=kl[NH3r

- UNMJ+k.3[No2r

$M=3kllmr
-

- 7k2[No2nH2r

Initial conditions

^

- ™°

[HJ(0)

= [HJ »

2k_3[N02]2

iM-TfeW^

lH2Om

= [H2O]0

at

d

-^=-2k3[N2][o2r+2k_3[No2r

MTO - M.
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It has been shown that the rules of mass action kinetics can be used to develop
model equations of the kinetics of a given stoichiometric reaction network in a
straightforward fashion. The stoichiometric reaction coefficients of the chemical species
were also shown to correlate to the reaction order (species concentration exponent) in the
derived rate equations, and this is true for elementary single step reactions, but not true in
general. In balanced stoichiometric equations the stoichiometric coefficients are
expressed as the simplest collective set of whole numbers for convenience. In general,
stoichiometric coefficients are not necessarily connected to the reaction order. The
explicit substitution of the stoichiometric coefficients as concentration exponents and
kinetic rate coefficients in the preceding examples was used as a device to clarify the
relations between the reaction networks and their coupled differential rate equations. To
illustrate, the application of fundamental molecular collision theory to reaction network
(2.31) suggests that seven H2 molecules and two NO2 molecules coming together
simultaneously in the correct proximity and orientation is an unlikely event. This reaction
probably occurs in several steps. In practice, the concentration exponents are replaced by
additional unknown parameters which must subsequently be determined by experiment,
and the stoichiometric coefficients are incorporated into the kinetic rate constant (also
determined by experiment). Models based on mass-action kinetics have the advantage of
being determined directly from the elemental reactions and their stoichiometry. However,
a detriment is the fact that a large number of rate constants and other parameters must be
determined in order to implement the model. In many cases, these elemental reactions are
not experimentally observable and the parameters would thus be difficult to acquire.

CHAPTER 3
MODEL DEVELOPMENT
The synaptic chemical transmission is an important part of the transport of
neuronal signals, and investigation of the molecular events was instrumental in creating
neurotransmitter theory. Analysis of such behavior can be best accomplished with the
transmission

process

represented

as

a

reaction-diffusion

simulation

for

the

neurotransmitter because experimental analysis is impractical for the molecular processes
in the cleft. Unless great care is taken, the tools used to collect the data can disrupt the
physical system so badly that it ceases natural function. Several mathematical models for
the dynamic behavior of acetylcholine in spontaneous generation of the action potential at
the neuromuscular junction have been implemented to analyze the transient process of the
synaptic chemical transmission. In the model of Rosenberry [5], the radial diffusion of
acetylcholine is treated in two axis-symmetrical compartments with homogeneity in the
transverse direction, while Thomas and Friboulet [57] used a model where the transverse
coordinate diffusion gradient was discretized and the effects of radial diffusion out of the
cleft were described as a uniform sink term. Models where the reaction-diffusion of
acetylcholine is developed in a volume consisting of two space variables r and x,
representing the radius and axis respectively, and the diffusion is symmetric about the
axis, have also been published [5]. A report by Naka and Shiba [58] described a two
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dimensional compartment model to examine the effects of transverse and radial diffusion
of acetylcholine on the transient behavior of the molecular dynamics of the action
potential event. The transmission process is represented as a reaction-diffusion system, in
which the acetylcholine concentration varies with time and position in a two dimensional
space between the axis-symmetrical discs of the synaptic cleft. The variation in
concentration of the open channel form of the receptor in response to the interaction of
receptor with incoming acetylcholine corresponds to transient evolution of the action
potential. Naka and Shiba [58] did much analytical development and support of
simplifying assumptions and modeling techniques which helped unravel the complexities
of simulating the neuromuscular action potential event; thus, their work was an integral
part of the development of the Jenkins-Szlavik model. This researcher was able to seize a
number of concepts and propositions and apply them to the pertinent portions of the
model herein which will show simulation of the key issues of the transient
neurotransmission process under the influence of acetylcholinesterase inhibitors, and the
therapeutic regeneration of inhibited acetylcholinesterase.
Based on an optimal selection of the subdivision numbers and critical radius for
their simulation, Naka and Shiba [58] proposed a minimal compartment model which
was comprised of three compartments in the transverse direction and ten compartments in
the radial direction, in a disc with 500 nm radius and 50 nm in height. Evaluation of
varying diffusion coefficients suggested anisotropic diffusion for this model to represent
the characteristic behavior of the chemical neurotransmission process. Their proposal of
anisotropic diffusion provides a solid case demonstrating that radial diffusion has
stronger effects than axial diffusion on the processes occurring in the neuromuscular
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junction. For this reason Jenkins chose to ignore axial diffusion in this model, and
discretized the cleft volume into 20 annular compartments. Jenkins found that the results
of the simulation did not become any smoother at compartment numbers larger than
twenty. This choice gave a benefit of simpler computations and still captured the essential
character of the dynamics involved in the generation and inhibition of the action potential
[58].
Jenkins assumed the neuromuscular junction as a whole to have the general shape
of a cylinder where the radius is approximately 10 times that of the height. To illustrate
this concept, consider a coin, one face represents the presynaptic membrane, while the
other face represents the postsynaptic membrane, as shown in Figure 3.1 below.

Presynaptic membrane, outer
surface

I
i

Postsynaptic membrane, inner
50 nm

Figure 3.1. A schematic diagram of the neuromuscular junction geometry used in the
model. The dimension of width is exaggerated for clarity.
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The material between each face has been removed such that the edge of the coin
becomes a void which represents the cleft that separates the presynaptic membrane and
the postsynaptic membrane (motor end-plate). The result is a model of the cleft as a very
thin disk comprised of two circular plates separated by a space of 50 nm, with a radius of
500 nm, and open to the environment along the circumference. The coordinate system is
embedded such that a line connecting each membrane through their respective centers
represents the direction along the axis, designated by the variable x; and the direction
normal to this axis, along the radius and which terminates at the circumference, is
designated by the variable r. As shown in Figure 3.2, acetylcholine vesicles are modeled
as a cylindrical shape entering the cleft through the surface of the presynaptic membrane
at the center. The pulse of acetylcholine is assumed to enter the cleft, instantaneously
diffuse axially across the cleft to the motor end-plate, and then diffuse radially towards
the circumference of the membranes and then into the environment. The radial diffusion
process is assumed to be angularly symmetric about the axis. It should be mentioned here
that in reaction-diffusion systems with anisotropic diffusion, it is important to make a
distinction between directions where diffusion occurs at some finite rate, and those
directions where the diffusion is modeled as instantaneous. Instantaneous diffusion is
often termed instantaneously well mixed or instantaneous uniform concentration.
The acetylcholine receptors are immobilized in the surface of the postsynaptic. A
schematic representation of this transport model is shown in Figure 3.3, as viewed along
the axis and normal to the surface of the cleft. The enzyme acetylcholinesterase is
assumed to be uniformly distributed and immobilized throughout the volume of the cleft,
and reacts with acetylcholine as it diffuses out of the cleft.
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Acetycholine pulse

Figure 3.2. The shape and diffusion of the acetylcholine pulse, and the relative location of
the acetylcholine receptors in the neuromuscular junction model.

The inhibitor and oxime species are each modeled as diffusing into the cleft from
the environment through the edge and towards the center, through the same series of
concentric annuli. None of the chemical species in this reaction-diffusion system are
allowed to permeate through both the presynaptic and postsynaptic membranes in either

the positive axial direction (postsynaptic membrane) or the negative axial direction
(presynaptic membrane).
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Figure 3.3. The transport model of the acetylcholine, inhibitor, and oxime species
in the neuromuscular junction.

The behavior of this reaction-diffusion system is mathematically expressed by a
one-dimensional, axially symmetric partial differential diffusion equation with nonlinear
reaction terms for acetylcholine, organophosphate inhibitor, and oxime species. These
equations are coupled with a set of nonlinear ordinary differential equations that represent
the immobilized receptor and enzyme species which are distributed at spatial
compartments in the cleft. The spatio-temporal analysis employs computer simulation via
discretization of the radial coordinates in the space for the partial differential equations,
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and numerical integration of the governing ordinary differential equations. Simulation of
the response of this system to release a discrete packet of acetylcholine into the cleft
leads to characterization of the radial diffusion process of acetylcholine in the chemical
transmission with reference to their effect on spontaneous generation of the action
potential during normal and inhibited conditions.
The stoichiometric Equations (3.1) to (3.5) represent the full set of chemical
species and their stoichiometric reactions that were modeled in this dissertation. Some of
kE±,

fcE-i

A+E *

kE2

> A-E

kE3

(3 i)

—> acE —> E + products

2kRv

fc/?_!

A + R <—
«-2

(T. O^

V'Z)

*A • R

kR2, 2fci?_2

A+A-R

,

. oR, cR

closed

1 A2 • R

<

/"2 1\
en

E.jaeaa

^E.l<ieaa

k
+ ox

^t^E.I.0xi^E

(3 3)

* A2 • R°P

k

E + IVlL^E.I

'

-

(3.4)
+ l-OX

(3

'5)

the stoichiometric equations depict two or more reactions, and these equations can be
collected into different groups, depending on which of the three processes in this model
are being described: normal cleft reactions, inhibited enzyme cleft reactions, and enzyme
regeneration reactions.
To begin, determine all the stoichiometric chemical equations which comprise the
reactions in the neuromuscular junction during a normal action potential event. By
choosing from the complete set, these equations are:
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Equation (3.6) represents the full kinetic cycle of acetylcholine initially reacting with
acetylcholinesterase and proceeding to the final renewal of the enzyme. The first step
shows acetylcholine, A, reacting with acetylcholinesterase, E, reversibly to form the
Michaelis complex of A-E. The forward reaction, controlled by the rate constant kEj, is
several orders of magnitude faster than the reverse reaction controlled by kE.j. In the next
step, species A-E then irreversibly reacts to form the acylated enzyme intermediate acE,
where the reaction rate is controlled by the constant kE2. The final step shows how acE
then decomposes back to acetylcholinesterase and reaction products, where the rate is
controlled by the rate constant kEi and one of the reaction products is choline. This final
step regenerates the enzyme and is the major resource for acetylcholine replacement
because choline is a precursor of acetylcholine. Water is also a reactant in this last step,
but in this case, water is treated as an excess solvent, and as such, its concentration does
not change and so it is not included in the reaction kinetics.
Equation (3.7) represents the first acetylcholine molecule reversibly binding to the
closed receptor. Because there are two sites available for docking, a numerical factor of
two is included with the kinetic rate constant 2kRj, which controls the forward binding
reaction. Because only one acetylcholine molecule can dissociate from the receptor in the
reverse reaction, the kinetic rate constant kR.j does not require an additional
multiplicative factor.
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The two-step process kinetics of acetylcholine receptor function is represented by
Equation (3.8). Just as in Equation (3.7), the first step of this equation shows a second
acetylcholine molecule binding reversibly to the ligand-receptor complex A-R. Only one
position for binding exists on the receptor in this case, so the forward kinetic rate
constant, kR2, does not require a multiplicative factor. In the reverse reaction, either of the
two acetylcholine molecules could dissociate from the closed ligand-receptor complex
^^ciosed

g0

^e

numerjcai

factor of two is included with the kinetic rate constant 2kR.2.

The second step of Equation (3.8) shows the closed, double bound, ligand-receptor
complex reversibly changing from the closed conformation to the open conformation,
A2Rope" (forward reaction), and back to the closed conformation (reverse reaction). The
forward and backward reactions are controlled by the kinetic rate constants oR and cR,
respectively. It is at this step where the redistribution of sodium and potassium ions
through this open channel leads to the eventual contraction of the muscle cell. Several
experiments, and kinetic-thermodynamic analyses, [8], [23], [41], have shown that the
conformational change from A2Rclosed to A2Ropen is energetically favored, so that a channel
which has two molecules of acetylcholine bound to it will spend most of its time of
existence in the open condition.
The inhibited enzyme cleft reactions include Equations (3.9) through (3.11) with
the addition of Equation (3.12), as shown below:
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The qualitative kinetics represented by the stoichiometric Equations (3.9) through (3.11)
has been discussed. Equation (3.12) shows the two-step kinetic process of
acetylcholinesterase, E, reacting with an inhibiting organophosphorus compound I, where
the reaction leads to the non-functional inhibited enzyme
E.jdead

^

t h e

first

step)

acetylcholinesterase reacts reversibly with the inhibitor to produce the intermediate
enzyme-inhibitor complex EL The forward and reverse reactions of this step are
controlled by the respective kinetic rate constants klj and kl.j. The second step represents
the enzyme-inhibitor complex irreversibly reacting to produce the non-functional
inhibited enzyme E-fead, and the reaction rate is controlled by the kinetic rate constant
i^dead-

The reactions which describe the process of acetylcholinesterase regeneration in
the neuromuscular junction in this model are given by:
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All the reactions of a normal action potential event are included again (Equations (3.13) (3.15)), and the addition of Equation (3.16). Equation (3.16) shows the two-step kinetic
process of regenerating functional acetylcholinesterase from the deactivated enzyme via
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the use of an oxime compound. In the first step, the inhibited enzyme, E-fead, reacts
reversibly with the oxime compound, OX, to form the intermediate phosphyl-oxime
complex EI-OX. The forward and backward reactions are controlled by the reaction rate
constants kox and k.ox, respectively, where kox is many orders of magnitude larger than k.
ox- The second step represents the irreversible dissociation reaction of the phosphyloxime complex, controlled by reaction rate constant kregen, to produce the phosphylated
oxime residue I-OX, and also regenerates functional acetylcholinesterase, E. This
completes the qualitative analysis of all the chemical reactions used in the JenkinsSzlavik model of the neuromuscular junction.
Next, it will be useful to develop a robust and general algorithm to describe how
to start with a set of stoichiometric equations, derive their resulting theoretical differential
kinetic equations, and finish with the set of coupled numerical equations. The numerical
equations can then be used to calculate numerical values that can be compared to
measurements obtained from the actual physical system, and the results of that
comparison can be used to evaluate the validity of the model. In this system, a key issue
is the reaction that occurs between mobile chemical species and immobile chemical
species. All the species vary in concentration with time; however, some of the species are
mobile, and some are immobile. The mobile species have concentrations that can vary
with respect to position in space, as well as time. Most kinetic chemical equations are
modeling chemical species which are assumed to be mobile in a uniformly mixed
environment, but one's first encounter with describing the kinetics of mobile and
immobilized molecules can be non-intuitive. To address this issue, two species which
include all of the important characteristics associated with the mobile and immobile
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kinetics will be selected, and a general algorithmic procedure that can be applied to all of
the other species and reactions will be developed.
The molecules acetylcholine and acetylcholinesterase have been chosen as the
species with the important characteristics which are shared by all the other different
molecules in this system, and as such are suitable for the detailed algorithmic derivation
and development. Collectively, the chemical kinetics of these two species includes
mobility, immobilization, reaction with different mobile and immobile species, and
reaction with each other. A detailed development of their chemical kinetics starting from
the stoichiometric reactions and finishing with the full set of numerical computable
equations will allow comparison between similarities and differences. This comparison
will lead to the recognition of patterns and establishment of the general principles which
describe the complete kinetic behavior of the system in time and space.
Both acetylcholine and acetylcholinesterase vary in concentration with time;
however, acetylcholine is mobile, and acetylcholinesterase is immobile. The mobile
species have concentrations that can vary with respect to position in space, as well as
time. Therefore, these species are modeled with partial differential equations. The
immobile chemical species are modeled with ordinary differential equations. The end
result is a set of coupled partial and ordinary differential equations that describe how
mobile molecular species and immobile molecular species are able to interact with each
other.
The stoichiometric equations that describe the normal cleft reactions are a suitable
choice for the forthcoming derivation because acetylcholine and acetylcholinesterase are
members of these reactions. The differential equation for acetylcholine will be derived
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first, and this goal will require knowledge of where acetylcholine occurs in the network
of coupled normal cleft reactions, shown as Equations (3.17) to (3.19), which have been
included here for easy reference:
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Because acetylcholine is known to be a mobile species in this system, it is known that the
general form of the kinetic partial differential equation (PDE) is shown below in (3.20)
according to the description given in Chapter 2 (page 11) of this dissertation. The details

dt

= V • (DAV[A\) + £ fcw(T) (]~[[^] w )

of the rigorous and general enumeration rules of ktj and Xh are omitted to avoid
unnecessary complexity. Recall that this equation is a function of the concentration of
acetylcholine, [A], and that the symbol for acetylcholine is given by A. The term on the
left-hand-side of (3.20) is the partial derivative of [A] with respect to time, t. The first
term on the right-hand-side of (3.20) describes the diffusion of acetylcholine throughout
the cleft, and the second term on the LHS relate to the reactions of acetylcholine with
other species in the cleft. At this point, it will be more instructive to show the fully
developed theoretical form of (3.20) and explain the rules used for its derivation while
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the reader can easily refer to it and the equations of the stoichiometric reaction network
that contains acetylcholine.
Equation (3.21) shows the full theoretical kinetic rate equation for the reaction of
acetylcholine in the neuromuscular junction. Recall that the neuromuscular junction
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geometry is modeled as a thin coin, in cylindrical coordinates, with acetylcholine entering
the coin between the plates at the center, and diffusing and reacting from the center to the
outer edge. Acetylcholine, chemical species A, is mobile, and is transported throughout
the cleft by diffusion where it reacts with some of the other species it encounters. This
reaction-diffusion process is described by Equation (3.21), and is known as a reactiondiffusion equation. A qualitative description of the terms on each side of (3.21) now
follows.
The first term on the left-hand side of the equal sign is of course the partial
derivative of acetylcholine concentration with respect to time. The first two terms on the
RHS of the equal sign account for the transport of acetylcholine in the cleft. These two
terms are the result of implementing the gradient and divergence operators on the
concentration of species A, embedded in cylindrical coordinates. The first term describes
transport by diffusion, and the second term accounts for the increased radial dispersion
effects caused by the geometry of the model. The rest of the terms in (3.21) relate to the
reaction of acetylcholine where it appears in each of the stoichiometric equations shown
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in (3.17) to (3.19), and these terms result from applying the same rules developed in
Chapter 2 (page 11) for deriving differential rate expressions from a given stoichiometric
network. Referring to those coupled stoichiometric equations, it is easy to see that
acetylcholine participates in six reactions, designated by the rate constants kEj, kE.lt
2kR;, kR„i, kR.2, and 2kR-2- These six reactions explain why (3.21) has six kinetic rate
terms for species A, each comprised of a multiplicative product of the particular rate
constant and all the reactant species concentrations participating in that reaction, where
each species concentration is raised to the power of its stoichiometric coefficient.
The derivation of the complete reaction-diffusion equation for acetylcholine is not
yet accomplished, but at this point it seems useful to walk through the derivation rules of
the kinetic reaction equation for the other representative species, acetylcholinesterase. In
the Jenkins-Szlavik

model

of the

neuromuscular

cleft

system,

the

species

acetylcholinesterase, E, is known to be immobilized and assumed uniformly distributed.
As an immobile species, the concentration of acetylcholinesterase depends only on time,
t. This means the kinetic reaction equation for acetylcholinesterase is an ordinary
differential equation (ODE), not another diffusion-reaction equation. As such, this
reaction equation will be less complicated than (3.21) and familiar to readers with some
experience with chemical kinetics. As was done with acetylcholine, the full theoretical
kinetic equation for acetylcholinesterase will be given in (3.22), and the rules of its
derivation will follow.
d\E]
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Equation (3.22) shows the full theoretical kinetic rate equation for the reaction of
acetylcholinesterase in the neuromuscular junction with the same conditions and
geometry of Equation (3.21). The first term on the left hand side is the derivative of the
concentration of species E, [E], with respect to time, t. Since species E is immobile in the
cleft, there are no transport terms appearing on the right hand side of (3.22). This means
all the right hand side terms are related to the reaction of species E where it appears in the
coupled stoichiometric reaction network depicted in Equations (3.17) to (3.19). Referring
to those coupled stoichiometric equations, the reader will note that species E participates
in three reactions, designated by the rate constants kEj, kE.j, and kE^. These three
reactions explain why (3.22) has three kinetic rate terms for species E, each comprised of
a multiplicative product of the particular rate constant and all the reactant species
concentrations participating in that reaction, where each species concentration is raised to
the power of its stoichiometric coefficient.
The full theoretical kinetic reaction rate equations for the representative mobile
species acetylcholine and immobile species acetylcholinesterase have now been derived.
All types of differential equations must have their initial and boundary conditions
specified before they can be solved, and the determination of these conditions for (3.21)
and (3.22) follow next.
Equation (3.23), the PDE which governs the reaction-diffusion of acetylcholine in
the neuromuscular junction, now needs to have the initial and boundary conditions
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determined. These conditions are imposed by the geometry and physio-chemical
parameters of the system. The determination of those conditions will now require a focus
on the partial derivative terms in Equation (3.23). Recall that the physical system is
modeled as the volume bounded by the two sides of a very thin coin, the two side
surfaces are impermeable, and the circumference edge is open to the environment.
Acetylcholine enters the cleft in the center of that volume and diffuses radially (outward)
towards the edge, reacting with other molecular species along the way. Because PDE
(3.23) contains a second derivative with respect to the radius, determining the solution
will require known information about the concentration of species A at two points in the
domain of r that is simultaneously true for all points in the domain of t. Intuitively, one
should suspect the best candidates would be the extreme values of r in its domain: r = 0
and r = 500 nm; i.e., those values of r designate the physical boundaries. The known
information about the concentration of acetylcholine at these points specifies the
boundary conditions. At the maximum value of r, the edge of the cleft and beyond, the
reader knows the concentration of species A is essentially zero for all time. Therefore,
this boundary condition is easy to understand and state mathematically:

[4(500,t)] = 0 , V t > 0

(3-24)

The physical interpretation is that acetylcholine diffuses from inside the cleft into a
region outside the cleft where its concentration is maintained at zero. At the center of the
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cleft where r = 0, intuition is of less help and it is beneficial to explain the situation in
more detail. There does not exist a known relationship describing the concentration of
acetylcholine at r = 0 as a function of all time, so seeking a boundary condition explicitly
in terms of [A(r,t)] is not useful. The next candidate is to examine what is known about
the first partial derivative of [A(r,t)] with respect to r at r = 0. By the use of symmetry, it
is possible to model diffusion in a two-dimensional space with a one-dimensional
direction. However, the diffusion process in this two-dimensional space is identical to a
particular one-dimensional problem where diffusion occurs in the x-direction. Imagine a
linear tube of length L, where 0 < x < L. At x = 0 the tube is closed, and at x = L the tube
is open to the environment. Particles of species A are inserted into this system at x = 0
and allowed to diffuse along the tube. In this case, because the tube is closed at x = 0 for
all values of time, the reader would determine the boundary condition there as
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This is known as a Neumann boundary condition, and it shows the mathematical
expression of describing how a quantity is not allowed to leave the system at some
identified location. Now imagine this one-dimensional problem is mathematically rotated
2% radians about the axis at x = 0. This will produce the symmetric two-dimensional
space, one-dimensional direction diffusion system, where x is now defined to be r and the
boundary condition at r = 0 is still the same Neumann condition. In this case, it is
expressed as:
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The physical interpretation means that acetylcholine cannot leave the cleft at its center.
Two thought experiments are described here to aid the reader's intuition in understanding
this condition at r = 0. First, imagine a perfectly frictionless and hemispherical surface
(concave down) at rest in a uniform gravitational field. By nature of the non-friction
surface, no object could be placed on it without sliding off, unless it was balanced exactly
at the top and center point, the "pole". Balanced at that point, all the forces acting on the
object would resolve to zero, and it would stay in place if not disturbed, regardless of the
lack of friction at the surface. Finally, imagine a traveler moving north along a
longitudinal. When the geographic North Pole is reached, the direction "North" no longer
exists. Every direction from that point is south.
The initial condition for acetylcholine is
3
[i4(r,0)] = { 0.17 mmole/cm
0

0 < r < 25nm
otherwise

(3.28)

The physical interpretation is that the vesicle of acetylcholine which instantaneously
enters the cleft centered at r = 0 has a radius of 25 nm, and no acetylcholine initially
exists anywhere else in the cleft.
Equation (3.29), the ODE which governs the reaction-diffusion of acetylcholine in
the neuromuscular junction, only needs to have the initial condition on the concentration
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of species E specified. The concentration of acetylcholinesterase in the neuromuscular
junction is known to be 0.845 mmole/cm ([5], [57], [58]), which means that when t = 0
[E](0) = 0.845 mmole/cm3

(3.30)

With the boundary and initial conditions of (3.23) and (3.29) determined, these
equations are now ready for numerical development. No general method for the analytic
solution of coupled nonlinear PDE/ODE systems yet exists. As a rule, transport-reaction
equations are "well behaved", albeit stiff (the variables can exhibit a wide distribution of
rates of change), and thus can be reliably approximated with numerical techniques. For
systems involving PDEs, the two usual numerical methods of choice are the finite
difference method (FDM) and the finite element method (FEM). The FEM can model a
broad array of physical systems and is better able to handle complex shapes and
boundaries. However, because the FEM approximates the solution of the PDE instead of
the actual PDE, implementing this method can be very abstract for the non-specialist in
numerical techniques. In contrast, finite difference methods approximate the original
equations that describe the physical model, and so the less experienced investigator has a
larger opportunity to use physical intuition during the implementation. Jenkins modeled
the neuromuscular junction as a cylinder because that shape captured the relevant
dynamics along with a simple geometry and boundaries [58], and so the finite difference
method was the natural choice.
Several classes of finite difference methods exist, of which one is the method of
lines (MOL). The MOL is well suited for equations developed from transport-reaction
processes, and is typically the first method of choice [59]-[65]. This technique involves
discretizing one or more PDEs in all but one dimension, and then integrating the semi-
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discrete problem m a system ofODEs. The advantage i§ that the methods for numerieally
solving coupled ODE systems are well understood and mature. If the original PDEs are
well posed as an initial value problem, then there are many algorithms that provide an
efficient and robust method of solution. This model's descriptive equations were
numerically solved with the method of lines and the Matlab ODE solver algorithm
odel5s [59].
To begin, one needs to have the coordinate system chosen and the applicable
equations derived, as per the description in this chapter beginning on page 3. The first
step in applying the MOL is to divide the system volume into a group of sub-volumes,
where the shape of the sub-volumes is influenced by the chosen coordinate system, as
shown below in Figure 3.4. A Cartesian system would be divided into squares or cubes,
and a spherical system would be partitioned into thin concentric shells. The model of this
dissertation uses a polar coordinate system with angular symmetry; therefore a series of
concentric circles was a natural choice. The neuromuscular cleft was modeled as a
cylinder with an axial length of L, and a radius of R. Further, the cleft was subdivided
into 20 concentric volumes, arranged such that the origin of the radial coordinate r was at
the center of the annuli, and the width of each annular volume r\ was centered at radial
coordinate (R/20)*(i - lA), for / = 2, 3, ...,20 (The centermost sub-volume at / = 1 is a
disk, not an annulus). Recall that twenty volumes was the optimal volume number for
accuracy and mitigation of computational labor, and this number was derived from the
analysis of the model developed by Naka. A change of variables will now be required
because of the large number of different chemical species in these equations.
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Inhibitor and
oxime diffusion

r3 = R/8
r, = 3R/20

rs = 9R/40
r4 = 7R/40

n = (i-V£)R/20

..

0 < ri < R

Figure 3.4. The relation between each annulus index and the corresponding location on
the cleft radius.

The complexity of the symbols used for the chemical species would obscure the
steps taken to transform the analytic equations into their respective numerical
approximations, so the variables will be re-expressed in a more standard notation that is
used in numerical calculations. The closer-to-standard notation should also provide a
better interface between the numerical equations and conceptualizing the computer code
that must be developed to compute those equations. The analytic PDE for the diffusion-
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reaction of acetylcholine and the associated initial and boundary conditions is shown by
Equation (3.31):
2
d[A(r,t)]
, n ld[A(r,t)}
n d [A(r,t)]
Jt
= DA
ap.
+ DA~
-Q-r

-kR2[A(r,

.......
. . _. (3.31)
2kR1[A(rlt)][R] + kR-jA • R]

t)][A • R] + kR.2[A2 • R*™°*] - kEi[A(r, t)][E] + kE.^A

[A(r,0)] = {

[i4(500,t)] = 0,

V

d[A(0,t)]
= 0,
dr

V t> 0

• E]

t>0

0.17 mmole/cm3
0

0 < r < 25nm
otherwise

Next, make the variable substitutions defined in (3.32)
[A(r,t)] = U,

[A-R] = U4
[A2-Rdosed]

[E] = C/2
[R] = t/5

(3.32)

= U5

/ * £ / = £/«,

After substitution, Equation (3.30) now becomes Equation (3.33)
dUx
d2\Jx
ldUi
"ST = DA—^ + DA-—±-2kR1U1U3
at
or'r or

(3.33)
+ kR_tU4 - kR2U1U4 + kR.2U5

-kE1U1U2 + kE.±U6

U1(r,0) = {

^ ( 5 0 0 , 0 = 0,

V

t>0

d
. •l/ 1 (0,t) = 0,
or

V

t>0

0.17 mmole/cm3
0

0 < r < 25nm
otherwise

Now discretize Equation (3.33) via application of a standard central difference
approximation to both the first and second partial derivative with respect to r. The result
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is that the original PDE (3.33) is transformed into the general form of its numerical
approximation, shown in Equation (3.34) below. This discretization "absorbs" the
boundary conditions of (3.33) and they are processed when the index i is given numeric

^

= W?[(f/l)i+1 -2iuDi + ( ( / l ) * - l ] + ^ o K U l ) i + 1 ~ iUl)i~l] (3'34)
-2fc/? 1 (t/ 1 ) £ ([/ 3 )i + kR-^UJi
-kE^UMUz^

0/i)i(o) = {

~ k^iUMUJt
+

0 A 7

0

mmole
~ cm^3 ~

+ kR-2(U5)t

kE-AUJt

i

~

1

i> 1

values. Discretizing the initial conditions of (3.33) requires applying the knowledge about
the initial distribution of acetylcholine in the cleft with respect to position. The above
equation represents the general expression a coupled system of ODEs that approximate
the behavior of analytic Equation (3.33), where each /-subscript represents one of the
enumerated sub-volumes. Each /-specific equation may differ from all the others
depending on the boundary, mobility, location, and time-dependence of each species in
the equation. For the system considered in this study, the ODEs in (3.34) are well
behaved initial value equations. However, in the general case, the resulting coupled ODE
system may contain boundary value equations, which do not use the same numerical
solution algorithms as initial value equations. The particular equation associated with
each index from i = 1, to i = 20 must now be determined.
The sub-volume at i = 1 represents the system being modeled at the system
boundary at r — 0, and is the location where species A enters the cleft. Substitution of i =
1 into (3.34) gives the result:
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^ ^ = eA[(u^2 - 2(1/01 + o / i ) o i + ^ KUO2 - (^1)0]
-IkR^UOiiUs)!

+ fcK-i(tf4)i - ^ 2 ( ^ 1 ) 1 ( ^ ) 1 +

(3,35)

fcfl-20's)i

-/c£ 1 ([/ 1 )i(f/ 2 )i + ^ - 1 ( ^ 6 ) 1
(f/i)i(0) = 0.17

04 =

*

mmote
cm 3

A4
(Ar) 2

As written, this equation presents two difficulties which may be unfamiliar to the nonspecialist, and a detailed explanation of their resolution is beneficial. First, the term
A

r x (Ar)

[(^1)2 — (^i)oJ contains an index where i = 0, when i was previously defined as

strictly 1 < i < 20. However, that term is an approximation of —boundary condition in (3.33) stated that ^

at r - 0, and the

= 0 at r = 0, thus ^ - [(U^

- ([/ x ) 0 ] = 0.

Second, notice that the term 6A[(U1)2 ~ 2(tfi)i + (£/i)o] also contains an index where i
= 0, but is not as easily resolved as the earlier, similar index. This index is an artifact of
the numerical solution method, and is defined as a ghost point. The ghost point is
resolved by using the boundary conditions to get a relationship between (f/i) 0 and the
valid points in the system's physical domain. This can be done by using the given
boundary condition and applying a central difference approximation about i = 1. To
begin, relate the analytic boundary expression to its general central difference numerical
analog:
d[A(r,t)]
dr

=
lr-

°

dQJJt _ (U,)t+1 - C^i) f -i
dr ~
2(Ar)

(3.36)
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Next, use algebra to relate the ghost point to a valid point in the physical domain of the
system when / = 1:
(t/i) 2 ~ (Ui)o
2(Ar)

(3-37)

=

0/i)2-a/i)o = 0

(3.38)

0/i)o = (UO2

(3-39)

The ghost point is now resolved. After substitution and algebraic manipulations, this
leads to the computable specific equation for species A in sub-volume z = 1, given by
(3.40):
^

^

= 29A[(U1)2 - (UM - 2kRx(Ux)x(U3)x

-kR2(Ux)x(U4)x

+ kR-2(U5)± - kEx(Ux)x(U2)x
(tfi)i(O) = 0.17

+
+

fc«-i0/4)i

(3 40)

'

kE.x(U6)x

mmole
cm3

In the annular volumes i = 2 through / = 19, species ^4 is transported into and out of each
annulus and reacts with other chemical species. These volume elements are all
mathematically similar and differ only by virtue of their index value, i. Therefore, for i =
2,..., 19, we represent for each of d(Ui)2/dt, d(Ui)i/dt,..., d(Ui)i9/dt, the entire set of
equations and their associated initial conditions as follows:

^ § ^ = 0A[(udi+1 - 2(ux)t + (Ux)t.x]

+ 7^Kux)i+x

-2fc/?1([/1)i(t/3)t + fcfl-iO/Jt - k^iUJiiUJi

- cuot-i]

+ kR„2(U5)i

(3<41)
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(tfi)i(O) = 0
The sub-volume at i = 20 represents the system being modeled at the system boundary at
r — 25 nm, and is the location where species A exits the cleft. Substitution of /' = 20 into
(3.41) gives the result:
^

^

= ^ [ ( ^ ) 2 1 - 2 ( ^ 0 + (^)19] + ^

5

-2fc/?1(f/1)20(f/3)20 + fci?_i(f/4)2o - kR2Wi)20{U,)20
-kE1(U1)20(U2ho

K«/l)21 - 0/l)l 9 ]
+

(3 42)

'

kR_2(U5)20

+ kE^CUe^o

(tfi) 2 o(0) = 0
Another ghost point, (Ui)2i> appears twice in this equation. In this case, (£/i)2i
represents the concentration of species v4 outside the cleft and this quantity has been
defined in the boundary condition of (3.33) as equal to zero. Since other molecular
species can be outside the cleft and may have constant (or time dependent) concentrations
other than zero, it will be useful to define a new symbol to represent a molecular species
concentration in the environment outside the neuromuscular junction. Consequently, it is
not complicated to attach a label, "inf', to indicate some species concentration outside the
cleft. Following this logic, define (UO21 = Ainf, where misrepresents the concentration of
species A outside the cleft. That ghost point is now resolved. The substitution of Ainf into
(3.42) leads to the computable specific equation for species A in sub-volume i = 20, given
by (3.43):
^

^

= eA[Ainf - 2(1/020 + ("Owl + ^

[Ainf - M19]

-2fe/? 1 (f/ 1 ) 2 o(t/ 3 )2o + ^ - 1 ( ^ 4 ) 2 0 - ^ 2 ( ^ 1 ) 2 0 ( ^ ) 2 0 +
-^1(1/1)20(^)20 + ^-1(^6)20

kR.2(U5)20

(3 43)

-
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0/i) 2 o(0) = 0
This completes the derivation of the numerical equations that describe the diffusionreaction of acetylcholine in the neuromuscular junction under normal conditions.
The analytic ODE for the reaction of acetylcholinesterase and the associated
initial condition is shown by Equation (3.44):
d\E~\
-j1 = -kEx [A (r, t)] [E] + kE_ t [A-E] + kE3 [acE]
[E](0) = 0.845

(3 44)
K
'

mmole/cm3

Next, make the variable substitutions defined in (3.45)
[A{r,t)} = Ux

[E] = U2

[A-E] = U3

(3.45)

[acE] = U7

After substitution, Equation (3.44) now becomes Equation (3.46)
dU2
- p = -kE1U1U2 + kE.±U6 + kE3U7
(72(0) = 0.845

(3.46)
'

K

mmole/cm3

Now prepare to discretize Equation (3.46) with respect to the space variable. This
discretization process will require knowledge about the functional relation between the
initial concentration of acetylcholinesterase and its position in the in the cleft
neuromuscular junction. In other words, the relation [E] = f(r) when t = 0 must be
known, and this relation would then be applied to the discretized initial condition. Since
the distribution of acetylcholinesterase in the junctional cleft is assumed to be uniform,
then the discretization result is that the theoretical ODE and the initial condition merely
become notationally compatible with the system of equations defined in (3.34) with no
other changes, as shown below in (3.47):
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dW2)i
-^p-

(3.47)
= -kExQJxMUdt

+ kE^(U6)t

(^)i(O) = 0-845

+ kE3(U7)t

l

>

mmole/cm3

The above equation represents the general expression of a coupled system of ODEs that
approximate the behavior of analytic Equation (3.46), where each /-subscript represents
one of the enumerated sub-volumes. Acetylcholinesterase is known to be immobilized
and distributed uniformly throughout the cleft; consequently, the volume elements
designated by indices i = 1 through i = 20 are all mathematically similar and differ only
by virtue of their index value, i. Therefore, for i - 1,..., 20, we represent for each of
d(U2)i/dt, d(U2)i/dt,..., d(U2)2(/dt, the entire set of equations and their associated initial
conditions as follows:
d(U2)i

(3.48)

- ^

l

= -kE^UJtMt

+ kE^(U6)t + kE3(U7)t

(^2)1(0) = 0.845

;

mmole/cm3

This finishes the derivation of the numerical equations which describe the reaction of
acetylcholinesterase in the neuromuscular junction under normal conditions for the two
representative species acetylcholine and acetylcholinesterase. Only two chemical species
were derived in detail, but the same process could be used to develop the numerical
equations for the remaining molecular species in the normal action potential reaction
network.
To derive the reaction equations associated with the inhibited enzyme regime, and
the enzyme regeneration regime, one would apply these same techniques and rules to
every chemical species in the stoichiometric reaction network of each of those reaction
regimes. For completeness, the stoichiometric reaction network, theoretical reaction
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equations, and numerical reaction equations for all the chemical species in each reaction
regime will be presented.
Normal action potential reaction regime:
Description:
This regime consists of 20 sub-volume elements, 8 chemical species, and 10
separate kinetic reactions.
Mobile species: A
Immobile species: E, A-E, acE, R, A-R, ArRdosed,

ArRopen

The initial concentration of A in the cleft is 0.17 mmole/cm3 for r < 25 nm, and
the concentration of A outside the cleft is Ainf for all t > 0. Species E and R are uniformly
distributed throughout the cleft with initial concentrations of 0.845 mmole/cm3 and
0.000664 mmole/cm , respectively. All other species have initial concentrations of zero.
Stoichiometric reaction network:
kEv
A + E

kE-i

<

kE?

kE3

/"3 AQ\

^,4yj

1 A . E _4 acE —> E + products
2kRx, kR-x

A + R <-^

(T. 5(V>

kR2, 2fcfi_2

. OR, CR

1 A2 • Rclosed

A+A•R ^

^Du;

1A •R
<

n

» A2 • R°ven

S11

<3-M>

Theoretical reaction equations:

d[A(r,t)]
g-t

= DA

^

1

g^

+ DA~

W
Yr

URx[A(r,t)][R]

+kR_x[A • R] - kR2[A(r, t)][A • R] + kR„2[A2 • Rclosed] - kE^r,
+

kE.x[A-E]
[A(S00,t)] = 0,

(3,52)

,tDr^rtiroi

Vt>0

t)][E]
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d L1/4(0,0]
v
J
dr

= 0,

Vt>0

3
U ( r , 0 ) ] = { 0.17 mmote/.cm

0 < r < 25nm
otherwise

- j p = - f c ^ U ( r , 0 ] [ f ] + kE_±[A • E] +
[£](0) = 0.845

fc£3[ac£]

(3 53)

"

mmole/cm3

{3M)

^ P = -2kRx[A{r, t)][R] + kR.x[A • R]
at
[i?](0) = 0.000664

d[A

'*]
at

= 2kR1[A(r,t)][R]

mmole/cm3

- kR_x[A • R] - kR2[A(r,t)][A

• R]

(3 55)

"

+2kR_2[A2 • Rclosed]
[A-R](0) = 0
d\A2 • Rclosed]
- ^ —
1=
at

, A
kR2[A{r,t)][A-R]-2kR.2[A2'Rclosed}

(3.56)

-oR[A2 • ftctoMd] + c/?[i42 • Ropen]
[A2 • flclMed](0) = 0
d\A-E]
1
,, J = kEdACr.QftE] ~ kE-dA • £] - fc£2[4 • E]
at
[A-E](0) = 0

(3 57)
K
' }

d[acE]
1

J

,
r
= kE2 [A-E]-

(3
kE3 [acE]

K

[acE](0) = 0

d[A2.R<v<«]_„nTA
_nTA
oclosedl
n m m
= oR[A2 • Rcl°™d] - CR[A2 • R°Pen]
[A2 • Ropen](0)

0

=0

Change of variable definitions:
[A(r,t)J = Uj

[A2Rclosed] = Us

[E] = U2

[A-E] = U6

[R] = U3

[acE] = U7

[AR] = U4

[ArRopen] = U8

(3

Numerical reaction equations:
^ l

= 2BA[W{)2 - WM

-kRiiUMU*)!

- 2/ci? 1 (f/ 1 ) 1 (y 3 ) 1 + kR-xQJt\

+ M?_2(tfs)i ~ ^ i ( f / i ) i ( t / 2 ) i + ^ - 1 ( ^ ) 1
(UMO)

Fori = 2, 3,4,..., 19

= 0.17

mmole
cm3

(3

-IkR^UMU^

+ fc/UOU - k^iUJiiUJi

+ kR.2(U5\

(tfi)t(O) = 0

^

^

= eA[Ainf - 2(^)20 + (f/i)i 9 ] + ^ ~ ^ [Ainf ~ (f/i)i 9 ]

-2fc/?1({/1)20(f/3)20 4- kR^iUJzo

- kR2(U1)20(U4)20

-kEl(U1)20{U2)20

^

+ kR_2(U5)20

+ kE.1(JJe)20

(f/i)2o(0) = 0

d(U2)i

(3

((/ 2 ).(0) = 0.845

mmole/cm3

Fori = 1,2, 3, ...,20
d(^3)i

(3
mmole/cm3

(^3)1(0) = 0.000664

Fori = 1 , 2 , 3, ...,20
^

i

= 2/ci?1(£/1)i(£/3)i -

fc/?.!^)!

- ^ 2 ( ^ 1 ) 1 ( ^ 4 ) ! " 2kR.2(U5)1

(i/ 4 )i(0) = 0

(3

Fori = 1,2, 3, ...,20

(^s)i(O) = 0

Fori = 1,2, 3, ...,20
~

-

= kE^U^QJ^

- kE^(U6)t

- kE2(U6)1

(3

(t/ 6 )!(0) =0

Fori = 1,2, 3, ...,20
d(tf 7 )i
- ^ l = kE2(U6)1-kE3(U7)1

(3
K

(y 7 )i(0) = 0

Fori = 1,2, 3, ...,20
^i=o/?(t/5)1-ci?(f/8)1
0/ 8 )i(0) = 0

The normal reaction regime produces a coupled numerical system comprised of 8
variables distributed among 160 ODEs.

P
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Inhibited enzyme reaction regime:
Description:
This regime consists of 20 sub-volume elements, 11 chemical species, 13 separate
kinetic reactions,
Mobile species: A, I
Immobile species: E, A-E, acE, R, AR, ArRdosed,

ArRopen,

EI, E-fmd

The initial concentration of A in the cleft is 0.17 mmole/cm3 for r < 25 nm, and
the concentration of A outside the cleft is Ainffor all t > 0. Species E and R are uniformly
distributed throughout the cleft with initial concentrations of 0.845 mmole/cm3 and
0.000664 mmole/cm3, respectively. The initial concentration o f / i n the cleft is zero, and
the concentration of / outside the cleft is 7;„/for all t > 0. All other species have initial
concentrations of zero.

Stoichiometric reaction network:
kE-i,

A + E <

fcE_i

kE2

> A-E

—» acE —> E + products
2kRlt

kE3

fcR_i

A + R <
kR2,

2fcfl_2

>
,

> A2 • Rclosed

A + A •R <
klx,

E + I <

Theoretical reaction equations:

fc/_!

/"J 7 1 ^

A-R
. oR,

<
kdead

cR

> A2 •

> E • I <—> E • laeaa

Ropen

K

°-'l)

+kR_1[A • R] - kR2[A(r, t)][A • R] + kR_2[A2 • Rclosed] - kE^A^r,t)][E]
+kE.1[A-E]
[4(500,t)] = 0,

Vt>0

d[A(0,t)]
dr

Vt>0

0,

lAfr 0^1 = ( ®'^ mmole/cm3
I
0

0 < r < 25nm
otherwise

(3

-LA = -kE1 [A(r, t)][£"] + kE^[A • E] + kE3[acE]
[£](0) = 0.845 mmole/cm3

d[A E]
dt

(3

= kEt[A(r, t)][E] - kE.M • £] - kE2[A • E]

d[acE]
1

,
r
=fc£2[i4 • E] - kE3 [acE]
[ac£](0) = 0

[/?](0) = 0.000664 mmole/cm3

(3
v
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'

= 2kRx[A(r,t)][R] - kR.x[A • R] - kR2[A(r,t)][A • R]

(3 ?7)

'

+2kR_2[A2 • Rclosed]
[A-R](fl) = 0

d[A2 • Rclosed]
, „
LJ
- -^t
~ = kR2[A(r, t)][A • R] - 2kR_2[A2 • Rclosed]

(3.78)

-oR[A2 • R*°se*] + CR[A2 • R°*>en]
[A2 • Rclosed)(0) = 0

d[A2-Ropen]
-±-~

,

(3.79)

cl sed

.
= oR[A2 • R ° ] -cR[A2- i?°Pen]

V

;

[A2 • fl°Pen](0) = 0

a[/(r,t)]

n

d2[Kr,t)]

t n

ld[/(r,t)]

rFirrr

[/(500,t)]= V ,
a[/(o.t)]
= 0,
dr
[/(r,0)] = (
l

W
0

rp

(3.80)

Vt>0
Vt > 0
r = 500 nm
otherwise

^ | l 3 = fc/Jf ][/(r, t)] - fc/.^F • /] - kdead[E • I]
[£-/](0) = 0

(3 81)

'

d[E • Ideaa]

(3

~ kdead [E * /]

dt

[E • Idead](0)

=0

Change of variable definitions:
[A(r,t)J = U,

[E] = U2

fA-EJ = U3

facEJ - U4

[R] = U5

[A-R] = U6

[ArRdosed] = U7

[ArRopen] = U8

[I(r,t)J =U9

[EI] = U10

fE.jdeadj

=

(3

U n

Numerical reaction equations
<*(tfi)i
dt

2^[(f/i) 2 - (f/i)i] - 2kR1(U1)1(U3)i

-kR2{Ui)i(lJ,)i

+ fc/?-i(^4)i

(3

+ WL 2 a/s)i " ^1(^1)1(^2)1 + ^ - 1 ( ^ ) 1
(I/^iCO) = 0.17

mmoZe
cm-3

Fori = 2, 3,4, ..., 19
= ^ [ ( ^
-IkR^UiU^i

+

i - 2 ( ^ + (y 1 ) £ _ 1 ]+ :
+ kR-^UJt

-kE^UJtMh

D*

- kRziUJiCUJi
+ kE-dUelt

Wi)i(0-) = 0

[(f/i)t + i - 0/i)i-i]
+ fe/?_2(t/5)i

(3
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^

= 9A[Ainf - 2 ( 1 ^ 0 + ( f / l ) l 9 ]

+

- ^ [ ^

n /

- (^)19]

(3 85)

-

-2fe/? 1 ([/ 1 )20(^)20 + ^ - l ( ^ 4 ) 2 0 - ^ 2 ( ^ 1 ) 2 0 ( ^ 4 ) 2 0

+kR_2(U5)20 - kE1{\J1)20{U2)20 + kE-dUeho
(^1)20(0) = 0

Fori = 1,2, 3, ...,20
^ ^

= -kEdUJt^t

+ kE-dUelt + kE3(U7)t

QM)

(U2)i(0) = 0.845 mmole/cm3

Fori = 1,2, 3, ...,20
^ 2 i = kE^UMUzlt

- kE.x(JJz)t - kE2(U3)t

(187)

(£/3)t(0) = 0

Fori =1,2, 3, ...,20

rifl^t

._„_,.

._„,.

(3.88)

—^— = kE2(U3)i - kE3(U4)i
([/4)i(0) = 0

Fori =1,2,3, ...,20
^ ^

= -ZkRWMUslt

+ kR.±(U6h

(3 89)

'
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(^s)i(O) = 0.000664

mmole/cm3

Fori = 1 , 2 , 3, ...,20
^ ^

= 2kR1(U1MUs)t

~ kR-dUJi

~ kR2(UxUUe)t

- 2kR_2(U7)t

(3 90)

'

(UJM = 0

Fori = 1,2, 3, ...,20
d(U?)i

dt

= kR2(UMU6)t

- 2kR_2(U7)t - oR(U7)t + cR(U8)i

(3<91)

(t/ 7 ) £ (0) = 0

Fori = 1 , 2 , 3, ...,20
d(f/s)£
dt

<3-92>

«pr/M
wmM
= oR(U7)i ~ cR(Ua)t

TOt(0) = 0

fc/.^o)!

(3 93)

= 0/[(i/9)*+i - 2 ( % + a / 9 ) i + i i + ^ 5 [W* + i - W / - i ]

(3 94)

^ 1

= 29,[([f9)2 - ( ^ J - kh(JJ2\(JJ9)x +

'

(t/ 9 )!(0) = 0

Fori = 2, 3,4, . . . , 19

^ -

-fc/i(I/ 2 )t(^)« + W-i(t/io)i

'

75

(U9M0) = 0

^ ^ = 0,[V - 2«/9)20 + «/9)19] + ^
-fc/i (f/2)20(^9)20 +

[ V - Ww]

(3 95)

'

fc/-l(t/10)20

(l/ 9 ) 20 (0) = 0

Fori = 1 , 2 , 3, ...,20
d(U10)i
. . , „ W f f x , f ,„ .
,
.
m
=
fc/i(f/
)i(^
)i
~
fc/-l(tflo)f
~
k
ead(U
2
9
d
10)i
dt

(3.96)

(tfio)i(O) = 0

Fori = 1,2, 3, ...,20
dO/ii);
"77

(3.97)
— Kdeadl^loJi

(^ll)f(O) = 0

The inhibited enzyme reaction regime produces a coupled numerical system comprised of
11 variables distributed among 220 ODEs.
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Enzyme regeneration reaction regime:
Description:
This regime consists of 20 sub-volume elements, 12 chemical species, 13 separate
kinetic reactions,
Mobile species: A, OX, IOX
Immobile species: E, A-E, acE, R, AR, ArRclosed, ArRopm,

EI, E-fead

The initial concentration of A in the cleft is 0.17 mmole/cm3 for r < 25 nm, and
the concentration of A outside the cleft is Ainf for all t > 0. Species E-fead and R are
uniformly distributed throughout the cleft with initial concentrations of 0.845 mmole/cm3
and 0.000664 mmole/cm3, respectively. The initial concentration of OX and IOX in the
cleft is zero, and the concentration of OX and IOX outside the cleft is OXinf and IOXinf
for all t > 0. All other species have initial concentrations of zero.
Stoichiometric reaction network:
kEv

/££_!

A+E <

kE2

kE3

2kRv

kR2,

2kR-2

A+A • R ^

> A-R
,

1 A2 • Rclosed

j oR, CR

<

£^E.I.0Xk^E

> A2 • R°Pen

k
+ 0X

V™>

kR-i

A+R <

E.J«eaa

/"J Q o \

> A-E —• acE - » E + products

+

l.0X

Theoretical reaction equations:
2
d[A(r,t)]
, n ld[A(r,t)]
n d [A(r,t)]
D
dl
= A
^ 2 + DA~
Yr

+kR^[A

(3.99)
^R^Air.tybR}

• R] - kR2[A(r, t)][A • R] + kR_2[A2 • Rcl°™d]
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-fcE1[i4(r,t)][Jf] + fe£,_1[i4-F]
[4(500, t)] = 0,

Vt > 0

d[,4(0,t)]
= 0,
dr

Vt>0

3
[A(r,0)] = { 0.17 mmole/cm

0

0 < r < 25nm
otherwise

-jS- = -fcEi[i4(r, t)][F] +feE_![i4• £"] + fcE3[ac£] + kregen[E • / • OX]

(3 100)

'

[tf](0) = 0

^P-

= Atf^Cr,*)]^] -fcF_iU• E] - kE2[A • E]

(3101)

[A-E](0) = 0

d[acE]
,
- ^ =fc£2[,4• E] - kE3[acE]

(3.102)
{XLUZ)

[acE](0) = 0

^ 1 = -2kRt[A(r, t)][R] + kR-dA • *]

(3 103)

'
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[f?](0) = 0.000664 mmole/cm3

^

^

= IkRMiT, t)][R] - kR_x[A • R] - kR2[A{r, t)][A • R]

(31

°4)

+2kR.2[A2 • Rclosed]
[A-R](0) = 0

d[A2 • Rclosed)
, w
i =fc/?2[^l(r,t)][/l • R] - 2kR.2[A2 • /?<*««*]

(3.105)

-oR[A2 • Rclosed] + CR[A2 • R°Pen]
[A2 • Rclosed](0) = 0

d[A2 • i?°Pen]
, w
-^-^-j
- = 0/?[42 • Rdosed^ _ ^ ^

. Ropen]

(3 106)
V-lw>)

[A2 • Ropen](0) = 0

<*[£./«*««*]
- ^
i = -fc0*[£ • 7 de « d ][0*(r, t)] + fc_o;f [£ • 7 • OX]

(3.107)
}
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[E • r e a £ * ] ( 0 ) = 0.845

d2[OX(r,t)]

d\OX(r,t)]_
Dox

d~t

ld[OX(r,t)]
+Dox

dP

• Idead][OX(r,

-k0X[E

rnmole/cm3

r

a [o^(o,t)]
<5r

d

J^l

= 0,

OZ in/
0

[0*(r,O)] = [

d~r

t)] + k-ox[E

[0^(500, t)] = OXinf ,

(3.108)

'I-OX]

Vt >0
Vt>0
r = 500 nm
otherwise

= W * • ^ - ] [ 0 « r . O ] - k-oxW •/•<*]

(3109)

-Kegen[E 'I ' OX]
[E • I • OX](0) = 0

d[I-OX(r,t)] _
Ft
~

D,ox

d2[I • OX(r,t)]
+D 0X
dr*
' r

ld[I • OXjr.t)]
dr

+kregen[E -1 - OX]
[I • OX(500, t)] = I- OX *lnf,
d[I-OX(p.t)]
dt

_ (

[i-ox(r,Q)] = {

= 0,

/ • OXinf
0

Vt > 0

Vt > 0

r = 500 nm
otherwise

(3.110)
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Change of variable definitions:
[A(r,t)] = Ui

[E] = U2

[A-E] = U3

facEJ = U4

[R] = U5

[AR] = U6

[ArRclosed]

(3.111)

[ArR°Pen] = U8

= u?

(E-IdeadJ = U9

[OX(r,t)] = U10

[EIOX] = Uj,

[I-OX(r, t)J = Uj2

Numerical reaction equations:
^ ^ i = 29A[QJi)2 ~ 0/i)i] ~ 2fc/?1(i/1)1((/3)1 + kR.^U^
-kR2(UMU4\

+ fc/?_2(tf5)i - kE^UJ^h
(f/OiCO) = 0.17

(3 U2)

-

+ ^-1(^)1

vn.rn.ole

cm3

Fori = 2, 3, 4, ... , 19
^ ^

= ^ [ ( ^ i ) ( + i - 2(tfx)( + (Vi) ( -i] + ^ [ ( t / i ) t + i - (l/i)/-i]

-IkR^UMUJi

+kR_1(U4)i-kR2(U1)i(U4)i
-kEdUiMUih

+

(UMO) = 0

kE^Wt

+kR-2(Us-)t

(3>113)
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^

(1114)

= BA[Aiuf ~ 2(^)20 + ( ^ ) i j + ^ 5 [Ainr ~ (ffi)u]

-2fc/? 1 ([/ 1 ) 2 0 (t/ 3 )2o + ^ - 1 ( ^ 4 ) 2 0 - ^ 2 ( ^ 1 ) 2 0 ( ^ ) 2 0 +

-kE1(U1)20(U2)20

+

kR.2(U5)20

kE_t(U6ho

(^1)20(0) = 0

Fori = 1 , 2 , 3, . . . , 2 0
d(f/ 2 );
- ^ i = -kE1iU1)iCU2)t

(3.115)
+ kE-dU6)i

}

+ kE3(U7)t + kreaen{Ux^

(U2)i(0) = 0

Fori = 1,2, 3, ... ,20
^

i

= kEiQJJiMlt

~ kE.x{U3)t

- kE2(U3)t

(3 116)

'

(tf 3 )i(0) = 0

Fori = 1,2, 3, . . . , 2 0
d(U*)i
dt

.„„,,
. - „ , ,
= kE2(U3)i - kE3(U4)t

(3-117)

(U4)i(0) = 0

Fori = 1 , 2 , 3, ... ,20
d(U5)i
- ^ P = -2/c/? 1 (t/ 1 ) i ([/ 5 ) i + /c/?_1(f/6)i
(^s)i(O) = 0.000664

mmole/cm3

(3.118)
V
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Fori = 1 , 2 , 3, . . . , 2 0
^ ^

= IkR^UMU^i

- kR^CUJi

- kR^UMUJt

- 2kR.2(U7)i

(3 U9)

'

(f/6)4(0) = 0

Fori = 1,2, 3, . . . , 2 0
d(tf 7 )i
- ^ P = kR2(U1UU6)i

~ 2kR_2(U7)i - oR{U7)t + cfl(tf 8 ),

f3 120)
;
^

(t/ 7 ) 4 (0) = 0

F o r i = 1,2,3, ... ,20
d(U8)i

D m

.

_„.,.

(3.121)

(£U(0) = 0

Fori = 1,2, 3 , . . . ,20
d(U9)i
—^= -kOx(U9)i(U10)i
(f/9)i = 0.845

^ ~ ^

(3.122)
+

k_ox(U11)i

mmole/cm3

= 29OX[(U10)2 - (U10)±] - koAUJdUio)!

+ k-oxWidi

^ ' ^

(tfio)i(O) = 0

F o r i - 2 , 3,4, ... , 19
d{Ulo)i

= eox[W10)i+1

dt

(3

- 2(u10)t + 0/io)*-i]

Dox
KUio)i+i ~ (.U10)i-i\ - koxWMU^t
rj(Ar)

+

k-oxWiJi

(tfio)*(0) = 0

dt
+

;r7^[

o ;

- 0o*[ OXinf - 2(f/ 10 ) 2 o + (i/io)i9j

W ~ ^10)19] - ^(^9)20(^10)20 +

k_ox(uxl)

(#10)20(0) = 0

Fori = 1,2, 3 , . . . ,20
d(tfii)i
d t

(3
= kOx(U9)i(U10)i

- k_ox(U1±)i

-

KegeniUidt

(#ll)t(0) = 0

^12)1 _ ,„

rm ^

m

M

(^12)1(0) = 0

^

"•regen

m

^

(3-
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F o r i - 2 , 3,4, . . . , 1 9
d(£/i2)i
dt

r,

Di-ox

.

.

(

1

(3.128)

, i

(3-129)

[C«/12)I+1 - 0/ 1 2 )i-i] + "•re.gen
(U12)2(0) = 0

rf

(^)2Q

I'OX

+r

_

0

r

r,ox

_2(u

,

,

(u

i

C ^ U ' °^in/ - (^12)l9j + Kegen(U\l)20
(^12)20(0) = 0

The enzyme regeneration reaction regime produces a coupled numerical system
comprised of 12 variables distributed among 240 ODEs.
This completes the derivation of the numerical equations which describe the
reaction of all the molecular species in the neuromuscular junction during the three
reaction regimes. The same procedure would produce the computable numerical
equations for any known or postulated reaction network. Assumption of mass-action
dynamics greatly simplifies deriving the differential kinetic equations, and it is a valid
first assumption for simple reactions. However, kinetics which does not follow massaction dynamics is also common, especially with stoichiometrically complex reactions.
Therefore, all kinetic expressions should be supported and verified with experimental
data. All the kinetic expressions written in this model have been verified by experiment,
predominantly in vitro. There are also some investigations supported by in vivo
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experiments ([3], [4], [7], [66]-[68]). That endeavor is presently much more difficult and
provides one of the reasons why description of the molecular transport and reaction
events occurring in the neuromuscular junction depends heavily on mathematical models.

CHAPTER 4

MEASURMENTS AND MODELS OF
PRIOR INVESTIGATIONS
There is substantial literature describing and modeling all the chemical reactions
in the neuromuscular cleft, along with incorporation of the transport effects [3]-[5], [18][21], [57], [58], [66]. While many investigators have examined the reactions of
acetylcholine with acetylcholinesterase, acetylcholine with its receptor, and in vitro
inhibition of acetylcholinesterase and acetylcholine, the Jenkins-Szlavik model is the first
attempt to model the simultaneous reaction-diffusion dynamics of acetylcholine, receptor,
acetylcholinesterase, and a mobile acetylcholinesterase inhibitor, in an in vivo
environment. This work shall also demonstrate a novel model of the reaction-diffusion
kinetics of in vivo reactivation of inhibited acetylcholinesterase via exposure to oxime
species diffusing into the cleft. In addition, this model shows that cleft-averaged receptor
kinetics is valid at the time scales of interest because the receptors always show uniform
conformation states across the entire post-synaptic membrane during the action potential
regardless of the degree of enzyme inhibition.
Figure 4.1, from Miledi [9], shows the results of experimentally measured endplate currents from the frog neuromuscular junction. Part A shows the response when
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approximately five acetylcholine quanta were released into the cleft from a Ca+2 filled
pipette, in a region restricted close to the pipette tip. Part B shows the response for a
release of five to eighteen quanta diffusely scattered across the entire end-plate, and part
C depicts the result when about 300 quanta are released over the entire end-plate area.
The arrow in each picture represents the half-decline time of each event.

Figure 4.1. Post-synaptic potentiation: interaction between quanta of acetylcholine at the
skeletal neuromuscular synapse [9].

Figure 4.2 depicts experimental measurements from the same investigators for the
response of increasing doses of acetylcholine applied iontophoretically onto the motor
end-plate [9]. A 0.5 ms acetylcholine pulse was varied in amplitude, and the circle on
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each falling phase marks the half-decline time. This time is progressively prolonged with
increasing peak amplitude because of potentiation.

These pictures show the general

shape of the amplitude vs. time course of the end-plate current, and that there is little
difference in the time course of the end-plate currents generated by one or many
acetylcholine quanta under normal physiological conditions [3] - [10]. Since the end-plate
current is directly proportional to the conductivity of an acetylcholine receptor, the time
course of an end-plate current should have the same shape as the time course of the
number of conducting (open) acetylcholine receptors under "clamped" voltage
conditions, differing only by some scaling factor. The Jenkins-Szlavik model was
concerned with simulating the transport and chemical reaction events in the
neuromuscular junction, so the population vs. time course of open receptors was a natural
product of the calculations.

Figure 4.2. Post-synaptic potentiation: interaction between quanta of acetylcholine at the
skeletal neuromuscular synapse [9].
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The effect of acetylcholinesterase inhibition on the end-plate current is of great
importance, and it has been investigated through experiment and simulation by several
researchers. Miledi [10], as shown in Figure 4.3, measured the inhibition effect of several
enzyme inhibitors during an end-plate current event on skeletal frog muscle.
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Figure 4.3. Computer averaged end-plate currents showing the increasing decay time
with increasing exposure to acetylcholinesterase inhibitors [10].

Friboulet [57] and Naka [58], shown in Figures 4.4 and 4.5, respectively, also
simulated the effect of acetylcholinesterase inhibition directly on the population of open
receptors with time. These two models are in good agreement with each other and
experimental measurements. There have been many such simulations in the last three
decades, [3]-[8], [18]-[21], but these are two of the latest and each has excellent clarity.
Most of the others have been overtaken by the advancement of experimental technique
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and computing resources. For example, Wathey [18] developed a simulation that used
sophisticated mathematical and numerical techniques which were implemented to
compensate for the low capacity (and expense) of the computer memory available in
1979.
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Figure 4.4. The number of open receptors per acetylcholine quantum from Friboulet's
simulation [57].
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Figure 4.5. The number of open receptors per acetylcholine quantum from Naka's
simulation [52].

The diffusion constant of acetylcholine is a critical parameter in every simulation
of the neuromuscular junction. Friboulet used a diffusion coefficient of 2.0-10"9 cm2/ms,
Naka [58] used diffusion coefficients in the range: 2.5-10"10 ~ 4.0T0"9 (cm2/ms) in the
development of their model, Wathey [18] used a value of 3.0-10"9 cm2/ms, Madsen [19]
used 4.0-10" cm /ms, and the diffusivities used by Tsoukaias [69] were valued at greater
than 3.0-10"9 cm2/ms. Diffusion constants in biological tissue are especially difficult to
measure quantitatively [48], [69]-[71], so differences in the published values for the
diffusion constant is expected.
While the time course of a normal action potential is not sensitive to the amount
of acetylcholine present, these data show that the degree of acetylcholinesterase activity
can drastically alter the time and magnitude profile of an action potential. Regarding the
degree of enzyme activity, note that all of these investigators have addressed
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acetylcholinesterase inhibition either with in vitro chemical kinetics, or via a "blanket"
degree of defined inactivity in cleft simulation calculations [6], [10], [21], [24], [57],
[58]. While those methods of enzyme inhibition are serviceable ways to investigate
acetylcholine kinetics, they are also artificial and not versatile. A model in which the
enzyme inhibition emerged from the coupled kinetics of acetylcholine, neurotoxin, and
acetylcholinesterase would provide more insight and greater resolution in simulations of
the neuromuscular junction.

CHAPTERS

RESULTS AND DISCUSSION

For the Jenkins-Szlavik simulation being presented in this dissertation, a model
was constructed to represent the chemical transmission and inhibition process of
acetylcholine in the neuromuscular junction as a reaction-diffusion system. This system
model is a one-dimensional space, radially symmetric about the axis, and the generation
of the receptor states that leads to the miniature end plate potential is included in the
simulation. The system is comprised of twenty annular compartments in the radial
direction which take advantage of the dominance of radial transport over axial transport
[58] at the length scales of the neuromuscular junction to reduce the computational
requirements. While this model can be considered as something of a synthesis of similar
two dimensional models by Naka and Wathey, [57], [18], it simultaneously builds on
their work and omits details which were non essential to mitigate the computational load.
Despite the omitted details, this model captured the essential temporal and spatial
behavior of the reaction-diffusion processes occurring in the neuromuscular junction.
The

Jenkins-Szlavik

model

is

the

first

to

quantify

the

degree

of

acetylcholinesterase inhibition as a process emerging from the reaction-diffusion kinetics
as the neurotoxin diffuses into the neuromuscular cleft. An illustration of this feature is
shown in Figure 5.1. This figure depicts the concentration of neurotoxin and active
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acetylcholinesterase in the cleft as a function of time as the neurotoxin diffuses into the
cleft. The graph is intended for illustrative purposes only, as the diffusion constant of the
neurotoxin was assigned an unrealistically low value. This low value allowed the process
to spread over a larger portion of time to clarify the illustration. Notice that the two
concentration curves are not reflections, where one curve could be derived from
knowledge of the other. Instead, they result from genuinely coupled chemical and
diffusional kinetics. The known initial amount of enzyme and the known amount of
enzyme as a function of some later time (and location) are easily translated into a number
which represents degree or percentage of enzyme inhibition.

The concentration of neurotoxin and enzyme in the cleft,
averaged over 20 sub-volumes

8

10
time, s

12

20

Figure 5.1. An illustration of the dynamically coupled enzyme and neurotoxin
concentrations in the neuromuscular junction during the diffusion-reaction process.
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The primary function of a simulation of the events in the neuromuscular junction
is to measure the state of the acetylcholine receptors during the course of an action
potential. The result of the Jenkins-Szlavik model of that process is shown in Figure 5.2.
The figure below shows the simulation of different degrees of enzyme inhibition on the
time course of open receptors in the cleft under an acetylcholine diffusion constant of
9.0-10"10 cm2/ms. The result visually resembles the same process trends as Friboulet and
Naka. This qualitative resemblance is initially reassuring, but some kind of quantitative
comparison of the error between the Jenkins-Szlavik model and the Naka and Friboulet
models will be needed.

Total molecules of open receptor species A2R* in the whole cleft,
at 0, 25, 50, 75, and 100 percent enzyme inhibition,
averaged over 20 annular volume elements,
D = 9.00e-010 cm2/ms, 1.50 XquantumA
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Figure 5.2. The Number of open receptors per acetylcholine
quantum from the Jenkins-Szlavik simulation.
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Figures 1 3 , 1 4 , 1 5 , and 16 show a e o m p a m plat of the Jenkins-Szlavlk
model with the Friboulet and Naka models, respectively, and show the error between the
Jenkins-Szalvik model and the respective Friboulet and Naka models. The results of the
Friboulet and Naka simulations were derived from numerical integration of differential
equations, so no mathematical expressions for the receptor vs. time curves were
available. Therefore, it was decided to approximate the Friboulet and Naka results as
two-parameter exponential decay processes: Ropen(t) = ae

.

Hie Jenkins-Szlavik model compared to the Friboulet model,
where the Friboulet model is approximated as an exponential decay
2500 r
JenkiiK&lavik model: 100,75,50,25,0% inhibition

»Friboulet approximation, 100% inhibition
75% inhibition
50%inhibition
25% inhibition

Figure 5.3. A comparison of the Jenkins-Szlavik and Friboulet models of the time course
of open receptors in the neuromuscular junction with time. The Friboulet model is
approximated as a set of exponential decay processes.
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Error between Jenkins-Szlavik model and the Fnboulet model
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Figure 5.4. The relative error between the Jenkins-Szlavik model and the Friboulet model
for different levels of enzyme inhibition.

All the receptor vs. time curves contained an inflection point, which does not
occur in a pure exponential decay process, so it was necessary to model the Friboulet and
Naka approximations at a time point later than the inflection point for all the curves. The
point t = 0.5 ms was chosen as the initial point to begin the approximations, which still
left 90% of the time domain available for analysis. The measurements used to develop
the equations for the approximations had to be taken directly from the graphs of the
Friboulet and Naka models, and these measurements contain much uncertainty derived
from the thickness of each curve's ink, the interpolation between increments on the axes,
the thickness of the increment markers on the ruler, and other sources.
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The Jenkins-Szlauk model compared to the Naka model,
where the Naka model is approximated as an exponential decay
2500
Jenkins-Szlavik model: 100,75,50,25,0% inhibition
Naka approximation, 100% inhibition
2000

75% inhibition

» 1500

•2 1000

500

Figure 5.5. A comparison of the Jenkins-Szlavik and Naka models of the time course of
open receptors in the neuromuscular junction with time. The Naka model is approximated
as a set of exponential decay processes.
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Firgure 5.6. The relative error between the Jenkins-Szlavik model and the Naka model
for different levels of enzyme inhibition.
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From Figures 5.4 and 5.6, which show the error between the Jenkins-Szlavik
model and Friboulet and Naka models, respectively, it is seen that over the interval of
[0.75, 5.0] milliseconds (85% of the time domain), the error between the models is never
greater than ±13%, and for most of the curves it is less than ±10%. This magnitude is
acceptable when all the sources of error and uncertainty are considered [57], [58].
The error comparison figures also show that in general, the Jenkins-Szlavik model
agrees better with the Naka model than the Friboulet model, and the error of the JenkinsSzlavik model increases as the degree in enzyme inhibition increases in both the
Friboulet and Naka models. The Friboulet system modeled acetylcholine diffusion in one
direction and along the axis, and the process of acetylcholine leaving the cleft was
modeled as a uniformly distributed sink in space. The Naka system modeled
acetylcholine diffusion along the axis and radially, the process of acetylcholine leaving
the cleft was modeled as radial diffusion to the edge of the cleft and into the external
environment, and is a process closer to physical reality. Recall that the Jenkins-Szlavik
system modeled acetylcholine diffusion in one dimension along the radius, and modeled
acetylcholine leaving the cleft in the same manner as Naka. In all three models,
increasing the degree of enzyme inhibition caused a greater number of acetylcholine
molecules to remain in the system, which in turn causes the effects of acetylcholine
diffusion to become more prominent [57], [58].
The investigation of Naka presented evidence which asserted that radial diffusion
in the neuromuscular junction is of greater importance than diffusion along the axis. If
true, that assertion would explain why the Jenkins-Szlavik model agrees better with the
Naka model than the Friboulet model. In addition, since the Jenkins-Szlavik system
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models diffusion processes differently from the Friboulet and Naka systems, one would
expect the error between the respective models to increase as diffusion begins to
predominate, i.e. as the degree of enzyme inhibition increases [57], [58].
The equations (5.1) - (5.3) below, derive the relation between the time course of
Iep(.t) = E - gep(t)

(5.1)

<5-2>

Iep(t)= £-yR-JV»-(t)
N

I m

r

f fd[A2R°Pen]\

lep(f) = E-YR- J [

j

t

Js.

(5-3)

J dt

the open acetylcholine receptors and the end-plate current. The relation shows that the
end-plate current is directly proportional to the number of open receptors in time, and
means that the end-plate current differs from the number of open receptors only by a
multiplicative constant. This result also gives a method to couple the chemical and
diffusional kinetics occurring in the cleft to the current and voltage dynamics which
follow in the neurons.
The Jenkins-Szlavik model has been constructed such that it can show the
temporal and radial concentration gradients of all the chemical species involved in action
potential kinetics, in the normal and inhibited regime. In addition, this model is the first
simulation to attempt modeling the kinetics of acetylcholinesterase inhibition with an
organophosphorus compound and the effects of this inhibition on the action potential

while the inhibitor diffuses into the neuromuscular cleft. It would be possible for this
model to resolve the position of a moving interface between different chemical species if
the process of the inhibitor diffusion could create such an event. Of particular interest
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might be the moving boundary between normal and inhibited enzyme, and the state of
receptor conformation in the inhibitor-occupied and inhibitor-free zones. While this
model should be able to detect the boundaries between different chemical species,
subsequent calculations show that under the conditions extant in the neuromuscular
junction, these boundaries are not likely to exist. An illustration of this conclusion
follows in the next paragraph.
By definition, if the existence of an interface or boundary requires the presence of
a type of gradient, and the larger the gradient in the interval of its domain; then the
greater the distinction of the interface across that same domain. In this case, the gradient
would refer to the molar concentration of one or more chemical species as a function of a
spatial coordinate. The illustration of an idealized case of this concept would be helpful,
and Figure 5.7 below shows a concentration distribution where the inhibitor is diffusing
radially into the neuromuscular junction from the blood, under conditions that produce a
sudden and large increase in concentration for a small change in the radial position (often
called a step change in concentration). This sudden concentration increase can be
interpreted as the boundary between high and low concentrations of the inhibitor. If this
boundary evolves in time and position, then it is called a moving boundary. The gradient
of this concentration distribution would measure the relative intensity of the change with
position, and would provide a metric of how closely the concentration profile resembles
this step increase. Figure 5.8 shows the derivative of the concentration distribution with
respect to the cleft radius (called the gradient) of the idealized step function and it
resembles the shape of a Gaussian distribution. The larger the magnitude and narrower
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the spread of a given gradient, then the closer the associated concentration distribution
resembles an ideal step function, which leads to the possibility of resolving and tracking
the evolution of a moving interface between different chemical species in the cleft.

System specific concentration distribution

x10

0.05

0.1

0.15

0.2
0.25
0.3
radius, micrometer

0.35

0.4

0.45

0.5

Figure 5.7. The idealized "step" concentration distribution.

Qualitatively describing the shape of a concentration distribution curve or
gradient curve as a metric for the intensity of an interface is not sufficient for scientific
research: one does not have science until one has numbers. It would be useful to develop
a numerical scale for the concentration distribution and concentration gradient whose
magnitude would indicate the intensity of the interface across a known distance. It would
also be useful to have a numerical description of an interface intensity that was more
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generally applicable to a wide range of conditions and parameters, instead of a case-bycase or system-by-system interpretation.

System specific concentration gradient
0.018

0

0.05

0.1

0.15

0.2 0.25 0.3
radius, micrometer

0.35

0.4

0.45

0.5

Figure 5.8. The idealized "step" concentration gradient

Towards this goal is the introduction of the relative length, and relative
concentration distribution, given respectively by
r

rel —

C(r)rel =

0< r < R

(5.4)

0 < C(r) < C,max

(5.5)

R
C(r)

where r is the variable radial distance, R is the maximum radial distance, C(r) is the
concentration as a function of the radius, and Cmax is the maximum concentration
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achieved in the cleft volume. The relative length and relative concentration distribution
are derived by a simple and common nondimensionalization technique which maps the
length and concentration variables onto a dimensionless and universal scale. This scale
can be used to express any known concentration distribution in a standard form. When
the standard form of an ideal step concentration is known, then the scaled concentration
distributions of any other system can be compared to it and the degree of step
concentration "membership" of those distributions can be judged, as shown in Equations
(5.6) to (5.8) below

0 < C(r) < Cmax

C(r) = / ( r )

0 < C(r)rei • Cmax < Cmax

C(r)rel • Cmax = f(rrel

0 < C(r)rel < 1

0< r < R
• R)

f(rrel-R)
L

VJrel

~

(5.6)

0 < rrel • R < R (5.7)
0 < rrel < 1

(5.8)

T.
'-•max

However, applying this same scaling method directly on the gradient of the
concentration distribution would restrict those resulting relative gradient values to a
domain whose magnitude could never be greater than unity, a condition which is not
useful and difficult to interpret. A better way to create a standard scale for the
concentration gradient is to take the derivative of the relative concentration distribution,
C(r)rei, with respect to rrei, thus:
d{C(x)rei)_
—
u,

rel

1

.
fl(r
/ (Jrel -R)-R

(5.9)

'-max

Equation (5.9) shows that this definition of the relative concentration gradient is
primarily another constant scaling factor applied to the concentration gradient function,
but this definition does not restrict the gradient to values between zero and unity.
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Applying these concepts to the idealized step concentration distribution and step
concentration gradient introduced in Figures 5.7 and 5.8 will illustrate their utility. When
the ideal step concentration distribution and step concentration gradient are scaled to their
relative forms, the results are shown in Figures 5.9 and 5.10.
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Figure 5.9. The idealized relative "step" concentration distribution.

106

Relative concentration gradient
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Figure 5.10. The idealized relative "step" concentration gradient.

From these graphs it can be seen that for a concentration distribution to have
credible step-like qualities, there should be some continuous interval in the length
domain, less than or equal to 0.05 fraction of the total length, where the rate of
concentration change is on the order of at least 20 concentration units per length unit
across that interval. This method of eveluation can be used with any system of arbitrary
size and arbitrary concentration units. Intuitively, one should suspect that the best
conditions to detect the presence of a chemical interface within the cleft would be an
initially large difference in concentration of a diffusible species between the cleft and the
bloodstream. Let us imagine the military neurotoxin ^(molecular weight 267.4 g/mole),
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one of the fastest and most potent acetylcholinesterase inhibitors, as the neurotoxin
diffusing into the neuromuscular junction from the blood. The lethal dose of VX for an
average human is about 10 mg VX per kg body mass. An average adult human male has a
mass of 86 kg and a blood volume of approximately 5.0 liters. Therefore, the lethal VX
blood concentration is 0.68 mM in the blood [72]. Let us assume a venous injection
process of VX which produces that particular blood concentration as a logistic function
of time over a 5 second period, as shown in Figure 5.11. Further, imagine the process
subsequently maintains that concentration indefinitely

under conditions where

physiological detoxification mechanisms are negligible.

Blood concentration of inhibitor (species I) with time

0

1

2

3

Figure 5.11. A hypothetical venous injection of inhibitor.
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The known military grade neurotoxins are all small molecules whose diffusion
constant in blood plasma are not precisely known, but are assumed to be not much
different from that of acetylcholine diffusing through water. Literature sources of
information, [73] - [77], on molecules of a similar size as the military neurotoxins give
10

8

9

diffusion coefficient values in the range 2.5-10"" - 3.0-10"° cm /ms and the same
diffusion constant as that used for acetylcholine in [5], [57], [58], namely 9.0-10"10
cm /ms has been assumed for these molecules. A surface plot of the simulated VX
concentration, represented by [I], in the cleft as a function of the radial distance and time
is shown in Figure 5.12, where the rapid rise and apparently close to uniform
concentration along the radius of the inhibitor can be viewed. The cleft reaches saturation
of inhibitor in 2.5 seconds.

concentration distribution of inhibitor, species I

Figure 5.12. The simulated concentration distribution of inhibitor in the neuromuscular
junction during diffusion.
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The curves shown in Figures 4.4, 4.5, 4.6, and 5.2 depict the concentration of a
substance as a function of time in a single, well mixed volume. The curves are naturally
smooth over the time domain because several hundred time points are calculated, and
separated by a small interval (A/) between them. The reader should now recall that in this
case the cleft of the neuromuscular junction is modeled as a cylinder with a very small
height to base ratio, and that cylindrical volume has been sectioned into 20 concentric
annular sub-volumes. In Figure 5.12 the simulation data has been arranged to represent a
cross-section of all the annular rings in sequence, along with their inhibitor concentration
data. Referring to the radius scale in Figure 5.12, 0 micrometers represents the center of
the cleft, and 50 micrometers represents the cleft/bloodstream interface. This radial
distance has been divided into 20 sections (Ar = 2.5 micrometers) each of which
represents one of the annular volumes, and the concentration in each of these sections as
a function of time has been plotted. Because Ar is large compared to the total radial
distance, a direct plot of the concentration vs. radius data would not necessarily appear
smooth. Therefore, it is more useful to fit a polynomial curve to the data via a regression,
and plot the derived polynomial curve.
Figure 5.12 shows multiple concentration vs. radius distributions in the
neuromuscular junction during the venous injection of VX process that was shown in
Figure 5.11. Figure 5.12 depicts these distributions over a 10 second period, where each
curve has been sampled at 200 millisecond intervals in the domains where the
concentration was rapidly changing. The maximum concentration of 0.68 mM is reached
at between 2 and 3 seconds (see Figure 5.11); however, no significant concentration
gradients are obviously visible for any of the distributions. After a period greater than 3
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seconds the cleft is saturated with the inhibitor, and the concentration distribution is
uniform throughout the cleft volume. A quadratic polynomial gave the best fit for the
data, shown as Equation (5.10):
[I](r) = ar2 + br + c
a = 8.8700 • 1 0 - 4

b = 0.0000

(5.10)

c = 0.0006

The polynomial coefficients a, b, and c shown in Equation (5.10) were arithmetically
averaged over the coefficient values of all the regressed polynomial distribution curves.
Even though the distribution curves appear flat with no significant gradients, such
a qualitative judgment is of course not sufficient. A numerical description of the
concentration gradients in the cleft during this injection process should be analyzed.
Figure 5.13 shows the concentration gradients of the same process in time and space, and
better illustrates the magnitude of the concentration differences along the radius. These
gradient curves were determined from the derivative of each of the quadratic
concentration distribution curves shown in Figure 5.12, and the surface in Figure 5.13 has
been rotated to a different perspective from that of Figure 5.12 to provide a better
intuitive grasp of the space and time relationship of the gradients. The axes in both
figures occupy the same relative positions and represent the same information. Figure
5.13 shows a series of gradient curves plotted over the same 10 second period and
sampled at approximately 200 millisecond intervals in the domain where the gradient was
changing rapidly. The curves show a concentration gradient process which is initially
zero across the entire radius, then shows linear relations which increase in slope to a
maximum value over time, and then the slopes of the linear relations decrease with time
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back to a zero value for the gradient across the radius. The maximum gradient value is
15.010" mM/cm and located at the radius end-point where the cleft interfaces with the
bloodstream. These results mesh with the process shown in Figure 5.12, as the quadratic
concentration distribution curves will have concentration gradient curves which are
linear. Initially, the distribution of inhibitor in the cleft is zero, and so it has a gradient of
zero as well. As the inhibitor enters the cleft, there should be some time when the
differences of inhibitor concentration along the radius in the cleft should be the greatest,
and this corresponds to a maximum value for the gradient at that time and location.
Finally, when the cleft is saturated with inhibitor, the concentration distribution will be
uniform, and at this same time the concentration gradient in the cleft will be zero.

concentration gradient of inhibitor, species I
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Figure 5.13. The simulated concentration gradient of inhibitor during diffusion into the
neuromuscular junction.
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Surface plots show the complete time and space relationships of the inhibitor
concentration in the cleft, but this can be more information than is needed to interpret the
relevant essential points in this analysis. Once the reader has an intuitive understanding of
the general shape of the time, space, and concentration function in the cleft provided by
the surface plots, it might be easier to interpret the salient characteristics of the inhibitor
diffusion process with ordinary concentration vs. radius graphs where time dimension is
presented as a set of level curves for different time values. Figure 5.14 shows the
inhibitor concentration distributions of Figure 5.12 projected onto the concentration vs.
radius plane, where the initial distribution is plotted with the symbol "x" and the final
distribution uses the symbol "o".

1Q"4

concentration distribution Df inhibitor, species I

Figure 5.14. The inhibitor concentration distributions in the cleft,
where Di = 9.0-10"10 cm2/ms, over a time period of 10 seconds.
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The distribution level curves are seen rising rapidly from zero and subsequently
crowding around the final cleft saturation value as time increases. Figure 5.15 shows the
inhibitor concentration gradients of Figure 5.13 projected onto the concentration vs.
radius plane, where the initial gradient is plotted with the symbol "x" and the final
gradient uses the symbol "o". The gradient level curves rise from zero to a maximum
value and decrease back to zero as time increases. The linear nature of these gradients is
easily seen in this type of graph. In both graphs the level curves were sampled frequently
where the concentration was changing rapidly, and sampled sparsely where the
concentration changed slowly. Because of this, the different level curves do not represent
a constant time interval between them.

Figure 5.15. The inhibitor concentration gradients in the cleft,
where Di = 9.0T0"10 cm2/ms, over a time period of 10 seconds.
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In Figures 5.12 and 5.14, the concentration distributions seem very flat across the
cleft radius, yet the representation of the gradients in Figures 5.13 and 5.15 suggest that at
certain times the gradients might be large. For this reason we shall now compare the
analysis in the previous paragraphs with the analysis which follows using the relative
concentration data. Normalizing the simulation data used to generate Figures 5.12 and
5.14 to their relative scales results in the graph depicted in Figure 5.16.
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Figure 5.16. The normalized inhibitor concentration distributions in the cleft,
where Di = 9.0-10"10 cm2/ms, over a time period of 10 seconds.
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Figure 5.16 shows the inhibitor concentration distributions of Figure 5.12
normalized and projected onto the concentration vs. radius plane, where once again the
initial distribution is plotted with the symbol "x" and the final distribution uses the
symbol "o". The distribution level curves rise rapidly from zero and subsequently crowd
around the final cleft saturation value as time increases. However, in this case it is also
seen that the level curves have a negligible slope (gradient) over time, which terminates
at a zero value as the concentration of inhibitor in the cleft reaches saturation. Because it
is known from the relative idealized step gradient (Figure 5.10) that a valid concentration
interface needs at least 10 concentration units per length unit over a continuous distance
that is less than 0.05 fraction of the total radius, we can easily conclude that no
concentration gradients significant enough to produce a concentration boundary exist in
the cleft under the conditions of this simulation. After 500 milliseconds no gradients large
enough to be considered as possible concentration boundaries exist anywhere in the cleft.
It would be useful to find the neurotoxin diffusion constant magnitude at which the
Jenkins-Szlavik model predicts concentration boundaries might resolve in the
neuromuscular junction.
In Figure 5.17 the level curves of normalized concentration distribution are shown
for a neurotoxin diffusion constant decreased by a factor of 10, sampled at 100
millisecond intervals over a period of 20 seconds. The gradients of the level curves are
seen to be negligible over the entire time domain.
Figure 5.18 shows the normalized concentration distribution curves for a
neurotoxin diffusion constant decreased by a factor of 100, and the same sample interval
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and time duration. The first few level curves show a small gradient that rapidly decays to
zero in a period of twenty seconds.
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Figure 5.17. The normalized inhibitor concentration distributions in the cleft,
where Di = 9.0-10" cm Iras, over a time period of 20 seconds.

In Figure 5.19 the neurotoxin diffusion constant is decreased by a factor of 1000,
and the level curves are sampled at 150 millisecond intervals over a period of 30 seconds.
It is seen that significant concentration gradients are predicted to exist in the cleft for
approximately 1.5 seconds. However, these gradients are not large enough to resolve a
boundary between concentrations over a distance less than 0.05 fraction of the total
radius. A diffusion constant approaching the magnitude of 10"13 cm2/ms is not physically
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realizable in a biologically functioning neuromuscular junction for molecules the size of
the known organophosphorus neurotoxins.
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Figure 5.18. The normalized inhibitor concentration distributions in the cleft,
where Di = 9.0-10"12 cm2/ms, over a time period of 20 seconds.

The data from this simulation shows that the concentration gradients of a
neurotoxin in the cleft are never very large at the values for the diffusion coefficients,
blood concentration, and length of time conditions which exist for typical biological
processes. The concentration of inhibitor in the neuromuscular junction and in the blood
are essentially always in equilibrium because the inhibitor transports throughout the cleft
essentially as fast as it enters the blood. The optimal conditions to create a concentration
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interface (for example between inhibited and normal acetylcholinesterase) inside the cleft
would be a very rapid, and preferably high, concentration increase of inhibitor in the
blood, coupled with a very small diffusion coefficient for the inhibitor within the cleft. A
much longer radial diffusion length would also increase the likelihood of an interface
being able to resolve.
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Figure 5.19. The normalized inhibitor concentration distributions in the cleft,
where Dj = 9.0-10"13 cm2/ms, over a time period of 30 seconds.

Most humans will quickly begin dying at VX blood concentrations higher than
0.68 raM [72], [48], [49], so the modeling of larger concentrations does not seem useful.
Faster methods to administer a lethal dose of toxin certainly exist, but most exposure
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events involving military neurotoxins will likely produce infiltration rates on the order of
minutes, or slower. Simulations with different diffusion coefficients produced data
showing that significant radial concentration gradients do not appear in the cleft until the
diffusion coefficient of the inhibitor is on the order of 10"12 cm2/ms or smaller. In
summary, this simulation shows that the volume of the neuromuscular junction will not
contain sharp concentration interfaces of inhibitor, enzyme, or significantly different
receptor states along its radius, and the assumption of a uniformly mixed inhibitor
concentration in the neuromuscular junction is valid. The kinetic events can be
adequately modeled by summation of the discrete radial inhibitor concentration values
and averaging them over the whole volume of the cleft.
It is well known that acetylcholinesterase is concentrated in the neuromuscular
junction. This enzyme is also embedded in the membranes of erythrocytes, where it is
thought to affect the functional life-span of red blood cells [78], [79], and occurs in other
tissues with a non-quantified distribution. It has also been established that in the military
or terrorist event context, the levels of exposure to military-grade neurotoxins can lead to
severe incapacitation and lethality within minutes [50], [72]. These conditions, along with
other factors such as the severe ethical barriers, combine to make the quantifiable time
course of the total degree of acetylcholinesterase inhibition throughout the human body a
non-trivial problem. Determining the parameters and exposure conditions needed to
establish such a relationship could become the core of a future research project.
It is possible to reactivate organophosphorus (OP) poisoned acetylcholinesterase
in vitro [12], [51], [80] - [84]. Therapeutic regimens using oxime compounds to
rehabilitate acetylcholinesterase have been developed as part of the clinical treatment for
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OP toxin exposure as well [50], [85], [86]. At this time, the standard treatment of
poisoning by OP-type toxin includes the administration of atropine (an antimuscarinic
agent) and obidoxime or pralidoxime as the enzyme reactivators.
Nerve

agents

act

by

inhibiting

the

hydrolysis

of

acetylcholine

by

acetylcholinesterase. They bind to the active site of acetylcholinesterase, rendering it
incapable of deactivating acetylcholine. Acetylcholine that is not hydrolyzed can
continue to interact with the postsynaptic receptor, which results in persistent and
uncontrolled stimulation of that receptor. After persistent activation of the receptor,
fatigue results. This is the same principle exhibited by the depolarizing neuromuscular
blocker succinylcholine. The clinical effects of nerve agents are the result of this
persistent stimulation and subsequent fatigue at the acetylcholine receptor. In an initial
step, the enzyme becomes inactivated, but not permanently. Some degree of reactivation
of the acetylcholinesterase enzyme occurs in this initial phase, but the process is slow. An
additional reaction between acetylcholinesterase and the nerve agent makes their
interaction irreversible, a phenomenon known as aging. The aging kinetics of VX is
completed after a period of approximately 48 hours [80]. For the clinical effect to be
reversed after aging occurs, new enzyme must be produced. This irreversible bond is one
difference between the reactive chemistry of organophosphate compounds (including
nerve agents) and carbamates, which bind reversibly to acetylcholinesterase. This concept
is also used for pretreatment of military personnel with the carbamate pyridostigmine
[87]. The qualitative kinetics of these reactions are becoming better understood, and
computational models for these reactions in vitro have been developed and published
[88]. Removal of the phosphyl moiety from the serine in the enzyme's active site is the
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primary mechanism of oxime action, and the Jenkins-Szlavik model is the first attempt to
computationally describe the kinetics of OP inhibited acetylcholinesterase reactivation
with oxime compounds in vivo. If the kinetic parameters are known, it is of course no
more difficult to compute the chemical dynamics of the reactivation reactions than it was
for the inhibition reactions. The adult OP-therapy dosage is 1-2 grams of pralidoxime
(137.16 g/mole) given intravenously over a period of 20-30 minutes [86]. The heart
pumps about 5 liters per minute and the human body holds about 5 liters, so within about
a minute most of the blood has made one circuit and can be modeled as uniformly mixed
[70], [79]. After 2 minutes, most of the blood has circulated twice through the
vasculature, and anything that did not mix the first time would be further equilibrated
throughout the blood medium during subsequent laps through the circulatory system.
Given this rapid blood mixing time relative to the period of pralidoxime administration,
then the rate of molar pralidoxime delivery to the blood can be treated as constant at 1.46
nmole-cm'^ms"1. The Jenkins-Szlavik simulation was used to model the process of
clinical acetylcholinesterase reactivation in one typical neuromuscular junction under the
following conditions: initially zero active enzyme, the diffusion constant of pralidoxime
was the same as that of acetylcholine, and the therapy began after the amount of
neurotoxin (VX) remaining in the blood became negligible.
Figure 5.20 below shows the average amount of inhibited enzyme in the cleft
decreasing with time from the initial value of 7.4-10" mmole/cm to zero in a five minute
time period. Figure 5.21 depicts the regeneration of acetylcholinesterase as the average
amount in the cleft rises from an initial value of zero to 7.4-10"5 mmole/cm3 (the amount
of enzyme in a normal junction) in the same time period.

122
The amount of species E*dead in the whole cleft averaged over 20 annular volumes
-5
D,oxime = 9.00e-010 cm 2 /ms
r
x 10
8r

Figure 5.20. The average amount of inactive acetylcholinesterase
in the cleft during oxime therapy.

Figure 5.22 shows the assumed linear rate of therapeutic pralidoxime entering the
junction via the method of injection. Keep in mind that this simulation models the
reactivation of enzyme which is occurring in one typical neuromuscular junction. In a
genuine therapy situation, the neuromuscular junction population would have differing
amounts of enzyme inhibition; the oxime kinetics would also reactivate the
acetylcholinesterase throughout the body, not just the neuromuscular cleft. Those
conditions, and other metabolic factors, suggest that recovery from a serious OP
neurotoxin event would (of course) require more time and resources than five or ten
minutes of chemical therapy. At this stage, these simulation results have been presented
as a proof-of-concept which has a high degree ability to assist the development of
feasible therapies to counter organophosphorus poisoning.
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Figure 5.21. The average amount of active acetylcholinesterase in the
cleft during oxime therapy.

This concludes the results portion of the dissertation. It has been shown that this
model can duplicate the experimental and simulation results of prior published research
concerning the normal and inhibited kinetics of the chemical species in the
neuromuscular junction during an action potential event. Further, it was shown that this
model is the first to simulate those kinetic events in vivo as a neurotoxin is
simultaneously diffusing into the neuromuscular junction, rather than first artificially
setting the degree of acetylcholinesterase inhibition to some value, then starting the
simulation. The model demonstrated the potential to detect and resolve moving
boundaries between concentration interfaces or different chemical species, and it was also
shown that these boundaries do not exist in the normal biological environment of the
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neuromuscular junction. Finally, this model is the first to simulate the regeneration of
organophosphate inhibited acetylcholinesterase in the neuromuscular junction in the
presence of an oxime compound diffusing into the cleft. It was shown that, in principle,
this enzyme regeneration process is no more difficult to simulate than the enzyme
inhibition process. The caveat of "in principle" is mentioned because coupling the
enzyme regeneration results with quantifying the efficacy of therapeutic oxime infusion
is another complex issue.

The amount of species OX in the whole cleft averaged over 20 annular volumes
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Figure 5.22. The average concentration of oxime in the cleft during oxime therapy.

CHAPTER 6

FUTURE WORK
Jenkins and Szlavik used a one dimensional diffusion model which took
advantage of geometric symmetry to focus on the dominant transport effects. It was
shown that the Jenkins-Szlavik simulation can reproduce the work of earlier research in
depicting the time and spatial course of a normal action potential, and the time and spatial
course of action potentials influenced by different degrees of acetylcholinesterase
inhibition. This is the first simulation to achieve a model of acetylcholinesterase
inhibition during the diffusion of a neurotoxic inhibitor into the neuromuscular junction,
and show the altered subsequent action potentials. Jenkins and Szlavik illustrated how
this simulation could detect the time and space dynamics of moving concentration
gradients in the neuromuscular junction under suitable conditions. In addition, this model
showed an in vivo simulation of inhibited acetylcholinesterase being returned to the
active state through the kinetics of pralidoxime therapy.
The mathematical method used in these simulations easily generalizes to a
complete three dimensional transport model of the diffusion-reaction processes occurring
in the neuromuscular junction. In most previous cleft models, the model was constructed
such that the injection of acetylcholine molecules is assumed to be a single quanta
entering at the center of the presynaptic membrane. However, freeze-fracture images, and
electron micrograph images, suggest that several quanta can simultaneously enter
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the cleft at different locations on the presynaptic memtaa surface. Figure 6.1 shows an
electron micrograph of acetylcholine vesicles in the presynaptic membrane, prior to
release of acetylcholine into the gap of the neuromuscular junction. The vesicles can be
seen distributed along the boundary of the gap. With a complete 3D transport-reaction
model (in cylindrical coordinates), the Jenkins-Szlavik model could address any valid
criticisms of centered-membrane-quanta models, and investigate the effects of
acetylcholine entering the cleft in different sectors.

Figure 6.1. An electron micrograph image of transmitter vesicle release at the
neuromuscular junction [30].

Figure 6.2 shows an example of this type of three dimensional model and the
structure of the coordinates. The detail resolved by the number of levels, annuli, and
sectors would, in principle, be limited only by the available computing power.
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Figure 6.2. An example of a three dimensional discretization of the
neuromuscular junction composed of three levels,
nine annuli, and seventy-two sectors.

The Jenkins-Szlavik model has a large potential to advance the therapeutic
methods of regenerating organophosphorus damaged acetylcholinesterase. The in vitro
kinetic models of this therapy are well established, but effective therapy for living
systems will require investigation of models that reflect a structure closer to that of the
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living systems. A model of the regeneration kinetics of acetylcholinesterase in the cleft is
a step closer to that goal.
This model can also provide a framework to develop models of prevention of
organophosphorus trauma, and prevention is a better countermove than therapy. The core
of this prevention process is human butylcholinesterase, and it is used something like a
"vaccine" to the organophosphorus "infection". This enzyme is closely related to
acetylcholinesterase, but it is not crucial to neuronal signaling. Butylcholinesterase is
found in glial cells and plasma; however, the detailed distribution of butylcholinesterase
in the human body is not known [37]. Because its structure is close to
acetylcholinesterase and it is a component of plasma, butylcholinesterase can be used as a
method to protect against organophosphorus poisoning in an animal model. The basic
strategy is to pretreat the blood with an infusion of butylcholinesterase before the
encounter with neurotoxin, whereupon it can "soak up" the toxin before the toxin can
enter the neuromuscular junction. This strategy of protection is an active area of research
and significant progress has been made with kinetic models and experimental
measurements [89]-[91]. Certainly the development of therapies and pharmacological
preventions to neurotoxin trauma is never trivial, but a big advantage of working with
butylcholinesterase is that it occurs in the body naturally, so toxicity issues are
minimized. The kinetic model of the reactions in the cleft used in the Jenkins-Szlavik
model can be readily adapted to address the chemistry of neurotoxicity prevention. It
would be a simple matter to couple the kinetics of butylcholinesterase reacting with
neurotoxin in the blood (well mixed) with the diffusion-reaction kinetic events in the
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neuromuscular junction in time and space. It would even be possible to examine the
effectiveness of butylcholinesterase combined with pyridostigmine, or other therapeutics.
This method-of-lines algorithm has a level of detail that is simple to scale up, and
is easily "tuned" to many kinds of physical models. Any number of mobile or immobile
chemical species can be implemented, along with their respective kinetic and diffusion
constants. Source and sink terms can be applied as a function of any of the system
variables, and at any location. In a real sense, the only practical limit is the degree of
computing power available. The Jenkins-Szlavik simulation provides an opportunity to
recursively couple a highly flexible model to data from experiments supported by stateof-the-art instruments, and this recursive coupling is an excellent way to quantify and
advance our knowledge of the processes that occur during neuromuscular transmission.

APPENDIX A
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MATLAB SOURCE CODES
% THIS PROGRAM QUALITATIVELY WORKS
% Models the complete normal and inhibited chemistry in the neuromuscular junction;
% the model consists of a series of instantly and uniformly mixed
% volumes which share transport of Acetylcholine via 1D diffusion at
% each adjacent border
%
% VOLUME 1
% f(t)
>A
%
%
% VOLUME 2 - 4 0
%
kD

% A —> @
%
%U1 U2 kE1 U3 kE2 U4 kE3 U2
% A + E <—> AE — > acE —-> E + ChP
%
kE_1
%
% U2
U9 kl1
U10
% E + I <—>
El
%
% U10 kjJead
U11
% El
> E dead

%
% VOLUME 41 - 50
%U1 U5 2*kR1
U6
%A + R <
> AR

%

kRJ

%
%U1 U5 kR2 U7
%A + AR <
>A2R
%
2*kR_2
%
% U7
oR
US
%A2R
<
> A2R*
%
CR

% five CSTR uniform volumes,
%function MQL_50

clc;
clear;
clear;
A j n f = 0.0; % mM
IJnf = 1.65e-7; % mM
% total volume in the cleft
V_cleft = 3.93e-17;%(L)
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% the length of the cleft (width, or height) (LA1/3)
L_cleft = 5.0e-7;
% the radius of the cleft (LA1/3)
R_cleft = 5.0e-6;
% the number of equal axial disks
P = 1;
x_cleft = zeros(1 ,P)
% the number of annular rings per disk
Q = 20;
% number of coupled sub-volumes
S = P*Q
%thickness of each radial annulus
dr = R_cleft/Q;
%thickness of each axial disk
dx = L_cleft/P;
% area of the cleft edge
Area_edge = 2*pi*R_cleft*L_cleft;
% axial direction vector
x = linspace(0.0, L_cleft, P+1);
%radial direction vector
r = linspace(0.0, R_cleft, Q);

% This loop assigns an x-value coordinate to the center of each well mixed
% axial disk
forj = 1:P
x_cleftG) = 0.5*(xG) + x(j+1));
end
x_cleft;
% create the "space", a 1-dimension vector that all the axial and radial volume points are mapped
% into
s = [1:S];
% axial diffusion constant (cmA2/ms)
D_x = 2.0e-9;

% radial diffusion constant for Ach (LA2/3*msA-1)
D_r = 3.50e-11;%3.50e-11
% radial diffusion constant for the inhibitor
D_r_tox = 3.5e-11;
%number of time points
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N=2000;
%number of time samples
n_sample = 15;
N_grad =floor(linspace(1, N, n_sample))%these values need to be integers because they will be
vector indices

%time interval vector for the normal and inhibited reactions (ms, 1e-3 s)
t_0 = 0.0; t_f = 5.0; % ms
t = linspace(tj), t_f, N);
tspan = [t];
%time interval vector for the diffusing toxin reaction
t_tox_0 = 0.0; t j o x j = 4.0e+7; % ms
t_tox = linspace(t_tox_0, t_tox_f, N);
tspan_tox = [t_tox];

% pulse parameters
t_on = 3.0; t_off = 4.50; %*THIS IS NOT THE TIME INTERVAL*
n_on = round((((t_on - t_0)/(t_f - t_0))*(length(t)-1)) + 1);
n_off = round((t_off - t_0)*(length(t) -1)/(t_f -1_0) + 1);
peak = round(0.5*(n_on + n_off));
spread = 20.0;
magnitude = 0.50;

% calculate the volume of each annulus
volume = zeros(1 ,Q); % ( L )
vol_frac = volume;
fori=1:Q
volume(i) = ((2*i-1)/QA2)*pi*L_cleft*R_cleftA2;
vol_frac(i) = volume(i)A/_cleft;
end
sum(volume(1 :Q)); % a check of the annuli sum should equal the V_cleft
sum(vol_frac(1 :Q));
V_cleft;
% forward and backwards difference vectors
r_grad_b = r(2:length(r));
r_grad_f = r(1 :length(r)-1);

% defining the initial value vectors of the diffusing toxin reaction reactants
A_0_tox = zeros(1 ,S);
E_0_tox = zeros(1 ,S);
AE_0_tox = zeros(1 ,S);
acE_0_tox = zeros(1 ,S);
R_0_tox = zeros(1,S);
AR_0_tox = zeros(1 ,S);

A2R_0_tox = zeros(1 ,S);
A2Ro_0_tox = zeros(1 ,S);
l_0_tox = zeros(1,S);
EI_0_tox = zeros(1,S);
E_dead_0_tox = zeros(1 ,S);
ChP_0_tox = zeros(1,S);
% defining the initial value vectors of the normal AP reaction reactants
A_0_n = zeros(1 ,S);
E_0_n = zeros(1 ,S);
AE_0_n = zeros(1,S);
acE_0_n = zeros(1,S);
R_0_n = zeros(1 ,S);
AR_0_n = zeros(1 ,S);
A2R_0_n = zeros(1 ,S);
A2Ro_0_n = zeros(1 ,S);
ChP_0_n = zeros(1,S);
% defining the initial value vectors of the inhibited AP reaction
% reactants,
A_0_i = zeros(1,S);
E_0_i = zeros(1,S);
AE_0_i = zeros(1 ,S);
acE_0_i = zeros(1 ,S);
R_0_i = zeros(1,S);
AR_0_i = zeros(1 ,S);
A2R_0_i = zeros(1 ,S);
A2Ro_0_i = zeros(1,S);
I 0 i = zeros(1 ,S);
EI_0_i = zeros(1,S);
E_dead_0_i = zeros(1 ,S);
ChP_0_i = zeros(1 ,S);

factor_R= 1.0;
standard_R = 0.664;
% Toxin diffusion reaction initial cleft values of A, E, R in mM
A_0_tox(1,1) =
0.0; % in mM (10 annuli is used as the control reference)
E_0_tox(1,:)=
0.0277; % in mM
R_P_tox(1,:) =
factor_R*standard_R; % in mM
% Toxin diffusion reaction initial value vector
W0 = [A_0_tox ... A ( V(1 )-V(Q))
E_0_tox ... E ( V(Q+1) - V(2Q))
AE_0_tox ...AE (V(2Q+1)-V(3Q))
acE_0_tox ... acE ( V(3Q+1) - V(4Q0))
R_0_tox ... R ( V(4Q+1) - V(5Q))
AR_0_tox ... AR ( V(5Q+1) - V(6Q))
A2R_0_tox ... A2R ( V(6Q+1) - V(7Q))
A2Ro_0_tox ... A2R* ( V(7Q+1) - V(8Q) )
l_0_tox ... I(V(8Q+1)-V(9Q))
El_0_tox ...EI ( V(9Q+1) - V(10Q))

E_dead_0_tox ...E_dead ( V(10Q+1) - V(11Q))
ChP_0_tox...ChP(V(11Q+1)-V(12Q) )
];

E_tox = zeros(length(t), length(r)); % toxin diffusion enzyme reaction matrix
R_tox = zeros(length(t), length(r));% toxin diffusion receptor reaction matrix
l_tox = zeros(length(t), length(r)); % toxin diffusion inhibitor of esterase
EI_tox = zeros(length(t), length(r)); % toxin diffusion enzyme-toxin reaction matrix
E_dead_tox = zeros(length(t), length(r)); %toxin diffusion poisoned enzyme reaction matrix

E_cleft_tox = zeros(N,1); % toxin diffusion reaction species
R_cleft_tox = zeros(N,1);
l_cleft_tox = zeros(N,1);
Elclefttox = zeros(N,1);
E_dead_cleft_tox = zeros(N,1);
molecule_E_cleft_tox = zeros(N,1); % toxin diffusion reaction species
molecule_R_cleft_tox = zeros(N,1);
molecule_l_cleft_tox = zeros(N,1);
molecule_EI_cleft_tox = zeros(N,1);
molecule_E_dead_cleft_tox = zeros(N,1);

% run the diffusing toxin reaction function
[t_tox, W]= odel 5s(@Func_Radial_toxin_kinetics, tspanjox, WO, rj, D_x, D_r, D_r_tox, r, dx, dr,
t_on, t_off);

for i = 1 :length(t) % time length vector
forj = 1:length(r) % radius length vector
E_tox(i,j) = W(i,j+Q); % toxic diffusion reaction species
R_tox(i,j) = W(i,j+4*Q);
l_tox(i,j) = W(i,j+8*Q);
Eljox(ij) = W(i,j+9*Q);
E_dead_tox(i,j) = W(i,j+10*Q);
end
end
% calculate the total amounts of these species in the cleft
fori = 1:N
forj = 1:Q
E_cleft_tox(i) = E_cleft_tox(i) +(volume(j)*E_tox(i,j))A/_cleft; % toxin diffusion molar
species
R_cleft_tox(i) = R_cleft_tox(i) +(volumeO)*R_tox(ij))A/_cleft;
l_cleft_tox(i) = l_cleft_tox(i) +(volumeO)*IJox(i,j))A/_cleft;

EI_cleft_tox(i) = EI_cleft_tox(i) +(volume(j)*EIJox(i,j))A/_cleft;
E_dead_cleft_tox(i) = E_dead_cleft_tox(i) +(vdume(j)*EjJead_tox(ij))/Vj:left;
molecule_E_cleft_tox(i) = E_cleft_tox(i)*V_cleft*(6.02e+20); % toxin diffusion molecule
species
molecule_R_cleft_tox(i) = R_cleft_tox(i)*V_cleft*(6.02e+20);
molecule_l_cleft_tox(i) = l_cleft_tox(i)*V_cleft*(6.02e+20);
molecule_EI_cleft_tox(i) = EI_cleft_tox(i)*V_cleft*(6.02e+20);
molecule_E_dead_cleft_tox(i) = E_dead_cleft_tox(i)*V_cleft*(6.02e+20);
end
end
t_min = t_tox./(1000*60);
%{
figure(1)
plot(t_min, E_dead_cleft_tox)
title(sprintf('Concentration of poisoned enzyme vs time \n soman kinetics and blood concentration
of %i mM\n initial active enzyme %i mM', Ijnf, E_cleft_tox(1,1)));
xlabel('time, min'); ylabel('Poisoned Enzyme, mM');
%}
figure(2)
E_tox_active_frac = 100*((E_0_tox( 1,1 )-E_dead_cleft_tox)/E_0_tox( 1,1));
plot(t_min, E_tox_active_frac)
title(sprintf('Percent enzyme active in cleft vs. time,\n with soman kinetics and blood concentration
of %i mM ', (Ijnf)));
xlabel('time, min'); ylabel('Percent active enzyme');

% tolerance value
tol = 0.0001;
loop_count = 0;
choice = 1;
while(choice == 1)
E_i_active_percent = input('What percent active enzyme will be in the cleft during the inhibited
action potential reaction?\n');
Ejnitialjnhibited = (E_i_active_percent/100)*E_0_tox(1,1); % in mM
disp(sprintf('\n The initial amount of active enzyme in the cleft \n during the inhibited reaction is
%i mM', E_initial_inhibited));
toxjndex = find((E_cleft_tox >= Ejnitialjnhibited - tol) & (E_cleft_tox <= Ejnitialjnhibited +
tol), 1);
disp(sprintf('\n The location of the time point index is % i ' , toxjndex));
disp(sprintf('\n This is equivalent to starting the action potential after %i minutes have passed
since exposure to the toxic inhibitor \n ', Mox(tox_index)/(60000)));

%E cleft tox'

factor_A = 1.0;
standard_A = 42.3*((Q/10)A2);
factor_E = 1.0;
standard_E = 0.0277;
% Normal AP reaction initial cleft values of A, E, R in mM
A_0_n(1,1) =
factor_A*standard_A; % in mM (10 annuli is used as the control reference)
E_0_n(1,:)=
factor_E*standard_E; % in mM
R_0_n(1,:) =
factor_R*standard_R; % in mM
%normal AP reaction initial value vector
U0 = [A_0_n ...A (U(1)-U(Q))
E_0_n ... E (U(Q+1)-U(2Q))
AE_0_n ...AE ( U(2Q+1) - U(3Q)}
acE_0_n ... acE ( U(3Q+1) - U(4Q))
R_0_n
... R (U(4Q+1)-U(5Q))
AR_0_n ... AR ( U(5Q+1) - U(6Q))
A2R_0_n ...A2R ( U(6Q+1) - U(7Q))
A2Ro_0_n ... A2R* ( U(7Q+1) - U{8Q))
ChP_0_n ... ChP (U(8Q+1) - U(9Q))

% Inhibited AP reaction initial cleft values of A, E, R in mM
A_0_i(1,1) =
factor_A*standard_A ; % in mM (10 annuli is used as the control reference)
E_0_i(1,:)=
E_tox(tox_index,:); % in mM
R_0_i(1,:) =
R_tox(tox_index,:); % in mM
l_0_i(1,:)=
l_tox(tox_index,:); % in mM
El_0_i(1,:) =
EI_tox(tox_index,:); % in mM
E_dead_0_i =
E_dead_tox(tox_index,:); % in mM
% Inhibited AP reaction initial value vector
V0 = [A_0_i ...A(V(1)-V(Q))
E_0_i ... E(V(Q+1)-V(2Q))
AE_0_i ... AE ( V(2Q+1) - V(3Q) )
acE_0_i ... acE ( V(3Q+1) - V(4Q0))
R_0_i
... R(V(4Q+1)-V(5Q))
AR_0_i ... AR ( V(5Q+1) - V(6Q))
A2R_0_i ... A2R ( V(6Q+1) - V(7Q) )
A2Ro_0_i ...A2R*(V(7Q+1)-V(8Q))
l_0_i
... I(V(8Q+1)-V(9Q))
El_0_i ...EI(V(9Q+1)-V(10Q))
E_dead_0_i ...E„dead (V(10Q+1) - V(11Q))
ChP_0_i... ChP(V(11Q+1)-V(12Q) )
];

% run the normal enzyme reacion function
[t,U] = ode15s(@Func_Radial_normal_kinetics, tspan, U0, rj, D_x, D_r, r, dx, dr, t_on, t_off);

% run the inhibited enzyme reaction function

[t,V] = ode15s(@Func_Radial_inhibited_kinetics, tspan, VO, rj, D_x, D_r, D_r_tox, r, dx, dr, t_on,
t_off);

% create the normal and inhibited reaction species concentration matrices as functions of r and t
A_n = zeros(length(t),length(r)); % normal acetycholine reaction matrix
E_n = zeros(length(t), length(r)); % normal enzyme reaction matrix
AE_n = zeros(length(t), length(r));% normal enzyme-complex reaction matrix
acE_n = zeros(length(t), length(r));% normal acylated-enzyme reaction matrix
R_n = zeros(length(t), length(r));% normal receptor reaction matrix
AR_n = zeros(length(t), length(r));% normal single bound receptor reaction matrix
A2R_n = zeros(length(t), length(r));% normal double bound receptor reaction matrix
A2Ro_n = zeros(length(t), length(r));% normal open receptor reaction matrix
ChP_n = zeros(length(t), length(r));% normal choline/product reaction matrix
A j = zeros(length(t), length(r)); % inhibited acetycholine reaction matrix
E j = zeros(length(t), length(r)); % inhibited enzyme reaction matrix
A E j = zeros(length(t), length(r)); % inhibited enzyme-complex reaction matrix
a c E j = zeros(length(t), length(r)); % inhibited acylated-enzyme reaction matrix
R j = zeros(length(t), length(r));% inhibited receptor reaction matrix
A R j = zeros(length(t), length(r));% inhibited single bound receptor reaction matrix
A2R_i = zeros(length(t), length(r));% inhibited double bound receptor reaction matrix
A2Ro_i = zeros(length(t), length(r));% inhibited open receptor reaction matrix
l_i = zeros(length(t), length(r)); % inhibitor of esterase
EM = zeros(length(t), length(r)); % enzyme-toxin reaction matrix
E_dead_i = zeros(length(t), length(r)); % poisoned enzyme reaction matrix
ChPJ = zeros(length(t), length(r)); % inhibited choline/product reaction matrix

for q = 1 :length(N_grad) %represents the distributed time points in N, accessed through
N__grad(q)
for i = 1 :length(t) % time length vector
forj = 1:length(r) % radius length vector
A_n(ij) = U(ij); % normal reaction species
E_n(i,j) = U(i j+Q);
AE_n(i,j) = U(i,j+2*Q);
acE_n(i,j) = U(i,j+3*Q);
R_n(i,j) = U(ij+4*Q);
AR_n(i,j) = U(i,j+5*Q);
A2R_n(i,j) = U(i,j+6*Q);
A2Ro_n(i,j) = U(i,j+7*Q);
ChP_n(i,j) = U(i,j+8*Q);
A

_i(iJ) = v (iJ);
% inhibited reaction species
E_i(i j) = V(i j+Q);
AE_i(i,j) = V(i,j+2*Q);
acEJ(iJ) = V(i,j+3*Q);
R_i(ij) = V(i,j+4*Q);
AR_i(i,j) = V(i,j+5*Q);
A2R_i(ij) = V(i,j+6*Q);
A2Ro_i(i,j) = V(i,j+7*Q);

I_i(i j ) = V(i,j+8*Q);
EU(iJ) = V(i,j+9*Q);
E_dead_i(i,j) = V(i,j+10*Q);
ChP_i(ij) = V(ij+11*Q);
end
end

% calculate the concentration gradients of these species
cocn_grad_A_n = diff(A_n(N_grad(q),:))./diff(r);
cocn_grad_l = diff(l_i(N_grad(q),:))./diff(r);
cocn_grad_E = diff(Ej(N_grad(q),:))./diff(r);

%plot(r, A_n(N_grad(q),:)); hold on;
figure(1)
title('[A] gradient')
plot(r_grad_b, cocn_grad_A_n); hold on;
figure (2)
title('[l] gradient')
plot(r_grad_b, cocn_grad_l); hold on;
figure (3)
title('[E] gradient')
plot(r_grad_b, cocn_grad_E); hold on;
end
hold off;

%2*pi*R_cleft*L_clefl*D_r/clr

% calculate the normal and inhibited Ach lost from the last annulus via diffusion
%[t, AJost] = ode15s(@Acetylcholine_lost, tspan, A_n(1,14), [], D_r, dr, r);
%A_nJost = (D_r/(2*r(15)*dr))*(A_inf -A_n(:,14))%cumtrapz(t(2*pi*R_cleft*L_cleft*D_r/1e18)*A_n(:,Q));
%Aj_lost = cumtrapz(t,(2*pi*R_clefl*L_cleft*D_r/1e-18)*Aj(:,Q));

% initialize the total concentration/molecules in the cleft vectors

A_cleft_n = zeros(N,1);% normal reaction species
E_cleft_n = zeros(N,1);
AE_cleft_n = zeros(N,1);
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acE_cleft_n = zeros(N,1);
R_cleft_n = zeros(N,1);
AR_cleft_n = zeros(N,1);
A2R_cleft_n = zeros(N,1);
A2Ro_cleft_n = zeros(N,1);
ChP_cleft_n = zeros(N,1);
molecule_A_cleft_n = zeros(N,1);% normal reaction species
molecule_E_cleft_n = zeros(N,1);
molecule_AE_cleft_n = zeros(N,1);
molecule_acE_cleft_n = zeros(N,1);
molecule_R_cleft_n = zeros(N,1);
molecule_AR_cleft_n = zeros(N,1);
molecule_A2R_cleft_n = zeros(N,1);
molecule_A2Ro_cleft_n = zeros(N,1);
molecule_ChP_cleft_n = zeros(N,1);
A_cleft_i = zeros(N,1); % inhibited reaction species
E_cleft_i = zeros(N,1);
AE_cleft_i = zeros(N,1);
acE_cleft_i = zeros(N,1);
R_cleft_i = zeros(N,1);
AR_cleft_i = zeros(N,1);
A2R_cleft_i = zeros(N,1);
A2Ro_cleft_i = zeros(N,1);
l_cleft_i = zeros(N,1);
El_cleft_i = zeros(N,1);
E_dead_cleft_i = zeros(N,1);
ChP_cleft_i = zeros(N,1);
molecule_A_cleft_i = zeros(N,1);% inhibited reaction species
molecule_E_cleft_i = zeros(N,1);
molecule_AE_cleft_i = zeros(N,1);
molecule_acE_cleft_i = zeros(N,1);
molecule_R_cleft_i = zeros(N,1);
molecule_AR_cleft_i = zeros(N,1);
molecule_A2R_cleft_i = zeros(N,1);
molecule_A2Ro_cleft_i = zeros(N,1);
molecule_l_cleft_i = zeros(N,1);
molecule_EI_cleft_i = zeros(N,1);
molecule_E_dead_cleft_i = zeros(N,1);
molecule_ChP_cleft_i = zeros(N,1);
%{
%Species names
species_names = rA,,,E,1'AE,,,acE,,,R,,,AR,I,A2R,,,A2R*,,,r,,EI,,,E_dead,,,ChP,,,AJosf];
species__names(1)

species_names(2)
%}
% calculate the total amounts of these species in the cleft
fori = 1:N
forj = 1:Q
A_cleft_n(i) = A_cleft_n(i) +(volume(j)*A_n(i,j))A/_cleft; %normal molar species

E_cleft_n(i) = E_cleft_n(i) +(volume(j)*E_n(i,j))/V_cleft;
AE_cleft_n(i) = AE_cleft_n(i) +(volumeG)*AE_n(iJ))A/_cleft;
acE_cleft_n(i) = acE_cleft_n(i) +(volume(j)*acE_n(i,j))A/_cleft;
R_cleft_n(i) = R_cleft_n(i) +(volumeG)*R_n(i,j))A/_cleft;
AR_cleft_n(i) = AR_cleft_n(i) +(volumeG)*AR_n(i,j))/V_cleft;
A2R_cleft_n(i) = A2R_cleft_n(i) +(volume(j)*A2R_n(i,j))A/_cleft;
A2Ro_cleft_n(i) = A2Ro_cleft_n(i) +(volumeG)*A2Ro_n(i,j))A/_cleft;
ChP_cleft_n(i) = ChP_cleft_n(i) +(volumeO)*ChP_n(ij))A/_cleft;
A_cleft_i(i) = A_cleft_i(i) +(volumeO)*A_i(ij))A/_cleft; % inhibited molar species
E_cleft_i(i) = E_cleft_i(i) +(volumeG)*E_i(i,j))/V_cleft;
AE_cleft_i(i) = AE_cleft_i(i) +(volumeG)*AE_i(i,j))/V_cleft;
acE_cleft_i(i) = acE_cleft_i(i) +(volume(j)*acE_i(i,j))A/_cleft;
R_cleft_i(i) = R_cleft_i(i) +(volumeG)*R_i(i,j))A/_cleft;
AR_cleft_i(i) = AR_cleft_i(i) +(volumeO)*AR_i(i,j))A/_cleft;
A2R_cleft_i(i) = A2R_cleft_i(i) +(volumeO)*A2R_i(i,j))A/_cleft;
A2Ro_cleft_i(i) = A2Ro_cleft_i(i) +(volume(j)*A2Ro_i(i,j))A/_cleft;
l_cleft_i(i) = l_cleft_i(i) +(volume(j)*l_i(i,j))A/_cleft;
El_cleft_i(i) = El_cleft_i(i) +(volume(j)*EI_i(i,j))A/_cleft;
E_dead_cleft_i(i) = E_dead_cleft_i(i) +(volume(j)*E_dead_i(i,j))A/_cleft;
ChP_cleft_i(i) = ChP_cleft_i(i) +(volumeG)*ChP_i(i,j))/V_cleft;

molecule_A_cleft_n(i) = A_cleft_n(i)*V_cieft*(6.02e+20);
%normal molecule species
molecule_E_cleft_n(i) = E_cleft_n(i)*V_cleft*(6.02e+20);
molecule_AE_cleft_n(i) = AE_cleft_n(i)*V_cleft*(6.02e+20);
molecule_acE_cleft_n(i) = acE_cleft_n(i)*V_cleft*(6.02e+20);
molecule_R_cleft_n(i) = R_cleft_n(i)*V_cleft*(6.02e+20);
molecule_AR_cleft_n(i) = AR_cleft_n(i)*V_cleft*(6.02e+20);
molecule_A2R_cleft_n(i) = A2R_cleft_n(i)*V_cleft*(6.02e+20);
molecule_A2Ro_cleft_n(i) = A2Ro_cleft_n(i)*V_cleft*(6.02e+20);
molecule_ChP_cleft_n(i) = ChP_cleft_n(i)*V_cleft*(6.02e+20);
molecule_A_cleft_i(i) = A_cleft_i(i)*V_cleft*(6.02e+20);
%inhibited molecule speci
molecule_E_cleft_i(i) = E_cleft_i(i)*V_cleft*(6.02e+20);
molecule_AE_cleft_i(i) = AE_cleft_i(i)*V_cleft*(6.02e+20);
molecule_acE_cleft_i(i) = acE_cleft_i(i)*V_cleft*(6.02e+20);
molecule_R_cleft_i(i) = R_cleft_i(i)*V_cleft*(6.02e+20);
molecule_AR_cleft_i(i) = AR_cleft_i(i)*V_cleft*(6.02e+20);
molecule_A2R_cleft_i(i) = A2R_cleft_i(i)*V_cleft*(6.02e+20);
molecule_A2Ro_cleft_i(i) = A2Ro_cleft_i(i)*V_cleft*(6.02e+20);
molecule_l_cleft_i(i) = l_cleft_i(i)*V_cleft*(6.02e+20);
molecule_EI_cleft_i(i) = EI_cleft_i(i)*V_cleft*(6.02e+20);
molecule_E_dead_cleft_i(i) = E_dead_cleftj(i)*V_cleft*(6.02e+20);
molecule_ChP_cleft_i(i) = ChP_cleft_i(i)*V_cleft*(6.02e+20);
end
end
%figure(loop_count + 3)
%plot( t, molecule_A2Ro_cleft_n(:),t,molecule__A2Ro_.cleftj(:));
%ylabel('molecules of open receptor');xlabel('t, ms');

%title(spnntf( Total molecules of open receptor species A2R* in the whole cleft,\n norm and
inhibited, averaged over %i annular volume elements,\n %i percent active enzyme; D__r = %i',Q,
E_i_active__percent, D_r));%
loop_count = loop_count+1;
choice = input('Do you want to run another inhibited reaction; 1(yes), 0(no)? \n');
end

% save the species concentration data to data files
save U U; save V V; save W W;
save A_0_n A__0_n; save A_0_i A_0_i; save E_0_i E_0j;
save E_0_tox E__0_tox;
save A_n A_n; save E_n E„n; save AE_n AE_n; save acE_n acE_n; save R_n R__n; save AR_n
AR_n; save A2R_n A2R_n;
save A2Ro_n A2Ro_n; save ChP_n ChP_n; %save A_n_lost A_n_lost;
save A_i A_i; save E_i E_i; save AE_i AE_i; save acE_i acE_i; save EM El_i; save E_dead_i
E_dead_i; save R j R_i;
save AR_i AR_i; save A2R_i A2R_i; save A2Ro_i A2Ro_i; save \J I j ; save C h P j C h P j ; %save
Ajjost Ajjost;
save A__cleft_n A_cleft_n; save E__cleft__n E_cleft_n;
save AE_cleft__n AE_cleft_n; save acE_cleft_n acE_cleft_n; save R_cleft_n R_cleft_n;
save AR_cleft_n AR_cleft_n; save A2R_cleft_n A2R_cleft_n;
save A2Ro_cleft_n A2Ro_cleft_n; save ChP_cleft_n ChP_cleft_n;
save A_cleft_i A_cleft_i; save E_cleft_i E_cleft_i; save AE_cleft_i AE_cleft_i;
save acE_cleft_i acE_cleft_i; save R_cleft_i R_cleft_i; save AR_cleft_i AR_cleft_i;
save A2R_cleft_i A2R_cleft_i; save A2Ro_cleft_i A2Ro_cleft_i; save l_cleft_i l_cleft_i;
save El_cleft_i El__cleft_i; save E_dead_cleft_i E_dead_cleft_i;
save ChP_cleft_i ChP_cleft_i;
save
save
save
save
save
save
save
save
save

molecule_A_cleft_n molecule_A_cleft_n;
molecule_E_cleft_n moleculeJE_cleft_n;
molecule_AE_cleft_n molecule_AE_cleft_n;
molecule_acE_cleft_n molecule_acE_cleft_n;
molecule_R_cleft_n molecule_R_cleft_n;
molecule_AR_cleft_n molecule_AR_cleft_n;
molecule_A2R_cleft_n molecule_A2R_cleft_n;
molecule_A2Ro_cleft_n molecule_A2Ro_cleft_n;
molecule_ChP_cleft_n molecule_ChP_cleft_n;

save
save
save
save
save
save
save
save
save

molecule_A_cleft_i molecule_A_cleftj;
molecule_E_cleft_i molecule_E_cleft_i;
molecule_AE_cleft_i molecule_AE_cleft_j;
molecule_acE_cleftj molecule_acE_cleft_i;
molecule_R_cleft_i molecule_R_cleft_i;
molecule_AR_cleft_i molecule_AR_cleft_i;
molecule_A2R_cleft_i molecule_A2R_cleft_i;
molecu!e_A2Ro_cleft_i molecule_A2Ro_cleft_i;
moleculeJ_cleftj moleculeJ_cleft_j;

save molecuie_EI_cleftJ molecule_EI_cleft_i;
save imolecule_E_dead_cleftj molecule_E_dead_cleft_i;
save molecule_ChP__cleftj molecule_ChP_cleft_i;
save
save
save
save
save

E_cleft_tox E_cleft_tox;
R__cleft_tox R_cleft_tox;
l_cleft_tox I_cleft__tox;
EI_cleft„tox EI_cleft_tox;
E_dead_cleft_tox E_dead_cleft_tox;

save molecule_E_cleft_tox molecule_E_cleft_tox;
save molecule_R_cieft__tox moleculeJR_cleft_tox;
save molecule_l_c!eft_tox molecule_l_cleft_tox;
save molecule_EI_cleft_tox molecule_EI_cleft_tox;
save molecule_E_dead_cleft_tox molecule_E__dead_cleft_tox;
save r r; save D_r D_r; save dr dr;
save 11; save t_tox t_tox;
save N N; save Q Q;
save volume volume;
save I inf Mnf;
disp('latest data saved, program finished');
%{
figure(2)
plot(t,AJost);
yiabelfnormal Ach, mM');xlabel{'t, ms');
title(sprintf('Molar normal Ach lost via diffusion, in the whole cleft\n averaged over %i annular
volume elements',Q));%
figure(1)
surf(t, r, A_n')
shading flat
title(sprintf('Species A in pure radial diffusion and reaction through %i volume elements', Q));
xlabel('time, ms'); ylabel('radius, cm'); zlabel(" concentration, mmo!e/cmA3');
AJost
%A__balance =
sum(U(:,1:10))+sum(U(:,21:30))+sum(U(:,51:60))+sum(U(:,61:70))+sum(U(:,71:80))
%}

% THIS PROGRAM QUALITATIVELY WORKS
% This program simulates the regeneration of acetylcholinesterase in the
% cleft
%******* CHECKED FOR UNIT/DIMENSION CONSISTENCY ON 4/15/07, 17:00
*************************
%

clc;
clear;
% if the diffusion constant has dimensions of cmA3/ms then the following
% units apply
AJnf = 0.0; % mmole/cmA3 = M
save A j n f Ajnf;
I j n f = 2.65e-2; % mmole/cmA3 = M
save I Jnf Ijnf;
OXjnf = 7.30e-5;% mmole/cmA3 = M
save OXjnf OXjnf;
% total volume in the cleft
V_cleft = 3.93e-14; % ( cmA3 )
% the length of the cleft (width, or height) (LA1/3)
L_cleft = 5.0e-6;% cm
% the radius of the cleft
R_cleft = 5.0e-5; % cm
% the number of equal axial disks
P = 1;
xcleft = zeros(1 ,P)
% the number of annular rings per disk
Q = 20;
% number of coupled sub-volumes
S = P*Q
%thickness of each radial annulus
dr = R_cleft/Q; % cm
%thickness of each axial disk
dx = L_cleft/P; %cm
% area of the cleft edge
Area_edge = 2*pi*R_cleft*L_cleft; %cmA2
% axial direction vector
x = linspace(0.0, L_cleft, P+1);
%radial direction vector

r = linspace(0.0, R_cleft, Q);
save r r;
% This loop assigns an x-value coordinate to the center of each well mixed
% axial disk
forj = 1:P
x_cleftG) = 0.5*(x(j) + xO+1));
end
x_cleft;
save x_cleft x_cleft;
% create the "space", a 1-dimension vector that all the axial and radial volume
% into
s = [1:S];
% axial diffusion constantfor Ach (cmA2/ms)
D_x = 2.0e-9;
% radial diffusion constant for Ach (crnA2/ms)
D_r_Ach = 0.90e-9; % 3.50e-9 cmA2/ms
save D_r_Ach D_r_Ach;
% radial diffusion constant for the inhibitor
D_r_tox= 0.90e-9 %cmA2/ms ; %logspace(~6,-12,10)
save D_r_tox D_r_tox;
% radial diffusion constant for the oxime
D_r_oxime = 0.9e-9 %crnA2/ms; %logspace(-6,-12,10) %
save D_r_oxime D_r_pxime;
%number of time points
N=7000;
%time interval vector for the normal and inhibited reactions (ms, 1e-3 s)
t_0 = 0.0; t_f = 5.0; % rns
t = linspace(t_0, t_f, N);
tspan = [t];
%time interval vector for the diffusing oxime reaction
t_regen_0 = 0.0; t_regen_f = 2.50e+5; % ms
t_regen = linspace(t_regen_0, tregen_f, N);
tspan_regen = [t_regen];

% pulse parameters
t_on = 3.0; t_off = 4.50; % ms

%*THIS IS NOT THE TIME INTERVAL*

n_on = round((((t_on - t_0)/(t_f - t_0))*(length(t)-1)) + 1);
n_off = round((t_off - t_0)*(length(t) -1)/(t_f -1_0) + 1);
peak = round(0.5*(n_on + n_off));
spread = 20.0;
magnitude = 0.50;

% calculate the volume of each annulus
volume = zeros(1,Q); % ( cmA3 )
vol_frac = volume;
fori=1:Q
volume(i) = ((2*i-1)/QA2)*pi*L_cleft*R_cleftA2;
vol_frac(i) = volume(i)/V_cleft;
end
sum(volume(1 :Q)); % a check of the annuli sum should equal the V_cleft
sum(vol_frac(1 :Q));
V_cleft;

% defining the initial value vectors of the diffusing toxin reaction reactants
A_0_tox = zeros(1 ,S);
E_0_tox = zeros(1 ,S);
AE_0_tox = zeros(1 ,S);
acE_0_tox = zeros(1,S);
R_0_tox = zeros(1,S);
AR_0_tox = zeros(1 ,S);
A2R_0_tox = zeros(1 ,S);
A2Ro_0_tox = zeros(1,S);
l_0_tox = zeros(1 ,S);
El_0_tox = zeros(1 ,S);
E_dead_0_tox = zeros(1 ,S);
ChP_0_tox = zeros(1 ,S);
% defining the initial value vectors of the normal AP reaction reactants
A_0_n = zeros(1 ,S);
E_0_n = zeros(1 ,S);
AE_0_n = zeros(1 ,S);
acE_0_n = zeros(1 ,S);
R_0_n = zeros(1 ,S);
AR_0_n = zeros(1 ,S);
A2R_0_n = zeros(1,S);
A2Ro_0_n = zeros(1 ,S);
ChP_0_n = zeros(1 ,S);
% defining the initial value vectors of the inhibited AP reaction
% reactants,
A_0_i = zeros(1,S);
E_0_i = zeros(1,S);
AE_0_i = zeros(1,S);
acE_0_i = zeros(1 ,S);
R_0_i = zeros(1 ,S);
AR_0_i = zeros(1,S);
A2R_0_i = zeros(1 ,S);
A2Ro_0_i = zeros(1 ,S);
l_0_i = zeros(1,S);
El_0_i = zeros(1 ,S);
E_dead_0_i = zeros(1 ,S);
ChP_0_i = zeros(1,S);

% defining the initial value vectors of the oxime regeneration reaction
% reactants,
A_0_regen = zeros(1,S);
E_0_regen = zeros(1 ,S);
AE_0_regen = zeros(1 ,S);
acE_0_regen = zeros(1,S);
R_0_regen = zeros(1 ,S);
AR_0_regen = zeros(1,S);
A2R_0_regen = zeros(1,S);
A2Ro_0_regen = zeros(1,S);
E_dead_0_regen = zeros(1,S);
OX_0_regen = zeros(1 ,S);
EIOX_0_regen = zeros(1 ,S);
IOX_0_regen = zeros(1 ,S);

0/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

% This runs the program for 10 values of the oxime diffusion constant
for loop = 1:1
factor_R= 1.0;
standard_R = 6.64e-4; %mmole/crnA3 = IV!
factor_E_dead = 0.5;
standard_E_dead = 7.4e-5; %mmole/cmA3 = M (Naka, et al)
% oxime diffusion reaction initial cleft values of A, E, R in mM
A_0_regen(1,1) =
0.0; % in mM (10 annuli is used as the control reference)
E_0_regen(1,:) = (1 - factor_E_dead)*standard_E_dead;
E_dead_0_regen(1,:)= factor_E_dead*standard_E_dead; % in mM
R_0_regen(1,:) = factor_R*standard_R; % in mM
% Toxin diffusion reaction initial value vector
Z0 = [A_0_regen ... A ( Z(1)-Z(Q))
E_0_regen ... E ( Z(Q+1) - Z(2Q))
AE_0_regen ... AE ( Z(2Q+1) -Z(3Q))
acE_0_regen ... acE ( Z(3Q+1) - Z(4Q0))
R_0_regen ... R ( Z{4Q+1) - Z(5Q))
AR_0_regen ... AR ( Z(5Q+1) - Z(6Q))
A2R_0_regen ... A2R (Z(6Q+1) - Z(7Q))
A2Ro_0_regen ... A2R* ( Z(7Q+1) - Z(8Q))
E_dead_0_regen
... E_dead (Z(8Q+1) - Z(9Q))
OX_0_regen ...OX ( Z(9Q+1) - Z(10Q))
EIOX_0_regen ...EIOX { Z(10Q+1) -Z(11Q))
%IOX_0_regen ... IOX ( Z(11Q+1) - Z(12Q) )
];
E_regen = zeros(length(t), length(r)); % oxime diffusion enzyme reaction matrix
R_regen = zeros(length(t), length(r));% oxime diffusion receptor reaction matrix
OX_regen = zeros(length(t), length(r)); % oxime diffusion reaction matrix
EIOX_regen = zeros(length(t), length(r)); % oxime diffusion enzyme-toxin-oxime reaction matrix
E_dead_regen = zeros(length(t), length(r)); %oxime diffusion poisoned enzyme reaction matrix

E_cleft_regen = zeros(N,1); % toxin diffusion reaction species
R_cleft_regen = zeros(N,1);
OX_cleft_regen = zeros(N,1);
EIOX_cleft_regen = zeros(N,1);
E_dead_cleft_regen = zeros(N,1);
molecule_E_cleft_regen = zeros(N,1); % toxin diffusion reaction species
molecule_R_cleft_regen = zeros(N,1);
molecule_OX_cleft_regen = zeros(N,1);
molecule_EIOX_cleft_regen = zeros(N,1);
molecule_E_dead_cleft_regen = zeros(N,1);

% run the diffusing toxin reaction function
[t_regen, Z]= ode15s(@Func_regen_parameters, tspan_regen, ZO, Q, D_x, D_r_Ach,
Droxime(loop), r, dx, dr, t_on, t_off, O X j n f ) ;

for i = 1:length(t) % time length vector
forj = 1 :length(r) % radius length vector
E_regen(i,j) = Z(i,j+Q); % toxic diffusion reaction species
R_regen(i,j) = Z(i,j+4*Q);
OX_regen(i,j) = Z(i,j+9*Q);
EIOX_regen(i,j) = Z(i,j+10*Q);
E_dead_regen(ij) = Z(i,j+8*Q);
end
end
switch loop
case(1)
E_regen_1 = E_regen;
save E_regen_1 E__regen_1;
R_regen_1 = R_regen;
save R_regen__1 R_regen_1;
OX_regen_1 = OX_regen;
save OX_regen_1 OX_regen__1;
EIOX_regen_1 = EIOX_regen;
save EIXO_regen__1 EIOXj-egen__1;
E_dead_regen_1 = E_dead_regen;
save E_dead_jegen_1 E__dead__regen_1;
case(2)
E_regen_2 = E_regen;
save E__regen___2 E_regen_2;
R_regen_2 = R_regen;
save R_regen_2 R_regen_2;
OX_regen_2 = OX_regen;
save OX_regen_2 OX_regen_2;
EIOX_regen_2 = EIOX_regen;
save EIOX_regen_2 EIOX_regen_2;
E_dead_regen_2 = E_dead_regen;
save E__dead__regen_2 E_dead__regen_2;

case(3)
E_regen_3 = E_regen;
save E_regen_3 E_regen_3;
R_regen_3 = R_regen;
save R_regen_3 R_regen_3;
0X_regen_3 = OX_regen;
save 0X_regen_3 0X_regen_3;
EI0X_regen_3 = EIOX_regen;
save EI0X_regen_3 EI0X_regen_3;
E_dead_regen_3 = E_dead_regen;
save E_dead__regen_3 E__dead_regen__3;
case(4)
E_regen_4 = E_regen;
save E_regen_4 E_regen_4;
R_regen_4 = R_regen;
save R_regen_4 R_regen_4;
0X_regen_4 = OX_regen;
save 0X_regen_4 0X_regen__4;
EI0X_regen_4 = EIOX_regen;
save EI0X_regen_4 EI0X_regen_4;
E_dead_regen_4 = Edeadregen;
save E_dead_regen_4 E_dead_regen_4;
case(5)
E_regen_5 = E_regen;
save E_regen_5 E_regen_5;
R_regen_5 = R_regen;
save R_regen_5 R_regen_5;
0X_regen_5 = OX_regen;
save 0X_regen_5 0X_regen_5;
EIOX_regen_5 = EIOX_regen;
save EI0X_regen_5 EI0X_regen_5;
E_dead_regen_5 = E_dead_regen;
save E_dead_regen_5 E_dead_regen_5;
case(6)
E_regen_6 = E_regen;
save E_regen__6 E_regen„6;
R_regen_6 = R_regen;
save R_regen_6 R_regen_6;
0X_regen_6 = OX_regen;
save 0X_regen_6 0X_regen_6;
EIOX_regen_6 = EIOX_regen;
save EI0X_regen__6 EIOX__regen_6;
E_dead_regen_6 = E_dead_regen;
save E_dead_regen_6 E__dead_regen_6;
case(7)
E_regen_7 = E_regen;
save E_regen_7 E_regen„7;
R_regen_7 = R_regen;
save R_regen_7 R_regen_7;
0X_regen_7 = OX_regen;
save 0X__regen_7 0X__regen_7;
EI0X_regen_7 = EIOX_regen;
save EI0X_regen_7 EI0X_regen_7;
E_dead_regen_7 = E_dead_regen;
save E_dead_regen_7 E_dead_regen_7;
case(8)

E_regen_8 = E_regen;
save E_regen_8 E_regen_8;
R_regen_8 = R_regen;
save R_regen_8 R_regen_8;
0X_regen_8 = OX_regen;
save 0X_regen_8 0X_regen_8;
EI0X_regen_8 = EIOX_regen;
save EI0X_regen_8 EI0X_regen_8;
E_dead_regen_8 = E_dead_regen;
save E_dead_regen__S E_dead_regen_8;
case(9)
E_regen_9 = E_regen;
save E_regen_9 E_regen_9;
R_regen_9 = R_regen;
save R_regen__9 R_regen_9;
0X_regen_9 = OXj-egen;
save OX_regen_9 OX_/egen__9;
EIOX_regen_9 = EIOX_regen;
save EIOX_regen_9 EIOX_regen_9;
E_dead_regen_9 = E_dead_regen;
save E_dead_regen_9 E_dead_regen_9;
case(10)
E_regen_10 = E_regen;
save E_regen_10 E_regen_10;
R_regen_10 = Rregen;
save R_regen__10 R_regen_10;
OX_regen_10 = OX_regen;
save OX_regen_10 OX_regen_10;
EIOX_regen_10 = EIOX_regen;
save EIOX_regen_10 EIOX_regen_10;
E_dead_regen_10 = E_dead_regen;
save E_dead_regen_10 E_dead_regen_10;

% calculate the total amounts of these species in the cieft
fori = 1:N
forj = 1:Q
E_cleft_regen(i) = E_cleft_regen(i) +(volume(j)*E_regen(i,j))A/_cleft; % toxin diffusion
molar species
R_cleft_regen(i) = R_cleft_regen(i) +(volume(j)*R_regen(i,j))/V_cleft;
OX_cleft_regen(i) = OX_cleft_regen(i) +(volume(j)*OX_regen(i,j))A/_cleft;
EIOX_cleft_regen(i) = EIOX_cleft_regen(i) +(volumeO)*EIOX_regen(ij))A/_cleft;
E_dead_cleft_regen(i) = E_dead_cleft_regen(i) +(volume(j)*E_dead_regen(i,j))A/_cleft;
molecule_E_cleft_regen(i) = E_cleft_regen(i)*V_cleft*(6.02e+20); % toxin diffusion
molecule species
molecule_R_cleft_regen(i) = R_cleft_regen(i)*V_cleft*(6.02e+20);
molecule_OX_cleft_regen(i) = OX_cleft_regen(i)*V_cleft*(6.02e+20);
molecule_EIOX_cleft_regen(i) = EIOX_cleft_regen(i)*V_cleft*(6.02e+20);
molecule_E_dead_cleft_regen(i) = E_dead_cleft_regen(i)*V_cleft*(6.02e+20);
end
end
t_min = t_regen./(1000*60);

%
figure(5*loop+1);
plot(t_min(:), E_cleft_regen(:)./standard_E_dead);
title(sprintf('The amount of species %s in the whole cleft averaged over %i annular
volumes\nD_roxime = %-5.2e cmA2/ms','E',Q,D_r_oxime(loop)));
xlabel(sprintf('t, minutes')); ylabel(sprintf('Species %s, fraction'.'E'));
figure(5*loop+2);
plot(t_regen(:), OX_cleft_regen(:));
title(sprintf('The amount of species %s in the whole cleft averaged over %i annular
volumes\nD_roxime = %-5.2e cmA2/ms','OX',Q,D_r_oxime(loop)));
xlabel(sprintf('t, ms')); ylabel(sprintf('Species %s, mM'.'OX'));
figure(5*loop+3);
plot(t_regen(:), EIOX_cleft_regen(:));
title(sprintf(The amount of species %s in the whole cleft averaged over %i annular
volumes\nD_roxime = %-5.2e cmA2/ms','EIOX',Q,D_r_oxime(loop)));
xlabel(sprintf('t, ms')); ylabel(sprintf('Species %s, mM'.'ElOX'));
figure(5*loop+4);
plot(t_regen(:), E_dead_cleft_regen(:));
title(sprintf(The amount of species %s in the whole cleft averaged over %i annular voiumes\n
D_roxime = %-5.2e cmA2/ms','E*dead',Q,D_r_oxime(loop)));
xlabel(sprintf('t, ms')); ylabel(sprintf('Species %s, mM','E*dead'));
figure(5*loop+5);
plot(t_regen(:), molecule_R_cleft_regen(:));
title(sprintf('The amount of species %s in the whole cleft averaged over %i annular volumes\n
D__roxime = %-5.2e cmA2/ms','R',Q,D_r_oxime(loop)));
xlabel(sprintf('t, ms')); ylabel(sprintf('Species %s. molecules'.'R'));
%
switch loop
case(1)
molecule_E_cleft_regen_1 = molecule_E_cleft_regen;
save molecule„E_cleft_regen_1 molecule„E_cleft_regen_1;
molecule_R_cleft_regen_1 = molecule_R_cleft_regen;
save molecule_R_cleft_regen_1 molecule_R_cleft_regen_1;
molecule_OX_cleft_regen_1 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_1 molecule_OX_cleft_regen_1;
molecule_EIOX_cleft_regen_1 = molecule_EIOX_cleft_regen;
save molecule__EIOX__cleft_regen_1 molecule_EIOX_cleft_regen_1;
molecule_E_dead_cleft_regen_1 = molecule_E_dead_cleft_regen;
save molecule_E_dead_cleft_regen_1 molecule_E_dead_cleft_regen_1;
case(2)
molecule_E_cleft_regen_2 = molecule_E_cleft_regen;
save molecule_E_cleft_regen_2 molecule_E_cleft_regen_2;
molecule_R_cleft_regen_2 = molecule_R_cleft_regen;
save molecule_R_cleft_regen_2 molecule_R_cleft_regen_2;
molecule_OX_cleft_regen_2 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_2 molecule_OX_cleft_regen_2;
molecule_EIOX_cleft_regen_2 = molecule_EIOX_cieft_regen;
save molecule„EIOX__cleft_regen__2 molecule_EIOX_cleft_regen__2;
molecule_E_dead_cleft_regen_2 = molecule_E_dead_cleft_regen;

savemolecule_E_dead_cleft_regen_2 molecule_E_dead_cleft_regen_2;
case(3)
molecule_E_cleft_regen_3 = molecule_E_cleft_regen;
save molecule_E_cleft__regeri„3 molecule_E__cleft_regen_3;
molecule_R_cleft_regen_3 = molecule_R_cleft_regen;
save molecule_R_cleft_regen_3 molecule_R_cleft_regen_3;
molecule_OX_cleft_regen_3 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_3 molecule_OX_cleft_regen_3;
molecule_EIOX_cleft_regen_3 = molecule_EIOX_cleft_regen;
save molecule_EIOX_cleft_.regen_3 molecule__EIOX_cleft_regen_3;
molecule_E_dead_cleft_regen_3 = molecule_E_dead_cleft_regen;
save molecule_E_dead__cleft__regen_3 moIecule_E_dead_cleft_regen_3;
case(4)
molecule_E_cleft_regen_4 = molecule_E_cleft_regen;
save molecule_E__cleft_regen__4 molecule_E_cleft_regen_4;
molecule_R_cleft_regen_4 = molecule_R_cleft_regen;
save molecule_R_cleft_regen_4 molecule_R_cleft_regen_4;
molecule_OX_cleft_regen_4 = molecule_OX_cleft_regen;
save molecule__OX_cleft_regen_4 molecule„OX_cleft_regen__4;
molecule_EIOX_cleft_regen_4 = molecule_EIOX_cleft_regen;
save molecule„EIOX_cleft_regen_4 molecule_EIOX__cleft__regen__4;
molecule_E_dead_cleft_regen_4 = molecule_E_dead_cleft_regen;
save molecule_E_dead_cleft_regen__4 molecule_E_dead_cleft_regen_4;
case(5)
molecule_E_cleft_regen_5 = molecule_E_cleft_regen;
save molecule_E_cleft_regen__5 molecule_E_cleft_regen_5;
molecule_R_cleft_regen_5 = molecule_R_cleft_regen;
save molecule_R_cleft_regen__5 molecule_R_cleft_regen_5;
molecule_OX_cleft_regen_5 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_5 molecule_OX_deft_regen_5;
molecule_EIOX_cleft_regen_5 = molecule_EIOX_cleft_regen;
save molecule_EIOX_cleft_regen_5 molecule__EIOX_c!eft_regen_5;
molecule_E_dead_cleft_regen_5 = molecule_E_dead_cleft_regen;
save molecule_E_dead_cleft_regen__5 molecule_E_dead_cleft_regen_5;
case(6)
molecule_E_cleft_regen_6 = molecule_E_cleft_regen;
save moleculeJE_cleft_regen_6 molecule_E_cleft_regen_6;
molecule_R_cleft_regen_6 = molecule_R_cleft_regen;
save molecule_R_cleft_regen_6 molecule_R__cleft_regen_6;
molecule_OX_cleft_regen_6 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_6 molecule_OX_cleft_regen_6;
molecule_EIOX_cleft_regen_6 = molecule_EIOX_cleft_regen;
save molecule_EIOX__cleft_/egen_6 molecule__EIOX___cleftj-egenJ3;
molecule_E_dead_cleft_regen_6 = molecule_E_dead_cleft_regen;
save molecule_E__dead_cleft_regen_6 molecule_E_dead_cleft_regen_6;
case(7)
molecule_E_cleft_regen_7 = molecule_E_cleft_regen;
save molecule_E_cleft_regeri_7 mo!ecule_E_cleft_regen_7;
molecule_R_cleft_regen_7 = molecule_R_cleft_regen;
save molecule_R_cleft_regen„7 molecule_R_cleft_regen_7;
molecule_OX_cleft_regen_7 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_7 molecule_OX_cleft_regen_7;
molecule_EIOX_cleft_regen_7 = molecule_EIOX_cleft_regen;
save molecule_EIOX_cleft_regen_7 molecule_EIOX_cleft_regen_7;
molecule_E_dead_cleft_regen_7 = molecule_E_dead_cleft_regen;
savemolecule_E_dead_cleft_regen_7 molecule_E_dead_cleft_regen_7;

case(8)
molecule_E_cleft_regen_8 = molecule_E_cleft_regen;
save molecule_E_cleft_regen_8 molecule_E_cleft_regen__8;
molecule_R_cleft_regen_8 = molecule_R_cleft_regen;
save molecule_R_cleft_regen_8 molecule_R_cleft_regen_8;
molecule_OX_cleft_regen_8 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_8 molecule_OX_cleft_regen_8;
molecule_EIOX_cleft_regen_8 = molecule_EIOX_cleft_regen;
save molecule_EIOX_cleft_regen_8 molecule_EIOX_cleft_regen_8;
molecule_E_dead_cleft_regen_8 = molecule_E_dead_cleft_regen;
save molecule__E_dead__cleft__regen__8 molecule_E_dead_cleft_regen_8;
case(9)
molecule_E_cleft_regen_9 = molecule_E_cleft_regen;
save molecule__E__cleft_regen__9 moleculeJE_cleft_regen_9;
molecule_R_cleft_regen_9 = molecule_R_cleft_regen;
save molecule_R_cleft_regen_9 molecule_R_cleft_regen_9;
molecule_OX_cleft_regen_9 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_9 molecule_OX_cleft_regen_9;
molecule_EIOX_cleft_regen_9 = molecule_EIOX_cleft_regen;
save molecule__EIOX_cleft_regen__9 molecu!e_EIOX_cleft_regen_9;
molecule_E_dead_cleft_regen_9 = molecule_E_dead_cleft_regen;
save molecule_E_dead_cleft_regen_9 molecule_E_dead_cleft_regen_9;
case(10)
molecule_E_cleft_regen_10 = molecule_E_cleft_regen;
save molecule_E_cleft_regen_10 molecule_E_cleft_regen_10;
molecule_R_cleft_regen_10 = molecule_R_cleft_regen;
save moleculeJ3_cleft_regen_10 molecule_R_cleft_regen_10;
molecule_OX_cleft_regen_10 = molecule_OX_cleft_regen;
save molecule_OX_cleft_regen_10 molecule_OX_cleft_regen_10;
molecule_EIOX_cleft_regen_10 = moiecule_EIOX_cleft_regen;
save molecule_EIOX_cleft_regen_10 molecule_EIOX_cleft_regen_10;
molecule_E_dead_cleft_regen_10 = molecule_E_dead_cleft_regen;
save molecule__E__dead_cleft_regen__10 rnolecule_E_dead_cleft_regen_10;
end
%{
disp{sprintf('Stop when loop count is 10, the present loop count is %i', loop__count+1));
loop_count = loop_count+1;
choice = inputfDo you want to run another inhibited reaction: 1(yes), 0(no)? \n');
if choice == 1
D_r_oxime = input(sprintf('What is the new radial diffusion constant for the inhibitor? The last
value was (%-5.2e) \n',D__r__oxime});
end
%}
loop %keeps track of where the program is computationally
end
save loop loop; save Q Q;
save 11; save t„regen t_jegen; save tjriin t_min;
dispfdata saved, program finished');
%{
loop_count = 0;
choice = 1;
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while(choice == 1]
E_i_active_percent = input('What percent active enzyme will be in the cleft during the inhibited
action potential reaction?\n');
Ejnitialjnhibited = (Ej_active_percent/100)*E_0Jox(1,1); % in mM
disp(sprintf('\n The initial amount of active enzyme in the cleft \n during the inhibited reaction is
%-5.2e mM', Ejnitialjnhibited));
toxjndex = fmd((E_cleft_tox >= Ejnitialjnhibited - tol) & (E_cleft_tox <= Ejnitialjnhibited +
tol), 1);
disp(sprintf('\n The location of the time point index is % i ' , toxjndex));
disp(sprintf('\n This is equivalent to starting the action potential after %-5.2f minutes have passed
since exposure to the toxic inhibitor \n ', t_tox(tox_index)/(60000)));

E_cleft_tox';
0/

*************************************************************
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*********
% species string array
species = fA
';'E ';'AE

';'acE ';'R

VAR

";'A2R ';'A2R* ';'!

';'EI

';'Ejdead';'ChP ' ] %

loop„count = loop_count+1;
choice = input('Do you want to run another inhibited reaction: 1(yes), 0{no)? \n');
end
save(sprintf('E_cleft_toxj%i',loop_count+1), 'E_cleft_tox' );
save(sprintf('Lcleft_toxj%i',loopj30unt+1), 'l_cleft_tox' );
save (sprintf('Elj3leftJ:ox_%i',Ioopjx>unt+1), 'Eljoleftjox' );
save (sprintf('E_dead_cleft_toxj%i',loop_count+1), 'E_dead_cleft_tox' );
save (sprintf('molecule_E_cleft_toxjyoi,lloop_count+1), 'molecule_E_cleft_tox');
save (sprintf('molecule_l_cleft_toxj%i,,loop_count+1), 'molecule_Lcleft_tox');
save (sprintf('moleculej=l_cleft_toxj%i',loop_count+1), 'molecule_EI_cleftj:ox');
save (sprintf('molecule_Ejdead_cleftJoxj%i',loopj;ount+1), 'moleculej=jdead_cleftj;ox');
%}

%
% Models the complete normal and inhibited chemistry in the neuromuscular junction;
% the model consists of a series of instantly and uniformly mixed
% volumes which share transport of Acetylcholine via 1D diffusion at
% each adjacent border
%
%The user inputs the degree of enzyme inhibition at which to run the
%simulation
% VOLUME 1
% f(t)
>A
%
%
% VOLUME 2 - 4 0

%

kD

% A —> @
%
%U1 U2 kE1 U3 kE2 U4 kE3 U2
% A + E <—> AE — > acE — > E + ChP
%
kE_1
%
% U2
U9 kl1
U10
% E + I <—>
El
%
% U10 k_dead
U11
% El
-> E dead

%
% VOLUME 41 - 50
%U1 U5 2*kR1
U6
%A + R <
> AR
%
kRJ
%
%U1 U5 kR2 U7
% A + AR <
> A2R
%
2*kR„2
%
% U7
oR
U8
%A2R
<
> A2R*
%
cR
%******* CHECKED FOR UNIT/DIMENSION CONSISTENCY ON 3/25/07, 17:45
*************************
%

clc;
clear;
A_inf = 0.0; % mmole/cmA3 = M
Mnf = 0.1*5.68e-4; % mrnole/cmA3 = M (the same concentration in blood as nitrogen at STP)

% total volume in the cleft
V_cleft = 3.93e-14; % ( crnA3 )
% the length of the cleft (width, or height)
L_cleft = 5.0e-6; % cm
% the radius of the cleft
R_cleft = 5.0e-5; % cm
% the number of equal axial disks
P = 1;
x_cleft = zeros(1 ,P)
% the number of annular rings per disk
Q = 20;
% number of coupled sub-volumes
S = P*Q
%thickness of each radial annulus
dr = R_cleft/Q; % cm
%thickness of each axial disk
dx = L_cleft/P; % cm
% area of the cleft edge
Area_edge = 2*pi*R_cleft*L_cleft; % cmA2
% axial direction vector
x = linspace(0.0, L_cleft, P+1);
%radial direction vector
r = linspace(0.0, R_cleft, Q);

% This loop assigns an x-value coordinate to the center of each well mixed
% axial disk
forj = 1:P
x_cleftO) = 0.5*(x(j) + xG+1));
end
x_cleft;
% create the "space", a 1-dimension vector that all the axial and radial volume points are mapped
% into
s = [1:S];
% axial diffusion constant (cmA2/ms)
D_x = 2.0e-6;
% radial diffusion constant for Ach (crnA2/ms)
D r = 0.90e-9; % 3.50e-9 cmA2/ms

% radial diffusion constant for the inhibitor
D_r_tox = D_r; %3.5e-9;
%number of time points
N=5000;
%time interval vector for the normal and inhibited reactions (ms, 1e-3 s)
t_0 = 0.0; t_f = 5.0; % ms
t = linspace(t_0, t_f, N);
tspan = [t];
%time interval vector for the diffusing toxin reaction
t_tox_0 = 0.0; t_tox_f = (3.0e+5); % ms, 5 minutes
tjox = linspace(t_tox_0, t_tox_f, N);
tspanjox = [t_tox];

% pulse parameters
t_on = 3.0; t_off = 4.50; %*THIS IS NOT THE TIME INTERVAL*
n_on = round((((t_on - t_0)/(t_f - t_0))*(length(t)-1)) + 1);
n_off = round((t_off - t_0)*(length(t) -1)/(t_f -1_0) + 1);
peak = round(0.5*(n_on + n_off));
spread = 20.0;
magnitude = 0.50;

% calculate the volume of each annulus
volume = zeros(1 ,Q); % ( cm A 3)
vol_frac = volume;
for i=1 :Q
volume(i) = ((2*i-1)/QA2)*pi*L_cleft*R_cleftA2;
vol_frac(i) = volume(i)/V_cleft;
end
sum(volume(1:Q)); % a check of the annuli sum should equal the V__cleft
sum(vol_frac(1:Q));
V_cleft;
% creation of function handle
l_blood = @Func_l_blood_cocn;
% this computes the concentration of the inhibitor in the blood as a
% function of time
l_cocn = Func_l_blood_cocn( tspan_tox, I inf);

% defining the initial value vectors of the diffusing toxin reaction reactants
A_0_tox = zeros(1 ,S);
E_0_tox = zeros(1 ,S);
AE_0_tox = zeros(1 ,S);
acE_0_tox = zeros(1,S);
R_0_tox = zeros(1,S);

AR_0_tox = zeros(1 ,S);
A2R_0_tox = zeros(1 ,S);
A2Ro_0_tox = zeros(1 ,S);
l_0Jox = zeros(1,S);
El_0_tox = zeros(1 ,S);
E_dead_0_tox = zeros(1,S);
ChP_0_tox = zeros(1 ,S);
% defining the initial value vectors of the normal AP reaction reactants
A_0_n = zeros(1,S);
E_0_n = zeros(1 ,S);
AE_0_n = zeros(1,S);
acE_0_n = zeros(1 ,S);
R_0_n = zeros(1,S);
AR_0_n = zeros(1,S);
A2R_0_n = zeros(1 ,S);
A2Ro_0_n = zeros(1 ,S);
ChP_0_n = zeros(1,S);
% defining the initial value vectors of the inhibited AP reaction
% reactants,
A_0_i = zeros(1,S);
E_0J = zeros(1,S);
AE_0_i = zeros(1 ,S);
acE_0_i = zeros(1 ,S);
R_0_i = zeros(1 ,S);
AR_0_i = zeros(1 ,S);
A2R_0_i = zeros(1,S);
A2Ro_0_i = zeros(1,S);
l_0_i = zeros(1,S);
EI_0_i = zeros(1,S);
E_dead_0_i = zeros(1 ,S);
ChP_0_i = zeros(1 ,S);

factor_R= 1.0;
standard_R = 6.64e-4; %mmole/cmA3 Friboulet, Wathey (2.0e-3, Naka, et al)
factor_E_tox = 1.0;
standard_E_tox = 7.4e-5; %mmole/cmA3 (Naka, et al)
% Toxin diffusion reaction initial cleft values of A, E, R in mM
A_0_tox(1,1) =
0.0; % in mM (10 annuli is used as the control reference)
E_0_tox(1,:) =
factor_E_tox*standard_E_tox; % in mM
R_0_tox(1,:) =
factor_R*standard_R; % in mM
% Toxin diffusion reaction initial value vector
W0 = [A_0_tox ... A ( V(1)-V(Q))
E_0_tox ... E ( V(Q+1) - V(2Q))
AE_0_tox ...AE (V(2Q+1)-V(3Q))
acEJMox ... acE ( V(3Q+1) - V(4Q0))
R_0_tox ... R ( V(4Q+1) - V(5Q) )
AR_0_tox ... AR ( V(5Q+1) - V(6Q) )
A2R_0_tox ... A2R ( V(6Q+1) - V(7Q))
A2Ro_0_tox ... A2R* (V(7Q+1) - V(8Q))
l_0_tox ... I(V(8Q+1)-V(9Q))

ELOJQX ...EI(V(8Qt1) = V(10Q))
E_dead_0_tox ... E_dead ( V( 10Q+1) - V( 11Q))
ChP_0_tox...ChP(V(11Q+1)~V(12Q) )
];

E_tox = zeros(length(t), length(r)); % toxin diffusion enzyme reaction matrix
R_tox = zeros(length(t), length(r));% toxin diffusion receptor reaction matrix
IJox = zeros(length(t), length(r)); % toxin diffusion inhibitor of esterase
EI_tox = zeros(length(t), length(r)); % toxin diffusion enzyme-toxin reaction matrix
E_dead_tox = zeros(length(t), length(r)); %toxin diffusion poisoned enzyme reaction matrix

E_cleft_tox = zeros(N,1); % toxin diffusion reaction species
R_cleft_tox = zeros(N,1);
l_cleft_tox = zeros(N,1);
EI_cleft_tox = zeros(N,1);
E_dead_cleft_tox = zeros(N,1);
molecule_E_cleft_tox = zeros(N,1); % toxin diffusion reaction species
molecule_R_cleft_tox = zeros(N,1);
molecule_l_cleft_tox = zeros(N,1);
molecule_EI_cleft_tox = zeros(N,1);
molecule_E_dead_cleft_tox = zeros(N,1);

% run the diffusing toxin reaction function
[t_tox, W]= ode15s(@Func_Radial_toxin_kinetics_test, tspan_tox, WO, 0, D_x, D_r, D_r_tox, r,
dx, dr, t_on, t_off, l_blood, I j n f ) ;

for i = 1 :length(t) % time length vector
forj = 1:length(r) % radius length vector
E_tox(ij) = W(i,j+Q); % toxic diffusion reaction species
RJox(ij) = W(i,j+4*Q);
IJox(ij) = W(i,j+8*Q);
Eljox(ij) = W(i,j+9*Q);
E_dead_tox(i,j) = W(i,j+10*Q);
end
end
% calculate the total amounts of these species in the cleft
fori = 1:N
forj = 1:Q
E_cleft_tox(i) = E_cleft_tox(i) +(volumeG)*E_tox(i,j))A/_cleft; % toxin diffusion molar
species
R_cleft_tox(i) = R_cleft_tox(i) +(volume(j)*RJox(i,j))A/_cleft;

l_cleft_tox(i) = l_cleft_tox(i) +(volumeG)*l_tox(i,j))/V_cleft;
EI_cleft_tox(i) = EI_cieft_tox(i) +(volumeG)*EI_tox(i,j))/V_cleft;
E_dead_cleft_tox(i) = E_dead_cleft_tox(i) +(volume(j)*E_dead_tox(i,j))/V_cleft;
molecule_E_cleft_tox(i) = E_cleft_tox(i)*V_cleft*(6.02e+20); % toxin diffusion molecule
species
molecule_R_cleft_tox(i) = R_cleft_tox(i)*V_cleft*(6.02e+20);
molecule_l_cleft_tox(i) = l_cleft_tox(i)*V_cleft*(6.02e+20);
molecule_EI_cleft_tox(i) = EI_cleft_tox(i)*V_cleft*(6.02e+20);
molecule_E_dead_cleft_tox(i) = E_dead_cleft_tox(i)*V_cieft*(6.02e+20);
end
end
t j n l n = t_tox./(1000*60);
figure(1)
plot(t_min, E_dead_cleft_tox)
title(sprintf('Concentration of poisoned enzyme vs time \n VX kinetics and blood concentration of
%i mM\n initial active enzyme %i mM', l_inf, E_cleft_tox(1,1)));
xlabel('time, min'); ylabel('Poisoned Enzyme, mM');
figure(2)
E_tox_active_frac = 100*((E_0_tox(1,1 )-E_dead_cleft_tox)/E_0_tox(1,1));
plot(t_min, E_tox_active_frac)
title(sprintf('Percent enzyme active in cleft vs. time,\n with VX kinetics and blood concentration of
%-5.2e mM', (l_inf)));
xlabel('time, min'); ylabel('Percent active enzyme');
figure(1)
plot(tspan_tox./60000,l_cocn);
title('Blood concentration of nerve agent')
xlabel('time, min'); ylabel('lnhibitor blood concentration, mmole/cmA3');

% tolerance value
tol = 1.0e-7;
loop_count = 0;
choice = 1;
while(choice == 1)
E_i_active_percent = input('What percent active enzyme will be in the cleft during the inhibited
action potential reaction?\n');
E_initial_inhibited = (E_i_active_percent/100)*E_0_tox(1,1); % in mM
disp(sprintf('\n The initial amount of active enzyme in the cleft \n during the inhibited reaction is
%-5.2e mM', E_initial_inhibited));
toxjndex = find((E_cleft_tox >= EJnitialJnhibited - tol) & (E_cleft_tox <= E_initial_inhibited +
tol), 1);
disp(sprintf('\n The location of the time point index is % i ' , tox index));

disp(sprintf(\n This is equivalent to starting the action potential after %-5.2f minutes have passed
since exposure to the toxic inhibitor \n ', t_tox(tox_index)/(60000)));

E cleft tox";

factor_A = 1.5;
standard_A = 0.0423*((Q/10)A2); %( mmole/cmA3)
factor_E = 1.0;
standard_E = 7.4e-5; %(rnmole/cmA3) (Naka, et al)
% Normal AP reaction initial cleft values of A, E, R in mM
A_0_n(1,1) =
factor_A*standard_A; % in mM (10 annufi is used as the control reference)
E_0_n(1,:) =
factor_E*standard_E; % in mM
R_0_n(1,:) =
factor_R*standard_R; % in mM
%normal AP reaction initial value vector
U0 = [A_0_n ...A (U(1)-U(Q))
E_0_n ... E (U(Q+1)-U(2Q))
AE_0_n ... AE ( U(2Q+1) - U(3Q))
acE_0_n ... acE ( U(3Q+1) - U(4Q))
R_0_n
... R (U(4Q+1)-U(5Q))
AR_0_n ...AR ( U(5Q+1) - U(6Q))
A2R_0_n ...A2R ( U(6Q+1) - U(7Q))
A2Ro_0_n ... A2R* ( U(7Q+1)-U(8Q))
ChP_0_n ... ChP (U{8Q+1) - U(9Q))
];

% Inhibited AP reaction initial cleft values of A, E, R in mM
A_0_i(1,1) =
factor_A*standard_A; % in mM (10 annuli is used as the control reference)
E_0_i(1,:) =
E_tox(tox_index,:); % in mM
R_0_i(1,:) =
R_tox(tox_index,:); % in mM
l_0_i(1,:) =
l_tox(tox_index,:); % in mM
El_0_i(1,:)=
EI_tox(tox_index,:); % in mM
E_dead_0_i =
E_dead_tox(tox_index,:); % in mM
% Inhibited AP reaction initial value vector
V0 = [A_0_i ... A(V(1)-V(Q))
E_0_i ... E(V(Q+1)-V(2Q))
AE_0_i ...AE (V(2Q+1)-V(3Q))
acE_0_i ... acE ( V(3Q+1) - V(4Q0))
R_0_i
... R(V(4Q+1)-V(5Q))
AR_0_i ... AR ( V(5Q+1) - V(6Q))
A2R_0_i ... A2R ( V(6Q+1) - V(7Q))
A2Ro_0_i ... A2R*(V(7Q+1)-V(8Q))
l_0_i
... I(V(8Q+1)-V(9Q))
El_0_i ...EI(V(9Q+1)-V(10Q))
E_dead_0_i ... E_dead ( V( 10Q+1) - V( 11Q))
ChP_0_i... ChP(V(11Q+1)-V(12Q) )
];

78 ryn m normal enzyme mem function
[t,U] = ode15s(@Func_Radial_normal_kinetics_test, tspan, UO, rj, D_x, D_r, r, dx, dr, t_on, t_off);

% run the inhibited enzyme reaction function
[t,V] = ode15s(@Func_Radial_inhibited_kinetics_test, tspan, VO, Q, D_x, D_r, D_r_tox, r, dx, dr,
t_on, t_off);

% create the normal and inhibited reaction species concentration matrices as functions of r and t
A_n = zeros(length(t),length(r)); % norma! acetycholine reaction matrix
E_n = zeros(length(t), length(r)); % normal enzyme reaction matrix
AE_n = zeros(length(t), length(r));% normal enzyme-complex reaction matrix
acE_n = zeros(length(t), length(r));% normal acylated-enzyme reaction matrix
R_n = zeros(length(t), length(r));% normal receptor reaction matrix
AR_n = zeros(length(t), length(r));% normal single bound receptor reaction matrix
A2R_n = zeros(length(t), length(r));% normal double bound receptor reaction matrix
A2Ro_n = zeros(length(t), length(r));% normal open receptor reaction matrix
ChP_n = zeros(length(t), length(r));% normal choline/product reaction matrix
A j = zeros(length(t), length(r)); % inhibited acetycholine reaction matrix
E j = zeros(length(t), length(r)); % inhibited enzyme reaction matrix
A E j = zeros(length(t), length(r)); % inhibited enzyme-complex reaction matrix
acE_i = zeros(length(t), length(r)); % inhibited acylated-enzyme reaction matrix
R j = zeros(length(t), length(r));% inhibited receptor reaction matrix
A R j = zeros(length(t), length(r));% inhibited single bound receptor reaction matrix
A2R_i = zeros(length(t), length(r));% inhibited double bound receptor reaction matrix
A2Ro_i = zeros(length(t), length(r));% inhibited open receptor reaction matrix
I j = zeros(length(t), length(r)); % inhibitor of esterase
El_i = zeros(length(t), length(r)); % enzyme-toxin reaction matrix
E_dead_i = zeros(length(t), length(r)); % poisoned enzyme reaction matrix
ChPj = zeros(length(t), length(r)); % inhibited choline/product reaction matrix

for i = 1 :length(t) % time length vector
forj = 1:length(r) % radius length vector
A

_ n (ij) = U(i,j); % normal reaction species
E_n(i,j) = U(i,j+Q);
AE_n(i,j) = U(i,j+2*Q);
acE_n(i,j) = U(i,j+3*Q);
R_n(i,j) = U(i,j+4*Q);
AR_n(i,j) = U(i,j+5*Q);
A2R_n(i,j) = U(i,j+6*Q);
A2Ro_n(i,j) = U(i,j+7*Q);
ChP_n(i,j) = U(i,j+8*Q);
A

%
_i(i.j) = v (iJ);
inhibited reaction species
E_i(i,j) = V(ij+Q);
AE_i(i,j) = V(ij+2*Q);

acE_i(i j ) = V(i,j+3*Q);
R j f l j ) = V(i,j+4*Q);
AR_i(i,j) = V(i,j+5*Q);
A2Rj(i,j) = V(i,j+6*Q);
A2Ro_i(i,j) = V(i,j+7*Q);
l_i(i j) = V(i,j+8*Q);
E l j ( i j ) = V(i,j+9*Q);
E_dead_i(i,j) = V(i,j+10*Q);
ChPJ(ij) = V(ij+11*Q);
end
end

%2*pi*R_cleft*L_cleft*D_r/dr

% calculate the normal and inhibited Ach lost from the last annulus via diffusion
%[t, AJost] = ode15s(@AcetylcholineJost, tspan, A_n(1,14), [], D_r, dr, r);
%A_nJost=(D_r/(2*r(15)*dr))*(Ajnf-A_n(:l14))%cumtrapz(t,(2*pi*R_cleft*L_cleft*D_r/1e18)*A_n(:,Q));
%A_iJost = cumtrapz(t,(2*pi*R_cleft*L_clefl*D_r/1 e-18)*A_i(: ,Q));

% initialize the total concentration/molecules in the cleft vectors

A_cleft_n = zeros(N,1);% normal reaction species
E_cleft_n = zeros(N,1);
AE_cleft_n = zeros(N,1);
acE_cleft_n = zeros(N,i);
R_cleft_n = zeros(N,1);
AR_cleft_n = zeros(N,1);
A2R_cleft_n = zeros(N,1);
A2Ro_cleft_n = zeros(N,1);
ChP_cleft_n = zeros(N,1);
molecule_A_cleft_n = zeros(N,1);% normal reaction species
molecule_E_cleft_n = zeros(N,1);
molecule_AE_cleft_n = zeros(N,1);
molecule_acE_cleft_n = zeros(N,1);
molecule_R_cleft_n = zeros(N,1);
molecule_AR_cleft_n = zeros(N,1);
molecule_A2R_cleft_n = zeros(N,1);

molecule A2Ro cleft n = 2§r8§(Ni1)i
molecule_ChP_cleft_n = zeros(N,1);
A_cleft_i = zeros(N,1); % inhibited reaction species
E_cleft_i = zeros(N,1);
AE_cleft_i = zeros(N,1);
a c E c l e f t i = zeros(N,1);
R_cleft_i = zeros(N,1);
AR_cleft_i = zeros(N,1);
A2R_cleft_i = zeros(N,1);
A2Ro_cleft_i = zeros(N,1);
l_cleft_i = zeros(N,1);
El_cleft_i = zeros(N,1);
E_dead_cleft_i = zeros(N,1);
ChP_cleft_i = zeros(N,1);
molecule_A_cleft_i = zeros(N,1);% inhibited reaction species
molecule_E_cleft_i = zeros(N,1);
molecule_AE_cleft_i = zeros(N,1);
molecule_acE_cleft_i = zeros(N,1);
molecule_R_cleft_i = zeros(N,1);
molecule_AR_cleft_i = zeros(N,1);
molecule_A2R_cleft_i = zeros(N,1);
molecule_A2Ro_cleft_i = zeros(N,1);
molecule_l_cleft_i = zeros(N,1);
molecule_EI_cleft_i = zeros(N,1);
molecule_E_dead_cleft_i = zeros(N,1);
molecule_ChP_cleft_i = zeros(N,1);
%{
%Species names
species_names = t'A,!,E,,,AE^'acE,,,RVAR','A2R,,,A2R*^T,'E^,lE„dead•,'ChP,!'AJost,];
species__names(1)
species_names(2)
%}
% calculate the total amounts of these species in the cleft
fori = 1:N
for j = 1:Q
A_cleft_n(i) = A_cleft_n(i) +(volumeG)*A_n(ij))A/_cleft; %normal molar species
E_cleft_n(i) = E_cleft_n(i) +(volume(j)*E_n(i,j))A/_cleft;
AE_cleft_n(i) = AE_cleft_n(i) +(volumeO)*AE_n(i,j))/V_cleft;
acE_cleft_n(i) = acE_cleft_n(i) +(volume(j)*acE_n(ij))A/_cleft;
R_cleft_n(i) = R_cleft_n(i) +(volumeG)*R_n(i,j))/V_cleft;
AR_cleft_n(i) = AR_cleft_n(i) +(volumeG)*AR_n(i,j))A/_cleft;
A2R_cleft_n(i) = A2R_cleft_n(i) +(volumeG)*A2R_n(i j))A/_cleft;
A2Ro_cleft_n(i) = A2Ro_cleft_n(i) +(volume(j)*A2Ro_n(ij))/V_cleft;
ChP_cleft_n(i) = ChP_cleft_n(i) +(volume(j)*ChP_n(i,j))A/_cleft;
A_cleft_i(i) = A_cleft_i(i) +(volume(j)*A_i(i,j))A/_cleft; % inhibited molar species
E_cleft_i(i) = E_cleft_i(i) +(volume(j)*E_i(i,j))A/_cleft;
AE_cleft_i(i) = AE_cleft_i(i) +(Volume{jrAE_i(i,j))A/_cleft;
acE_cleft_i(i) = acE_cleft_i(i) +(volumeO)*acE_i(i,j))A/_cleft;
R_cleft_i(i) = R_cleft_i(i) +(volumeO)*R_i(i,j))A/_cleft;

AR_cleft_i(i) = AR_cleft_i(i) +(volume(j)*AR_i(i,j))A/_cleft;
A2R_cleft_i(i) = A2R_cleft_i(i) +(volumeO)*A2R_i(i,j))/V_cleft;
A2Ro_cleft_i(i) = A2Ro_cleft_i(i) +(volumeG)*A2Ro_i(i,j))A/_cleft;
l_cleft_i(i) = l_cleft_i(i) +(volumeG)*l_i(i,j))A/_cleft;
El_cleft_i(i) = El_cleft_i(i) +(volumeG)*EI_i(i,j))/V_cleft;
E_dead_cleft_i(i) = E_dead_cleft_i(i) +(volumeG)*E_dead_i(i,j))A/_cleft;
ChP_cleft_i(i) = ChP_cleft_i(i) +(volume(j)*ChP_i(i,j))A/_cleft;

molecule_A_cleft_n(i) = A_cleft_n(i)*V_cleft*(6.02e+20);
%normal molecule species
molecule_E_cleft_n(i) = E_cleft_n(i)*V_cleft*(6.02e+20);
molecule_AE_cleft_n(i) = AE_cleft_n(i)*V_cleft*(6.02e+20);
molecule_acE_cleft_n(i) = acE_cleft_n(i)*V_cleft*(6.02e+20);
molecule_R_cleft_n(i) = R_cleft_n(i)*V_cleft*(6.02e+20);
molecule_AR_cleft_n(i) = AR_cleft_n(i)*V_cleft*(6.02e+20);
molecule_A2R_cleft_n(i) = A2R_cleft_n(i)*V_cleft*(6.02e+20);
molecule_A2Ro_cleft_n(i) = A2Ro_cleft_n(i)*V_cleft*(6.02e+20);
molecule_ChP_cleft_n(i) = ChP_cleft_n(i)*V_cleft*(6.02e+20);
molecule_A_cleft_i(i) = A_cleft_i(i)*V_cleft*(6.02e+20);
%inhibited molecule species
molecule_E_cleft_i(i) = E_cleftj(i)*V_cleft*(6.02e+20);
molecule_AE_cleft_i(i) = AE_cleft_i(i)*V_cleft*(6.02e+20);
molecule_acE_cleft_i(i) = acE_cleft_i(i)*V_cleft*(6.02e+20);
molecule_R_cleft_i(i) = R__cleft_i(i)*V_cleft*(6.02e+20);
molecule_AR_cleft_i(i) = AR_cleft_i(i)*V_cleft*(6.02e+20);
molecule_A2R_cleft_i(i) = A2R_cleft_i(i)*V_cleft*(6.02e+20);
molecule_A2Ro_cleft_i(i) = A2Ro_cleft_i(i)*V_cleft*(6.02e+20);
molecule_l_cleft_i(i) = l_cleft_i(i)*V_cleft*(6.02e+20);
molecule_EI_cleft_i(i) = EI_cleft_i(i)*V_cleft*(6.02e+20);
molecule_E_dead_cleft_i(i) = E_dead_cleft_i(i)*V_cleft*(6.02e+20);
molecule_ChP_cleft_i(i) = ChP_cleft_i(i)*V_cleft*(6.02e+20);
end
end
figure(3)
plot( t, molecule_A2Ro_cleft_n(:),t,molecule_A2Ro_cleft_i(:)); hold on;
ylabel('molecules of open receptor');xlabel('t, ms');
title(sprintf(Total molecules of open receptor species A2R* in the whole cleft,\ri at 0, 25, 50, 75,
and 100 percent enzyme inhibition,\n averaged over %i annular volume elements,\n D_r = %5.2e cmA2/ms, %-5.2f X quantum A',Q, D_r, factor_A));%
%{
figure(4*loop_count + 2)
plot( t{:), molecule_A___cleft__n(:),t(:),molecule__A_cleftj(:));
ylabel('molecules of Acetylchoiine'^xlabelCt ms');
title(sprintf('Total molecules of acetylcholine species A in the whole cleft,\n norm and inhibited,
averaged over %i annular volume elements,\n %-5.2f percent active enzyme; D_r = %-5.2e
cmA2/ms\n %-5.2f X quantum A',Q, Ej_active_percent,D__r,factor_A));%
figure(4*loop_count + 3)
plot( t, molecule_E_cleft_n(:),t,molecu!e_E_cleftj(;));
ylabel('molecules of Acetylcholinesterase');xlabel('t, ms');

title(sprintf(Total molecules of acetylcholinesterase species E in the whole cleft,\n norm and
inhibited, averaged over %i annular volume elementsAn %-5.2f percent active enzyme; D_r = %5.2e cmA2/ms\n %-5.2f X quantum A',Q, Ej_active_percent,D_r,factor_A));%
figure(4*loop__count + 4)
plot( t j o x , molecule„E_cleft_tox(:));
ylabel('molecules of Acetylcholinesterase');xlabel('t, ms');
title(sprintf(Total molecules of acetylcholinesterase species E in the whole cleft,\n averaged over
%i annular volume elementsAn %-5.2f percent active enzyme; D_r = %-5.2e cmA2/ms\n %-5.2f X
quantum A',Q, E_i_active_percent,D_r,factor_A));%
%}
loop_count = loop_count+1;
choice = input('Do you want to run another inhibited reaction: 1(yes), 0(no)? \n');
end

% save the species concentration data to data files
save U U; save V V; save W W;
save A_0_n A_0_n; save A_0_i A_0_j; save E_0_j E_0_i;
save E_0_tox E_0_tox;
save A_n A_n; save E_n E_n; save AE_n AE_n; save acE_n acE_n; save R_n R_n; save AR_n
AR_n; save A2R_n A2R_n;
save A2Ro_n A2Ro_n; save ChP_n ChP_n; %save A_n_lost A_n_lost;
save A j A_i; save E_i E_i; save A E j A E j ; save acE__i a c E j ; save EM EM; save E_dead_i
E_dead_j; save R_i R_i;
save A R j A R j ; save A2R_i A2R_i; save A2Ro_i A2Ro_i; save M M; save C h P j C h P j ; %save
AJJost A_i__lost;
save A_cleft_n A__cleft__n; save E__cleft_n E__cleft_n;
save AE_cleft_n AE_cleft_n; save acE_cleftmn acE__cleft__n; save R_cleft_n R_cleft„n;
save AR_cleft__n AR„cleft_n; save A2R_cleft_n A2R_cleft_n;
save A2Ro_cleft_n A2Ro_cleft_n; save ChP_cleft_n ChP_cleft_n;
save A_cleft_i A_cleft_i; save E_cleft_i E_cleft_i; save AE__cleft_i AE_cleft_i;
save acE_cleft_i acE__cleft_i; save R_cleft_i R_cleft__i; save AR_cleftj AR_cieft_i;
save A2R_cleft_i A2R_cleft_i; save A2Ro_cleft_i A2Ro_cleft_i; save l_cleft_i l_cleft_i;
save El_cleft_i El_cleft_i; save E_dead_cleft_i E__dead_cleft_i;
save ChP_cleft„i ChP_cleft_i;
save molecule_A_cleft_n molecule_A_cleft_n;
save molecule_E_cleft_n moiecule_E_cleft_n;
save molecule_AE__cleft_n molecule_AE_cleft_n;
save molecule__acE__cleft__n molecule__acE_cleft_n;
save molecule_R__cleft_n molecule_R_cleft_n;
save molecule_AR_cleft_n molecule_AR_cleft_n;
save molecule_A2R_cleft_n molecule_A2R_cleft_n;
save molecule_A2Ro_cleft_n molecule_A2Ro_cleft_n;
save molecule_ChP_cleft_n molecule_ChP_cleft_n;
save molecule_A_cleft_i molecule_A_cleft_i;
save molecule_E_cleftj molecule_E_cleft_i;

save
save
save
save
save
save
save
save
save
save

molecule_AE_cleft_i molecule_AE_cleft_i;
molecule_acE_cleft_i molecule_acE__cleft_i;
molecule_R_cleft_i moleculeJR__cleftJ;
molecule_AR_cleft_i molecule_AR_cleft_i;
molecule_A2R_cleft_i molecule_A2R_cleft_i;
molecuie_A2Ro_cleft_i molecuie_A2Ro_cleft_i;
moleculeJ_cleft_i moleculeJ_cleft_J;
molecule_El_cleft_i molecule_EI__c!eft_i;
molecule_E_dead_cleft_i molecule_E__dead_cleft_i;
molecule_ChP_cleft_i molecule_ChP_cleft_i;

save
save
save
save
save

E_cleft_tox E_cleft_tox;
R_cleft_tox R_cleft_tox;
l_cleft_tox l__cleft_tox;
EI_cleft_tox EI__cleft_tox;
E_dead_cleft_tox E_dead_cleft_tox;

save
save
save
save
save

rnolecule_E_cleft_tox molecule_E_cleft_tox;
molecule_R_cleft__tox molecule_R_cleft__tox;
molecule_l__cleft_tox mo!ecule_l_cleft_tox;
molecule_EI_cleft_tox molecule_EI_cleft_tox;
molecule_E_dead_cleft_tox molecule_E_dead_cleft_tox;

save r r; save D_r D__r; save dr dr;
save 11; save t_tox t_tox;
save N N; save Q Q;
save volume volume;
save Mnf IJnf;
disp('latest data saved, program finished');
%{
figure{2)
plot(t,AJost);
ylabel('normal Ach, mM');xlabel('t, ms');
title(sprintf('Molar normal Ach lost via diffusion, in the whole cleflAn averaged over %i annular
volume elements',Q));%
figure(1)
surf(t, r, A_n')
shading flat
title(sprintf('Species A in pure radial diffusion and reaction through %i volume elements', Q));
xlabel('time, ms'); ylabel('radius, cm'); zlabel(* concentration, mmoie/cmA3');
AJost
%A_balance =
sum(U(:,1:10))+sum(U(:,21:30))+sum(U(:,51:60))+sum(U(:,61:70))+sum(U(:,71:80))
%}
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The parameters for the exponential decay approximations used in the error comparison

Naka

#1

#2

#3

#4

#5

y = al*exp(-a2*t)

t

R

lnt

InR

2

118

0.693 4.77

1.2

500

0.182 6.215

0.64

1250 -0.446 7.131

2

174

0.693 5.159

2.5

153

0.916 5.03

0.55

1500 -0.598 7.313

0.75

1500 -0.288 7.313

3.5

125

0.85

1759 -0.162 7.472

4.5

334

al* 10"3

a2* 10"3

4.3699

0.00018

3.1621

0.0015

2.8553

0.0012

2.9534

0.0009

2.5884

0.0005

3.046

0.0018

1.194 4.828

1.504 5.811

Fribulet

#1

0.5

1257 -0.693 7.136

3.0

15

1.10

2.708

170

#2

#3

#4

#5

0.5

1529 -0.693 7.332

3.0

50

0.5

1676 -0.693 7.424

4.0

30

1.386 3.401

0.5

1853

-0.693 7.524

5.0

88

1.609 4.477

1.0

1800 -0.693 7.495

6.5

345

1.10

3.029

0.0014

2.9771

0.0011

2.5982

0.0007

2.4333

0.0003

3.912

1.872 5.843
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